data_2dnn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2dnn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.779 0.241 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.498 ' O ' ' CE ' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.498 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.482 ' CZ ' HG23 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.477 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.482 HG23 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.48 ' CH2' ' HB2' ' A' ' 279' ' ' LYS . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.767 0.236 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.466 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.491 ' O ' ' CE ' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . 0.435 ' ND2' ' H ' ' A' ' 248' ' ' ASN . 0.2 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.511 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 260' ' ' ASP . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.459 ' N ' HG11 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.545 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.511 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.49 HD13 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.49 ' CE1' HD13 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.406 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.418 ' O ' ' CG ' ' A' ' 232' ' ' ASP . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.427 ' HB3' ' CD2' ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.811 0.254 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.483 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.483 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.453 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . 0.453 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.443 ' CA ' ' HE2' ' A' ' 241' ' ' MET . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.56 HD12 ' CE3' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 280' ' ' PHE . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 278' ' ' VAL . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.497 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 301' ' ' TYR . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 296' ' ' LEU . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.56 ' CE3' HD12 ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.781 0.242 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.581 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' NH1' ' A' ' 292' ' ' ARG . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . 0.411 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.413 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 260' ' ' ASP . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.411 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.581 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.402 ' NH1' HD12 ' A' ' 257' ' ' LEU . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 309' ' ' GLU . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.2 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.787 0.244 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.557 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.468 ' CG1' HD23 ' A' ' 290' ' ' LEU . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.479 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.468 HD23 ' CG1' ' A' ' 236' ' ' VAL . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.473 HD23 ' CE1' ' A' ' 301' ' ' TYR . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 296' ' ' LEU . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.774 0.239 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 283' ' ' PRO . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.401 HD22 ' CB ' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 235' ' ' TYR . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.53 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.443 ' N ' HD21 ' A' ' 234' ' ' LEU . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.465 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.401 ' CB ' HD22 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.783 0.243 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.462 ' CG1' HD23 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.432 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.405 ' C ' HG22 ' A' ' 262' ' ' VAL . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.405 HG22 ' C ' ' A' ' 261' ' ' ALA . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.442 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.442 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.452 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.432 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.462 HD23 ' CG1' ' A' ' 236' ' ' VAL . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.416 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.791 0.246 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.402 ' CB ' HD22 ' A' ' 277' ' ' LEU . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.563 ' CD1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 260' ' ' ASP . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.402 HD22 ' CB ' ' A' ' 237' ' ' SER . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.449 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.563 ' HB1' ' CD1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.493 HG23 ' CE2' ' A' ' 253' ' ' PHE . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.23 0.117 0 CA-C-O 120.829 0.262 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.534 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.527 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.453 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.827 0.261 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t60 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 260' ' ' ASP . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.453 ' N ' HG11 ' A' ' 259' ' ' VAL . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 262' ' ' VAL . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 261' ' ' ALA . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.481 ' O ' ' CG2' ' A' ' 278' ' ' VAL . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 280' ' ' PHE . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 236' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.403 ' CD1' HD22 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 289' ' ' ALA . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 311' ' ' GLN . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 308' ' ' THR . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.476 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 311' ' ' GLN . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.753 0.231 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.436 ' O ' ' CE ' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.54 ' CD1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 260' ' ' ASP . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 259' ' ' VAL . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 263' ' ' HIS . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.423 ' N ' HG11 ' A' ' 262' ' ' VAL . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.473 HG13 ' CZ ' ' A' ' 280' ' ' PHE . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 278' ' ' VAL . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.429 ' N ' HG21 ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.471 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 301' ' ' TYR . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.409 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.447 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.735 0.223 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.491 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.463 ' CG1' HD22 ' A' ' 290' ' ' LEU . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.459 ' O ' ' CE ' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.459 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.441 ' CG1' HG12 ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . 0.421 ' CD2' ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 260' ' ' ASP . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.402 ' N ' HG11 ' A' ' 262' ' ' VAL . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.412 ' CA ' ' HE1' ' A' ' 241' ' ' MET . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.559 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.426 ' CD2' ' HB2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.463 HD22 ' CG1' ' A' ' 236' ' ' VAL . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.453 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.422 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.81 0.254 . . . . 0.0 112.4 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.409 HD11 ' NZ ' ' A' ' 279' ' ' LYS . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.535 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.42 HG21 ' NH1' ' A' ' 251' ' ' ARG . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.523 ' CD2' ' HB1' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.409 ' NZ ' HD11 ' A' ' 234' ' ' LEU . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 280' ' ' PHE . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.535 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' A' ' 301' ' ' TYR . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 296' ' ' LEU . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 263' ' ' HIS . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.813 0.256 . . . . 0.0 112.397 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.509 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.401 ' O ' ' CE ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.401 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 246' ' ' MET . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . 0.422 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . 0.446 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.567 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.567 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . 0.422 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.447 ' HB3' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.466 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.463 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 299' ' ' GLN . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . 0.466 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.805 0.252 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 231' ' ' PRO . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.516 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.551 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . 0.419 HG12 ' CG2' ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.414 ' C ' HG23 ' A' ' 278' ' ' VAL . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 277' ' ' LEU . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.551 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.402 ' CE3' HD12 ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.756 0.232 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.569 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.569 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.411 ' CE3' ' HB3' ' A' ' 277' ' ' LEU . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.802 0.251 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.561 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.504 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.458 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.436 ' CD1' ' OD1' ' A' ' 275' ' ' ASN . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' CD1' ' A' ' 265' ' ' LEU . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.46 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 279' ' ' LYS . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.444 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.444 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' MET . . . . . 0.458 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.747 0.228 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.544 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.453 ' HB2' ' CD2' ' A' ' 277' ' ' LEU . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 260' ' ' ASP . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.491 HD13 ' CE3' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . 0.455 ' N ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.442 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.457 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.457 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.477 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.491 ' CE3' HD13 ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.748 0.228 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' SER . . . . . 0.408 ' CB ' HD21 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t60 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.572 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.47 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.646 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.47 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . 0.443 ' ND2' ' HE ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.443 ' HE ' ' ND2' ' A' ' 293' ' ' ASN . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.461 ' O ' ' CG ' ' A' ' 299' ' ' GLN . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.478 ' CE1' HD13 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.8 0.25 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 231' ' ' PRO . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' VAL . . . . . 0.496 ' O ' ' CE ' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' MET . . . . . 0.496 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' PHE . . . . . 0.474 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 260' ' ' ASP . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 259' ' ' VAL . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' GLY . . . . . 0.445 ' N ' ' HE3' ' A' ' 241' ' ' MET . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' VAL . . . . . 0.564 HG12 ' CE2' ' A' ' 280' ' ' PHE . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 289' ' ' ALA . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' ALA . . . . . 0.579 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.461 ' HA ' ' CG1' ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' LEU . . . . . 0.514 HD23 ' CE1' ' A' ' 301' ' ' TYR . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' TYR . . . . . 0.514 ' CE1' HD23 ' A' ' 296' ' ' LEU . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' TRP . . . . . 0.47 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 47.8 t -170.45 146.13 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 110.825 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 8.6 t -169.44 146.0 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -94.07 161.78 24.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.8 m -115.32 96.82 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.9 t -119.9 96.34 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -126.59 177.62 17.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -139.03 153.49 71.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.689 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.31 98.7 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 pp -122.81 153.93 63.71 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 229' ' ' ILE . 60.5 Cg_endo -74.35 147.79 37.52 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.729 2.286 . . . . 0.0 112.32 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 228' ' ' PRO . 45.8 mm -34.09 126.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -93.99 130.24 35.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo -46.04 -45.93 16.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.496 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.498 ' O ' ' CE ' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.498 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.482 ' CZ ' HG23 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.481 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -134.21 177.45 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.449 ' OD1' ' CG2' ' A' ' 269' ' ' VAL . 21.6 p30 -111.72 -175.05 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.434 ' CE1' ' CG1' ' A' ' 269' ' ' VAL . 4.2 p80 -52.16 -40.84 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.449 ' CG2' ' OD1' ' A' ' 267' ' ' ASP . 34.0 m -81.85 16.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 49.62 48.03 36.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 51.4 mtt180 -121.95 139.81 53.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.83 86.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -55.2 -52.48 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.96 55.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.569 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.496 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.569 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.481 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.473 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.485 ' CD ' ' O ' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.477 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.477 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.482 HG23 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.473 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.48 ' CH2' ' HB2' ' A' ' 279' ' ' LYS . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.44 46.35 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -94.48 -169.73 37.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -166.77 131.32 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.0 pt -145.24 151.71 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.6 p -96.39 109.39 21.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -59.79 -59.11 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.19 71.03 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.74 99.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.68 2.254 . . . . 0.0 112.371 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.6 t -111.37 152.66 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.8 m 61.37 43.37 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.0 m -90.17 148.13 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.58 144.98 8.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.9 m -137.38 157.03 47.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -87.41 161.18 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.403 ' C ' ' HD2' ' A' ' 225' ' ' LYS . . . -150.87 47.31 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.529 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.403 ' HD2' ' C ' ' A' ' 224' ' ' GLY . 10.9 mptt -135.26 146.08 56.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.39 92.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.264 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 pp -121.31 154.95 59.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.8 149.54 33.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.432 HG23 ' N ' ' A' ' 230' ' ' ASN . 77.0 mt -53.52 136.34 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.432 ' N ' HG23 ' A' ' 229' ' ' ILE . 7.3 t-20 -89.82 111.63 47.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.887 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -45.71 -62.87 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.64 2.226 . . . . 0.0 112.326 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.466 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.491 ' O ' ' CE ' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.491 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.435 ' H ' ' ND2' ' A' ' 248' ' ' ASN . 0.2 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.406 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.511 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.459 HG11 ' N ' ' A' ' 260' ' ' ASP . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.459 ' N ' HG11 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -132.63 138.17 47.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -49.75 169.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.422 ' CD2' ' H ' ' A' ' 269' ' ' VAL . 0.3 OUTLIER -46.76 -35.14 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.442 HG21 ' N ' ' A' ' 270' ' ' GLY . 19.0 m -85.03 -35.66 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.442 ' N ' HG21 ' A' ' 269' ' ' VAL . . . 125.43 30.8 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.419 ' HG3' ' CG2' ' A' ' 269' ' ' VAL . 31.5 mtp180 -101.6 128.58 47.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.905 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -54.45 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 271' ' ' ARG . 12.6 p-10 -59.01 -38.48 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 129.24 47.73 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.462 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.545 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.545 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.511 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.49 HD13 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.49 ' CE1' HD13 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.406 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.418 ' O ' ' CG ' ' A' ' 232' ' ' ASP . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.427 ' HB3' ' CD2' ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 124.12 48.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.39 -162.6 3.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 318' ' ' HIS . 0.5 OUTLIER -126.7 61.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.409 ' CD1' ' N ' ' A' ' 319' ' ' ILE . 0.2 OUTLIER -132.39 25.42 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 53.0 m -137.62 129.53 28.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.6 p -116.94 158.32 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -147.77 61.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.6 154.85 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.721 2.28 . . . . 0.0 112.302 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.0 m -139.95 169.63 17.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.1 m -131.23 -59.04 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.833 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.0 p -61.44 85.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.23 18.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.7 p -90.77 140.24 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.1 p -128.3 153.28 47.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.39 53.87 40.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -136.75 156.55 76.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.584 0.707 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.55 84.67 1.7 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 0.0 112.388 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.38 156.98 57.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.39 160.08 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.8 mm -84.32 122.77 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.464 ' ND2' ' HD2' ' A' ' 231' ' ' PRO . 24.7 t-20 -72.9 137.01 79.64 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.63 0.729 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.464 ' HD2' ' ND2' ' A' ' 230' ' ' ASN . 61.4 Cg_endo -77.46 -50.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.534 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.483 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.483 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.453 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.453 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.43 ' CD2' ' HB3' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -117.79 154.19 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.42 -176.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -29.98 66.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.34 -19.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.93 1.51 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -125.72 122.94 37.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 0.7 OUTLIER -63.87 90.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -56.58 -47.36 79.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 157.48 55.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.443 ' CA ' ' HE2' ' A' ' 241' ' ' MET . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.56 HD12 ' CE3' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.558 HG13 ' CZ ' ' A' ' 280' ' ' PHE . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.558 ' CZ ' HG13 ' A' ' 278' ' ' VAL . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.497 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.497 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.433 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.568 HD21 ' CE1' ' A' ' 301' ' ' TYR . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.568 ' CE1' HD21 ' A' ' 296' ' ' LEU . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.56 ' CE3' HD12 ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.43 ' HB3' ' CD2' ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 118.06 39.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -58.66 -155.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.463 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -169.81 106.16 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.747 0.308 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.5 pt -133.3 127.72 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.7 p -140.43 145.18 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 49.3 m 51.74 43.27 30.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -97.13 -176.38 34.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.9 117.98 4.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.622 2.215 . . . . 0.0 112.342 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -87.14 137.14 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.1 t 45.85 42.56 9.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.885 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.9 t -126.51 108.26 11.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 150.29 67.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.7 m -127.27 103.62 7.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.1 m -127.12 121.89 32.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.09 135.12 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.06 141.02 4.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.86 137.47 16.29 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 151.93 70.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.39 130.96 11.81 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.423 ' CG2' ' HG3' ' A' ' 283' ' ' PRO . 33.7 mt -51.67 144.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -100.42 106.37 42.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo -47.22 -52.5 7.76 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.581 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.402 HD12 ' NH1' ' A' ' 292' ' ' ARG . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.411 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.413 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -136.6 -175.04 3.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.27 -75.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 269' ' ' VAL . 5.1 p-80 -133.17 -56.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.446 ' H ' ' CG ' ' A' ' 268' ' ' HIS . 19.2 m -91.46 -34.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 143.3 52.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -110.2 148.02 32.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.05 87.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -59.41 -49.13 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 136.01 33.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.45 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.413 ' CD2' ' HB2' ' A' ' 260' ' ' ASP . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.423 ' HG3' ' CG2' ' A' ' 229' ' ' ILE . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.411 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.517 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.581 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.517 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.402 ' NH1' HD12 ' A' ' 257' ' ' LEU . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 309' ' ' GLU . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.45 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.66 41.33 0.5 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -93.54 173.57 34.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -159.27 118.41 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.728 0.299 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.408 ' N ' HD11 ' A' ' 319' ' ' ILE . 0.2 OUTLIER -133.76 156.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 321' ' ' SER . 9.1 t -99.52 45.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 320' ' ' THR . 24.3 t 36.96 46.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.37 160.96 30.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.67 148.0 2.68 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.7 m -57.66 -58.98 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 44.4 p -174.86 132.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 92.6 p -168.65 149.84 4.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -144.03 -174.02 15.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.6 t -74.01 152.36 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 87.8 p -139.71 164.32 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -133.45 -80.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -109.73 162.43 20.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.62 0.724 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.57 138.12 11.09 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.371 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.51 153.51 44.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.57 144.94 25.78 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.455 HG23 ' N ' ' A' ' 230' ' ' ASN . 79.8 mt -41.79 146.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.455 ' N ' HG23 ' A' ' 229' ' ' ILE . 6.7 t-20 -100.42 103.48 23.92 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.2 Cg_exo -42.72 -50.07 6.2 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.235 . . . . 0.0 112.381 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.557 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.468 ' CG1' HD23 ' A' ' 290' ' ' LEU . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.479 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -133.39 159.57 39.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.81 -175.04 0.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.413 ' NE2' HG13 ' A' ' 269' ' ' VAL . 0.3 OUTLIER -59.7 -30.54 68.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.413 HG13 ' NE2' ' A' ' 268' ' ' HIS . 25.6 m -91.9 -24.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 111.38 46.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -112.29 139.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -64.58 81.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -61.07 -53.43 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.24 43.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.526 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.442 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.481 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.557 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.481 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.55 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.479 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.468 HD23 ' CG1' ' A' ' 236' ' ' VAL . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.55 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.473 HD23 ' CE1' ' A' ' 301' ' ' TYR . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.473 ' CE1' HD23 ' A' ' 296' ' ' LEU . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.442 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.83 41.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -109.45 122.39 6.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -111.91 96.86 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -100.06 147.86 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 12.7 p -123.07 -4.63 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 95.2 p -90.03 112.97 24.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.83 88.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.2 -16.66 17.51 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.674 2.25 . . . . 0.0 112.341 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.2 t -75.69 124.56 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.0 m 51.06 36.31 15.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.4 p -73.79 165.78 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 132.1 -117.34 2.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.3 m 52.3 44.61 29.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 80.0 p -103.9 118.49 36.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.82 -47.65 0.8 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -134.37 146.51 59.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.03 108.65 2.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.82 152.3 74.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.731 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 163.48 37.41 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.6 mt -72.42 137.69 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.42 ' ND2' ' HB3' ' A' ' 232' ' ' ASP . 24.0 t30 -82.9 139.88 43.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.853 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo -79.56 -46.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.443 HD21 ' N ' ' A' ' 283' ' ' PRO . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.465 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.401 HD22 ' CB ' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -119.14 167.86 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.39 -177.06 4.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.425 ' CE1' HG13 ' A' ' 269' ' ' VAL . 6.8 p80 -61.84 -20.48 63.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.425 HG13 ' CE1' ' A' ' 268' ' ' HIS . 3.3 m -97.26 -8.25 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 86.51 41.42 6.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.9 ptt85 -127.22 142.19 51.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.912 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -58.53 123.6 16.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.25 -40.33 10.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . 135.05 46.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.46 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 235' ' ' TYR . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.53 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.443 ' N ' HD21 ' A' ' 234' ' ' LEU . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.47 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.465 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.47 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.461 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.401 ' CB ' HD22 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.04 38.17 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.55 152.82 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.85 110.55 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 320' ' ' THR . 2.2 pp -133.52 -40.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 319' ' ' ILE . 0.5 OUTLIER 32.92 54.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.8 t -122.26 103.81 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 177.23 140.2 3.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 126.23 11.72 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.728 2.285 . . . . 0.0 112.31 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 18.7 t -123.06 79.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.5 m -152.84 144.24 23.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.4 m -153.8 117.6 4.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.817 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.46 129.11 3.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.1 m -166.26 172.02 11.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.853 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -144.31 152.04 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -117.71 55.81 0.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -138.21 158.81 70.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 102.47 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.248 . . . . 0.0 112.344 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.8 mt -121.13 154.07 58.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.667 0.746 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.63 160.47 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.369 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 27.1 mt -58.42 133.54 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.11 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -94.11 110.74 49.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.74 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.64 -47.16 21.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.71 2.273 . . . . 0.0 112.37 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.462 ' CG1' HD23 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.432 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.405 ' C ' HG22 ' A' ' 262' ' ' VAL . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.405 HG22 ' C ' ' A' ' 261' ' ' ALA . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -125.64 168.02 14.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.78 -175.76 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.475 ' CD2' HG13 ' A' ' 269' ' ' VAL . 0.3 OUTLIER -54.15 -33.21 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 268' ' ' HIS . 17.6 m -95.77 21.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 60.75 40.4 98.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.471 ' CG ' HG21 ' A' ' 269' ' ' VAL . 14.1 mmt180 -123.52 137.71 54.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.67 119.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.2 -44.72 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.72 41.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.416 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.442 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.442 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.452 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.432 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.462 HD23 ' CG1' ' A' ' 236' ' ' VAL . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.452 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.459 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.416 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.7 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.11 178.45 53.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.521 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -129.81 92.6 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.507 ' N ' ' CD1' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -140.57 161.09 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.08 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.2 m -129.84 145.65 51.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 46.0 t -93.02 142.35 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.18 144.8 13.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.83 116.57 3.77 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.308 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 53.7 p -110.3 121.7 45.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 51.1 p -101.38 104.63 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 t 38.66 45.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.53 51.15 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.5 m -138.67 131.35 29.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.7 m -120.38 139.09 53.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 225' ' ' LYS . . . 103.6 -114.05 4.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.467 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 224' ' ' GLY . 55.3 mttp -33.55 96.9 0.11 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 224' ' ' GLY . 61.2 Cg_endo -75.43 79.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -52.15 153.23 5.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.729 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 148.26 33.77 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.346 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.442 HG22 ' N ' ' A' ' 230' ' ' ASN . 19.6 mt -40.14 137.83 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 229' ' ' ILE . 3.7 t-20 -94.62 108.67 38.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -43.51 -48.1 8.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.361 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.413 ' O ' ' N ' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.402 ' CB ' HD22 ' A' ' 277' ' ' LEU . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.551 ' N ' ' CD1' ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.494 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.563 ' CD1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.414 HG12 ' N ' ' A' ' 260' ' ' ASP . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.439 ' O ' ' ND2' ' A' ' 273' ' ' ASN . 10.6 mmtp -115.39 -177.52 3.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -117.38 -179.82 3.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 5.8 p-80 -45.93 -48.63 16.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.1 m -74.94 -17.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.09 30.28 6.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -121.74 146.02 47.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -51.44 113.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 266' ' ' LYS . 4.5 p30 -87.78 -51.35 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 151.48 46.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.532 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.402 HD22 ' CB ' ' A' ' 237' ' ' SER . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.51 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.439 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.51 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.449 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.563 ' HB1' ' CD1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.449 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.493 HG23 ' CE2' ' A' ' 253' ' ' PHE . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . . . . . . . . . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 132.95 39.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -92.81 -173.22 41.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.469 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -143.64 111.02 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.55 144.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 15.1 t -154.47 149.44 26.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.9 t -111.32 92.51 4.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 160.91 145.89 4.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.52 -51.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 63.8 m -143.28 175.64 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 36.5 m -157.0 150.41 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 110.906 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -164.34 156.65 16.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 151.99 137.62 2.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.0 t -163.36 149.98 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.4 p -170.75 146.61 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.41 24.64 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -90.0 155.0 47.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.46 105.66 2.12 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.6 mt -146.29 158.5 47.5 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.91 145.46 2.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.432 ' CG2' ' HG3' ' A' ' 283' ' ' PRO . 55.3 mt -48.87 121.69 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -81.49 124.21 80.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.23 -25.35 4.46 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.534 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -105.72 165.54 11.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.498 ' OD1' ' N ' ' A' ' 270' ' ' GLY . 6.6 p-10 -104.45 -174.9 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -25.84 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.416 ' CG2' ' OD2' ' A' ' 267' ' ' ASP . 27.7 m -115.22 25.03 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 267' ' ' ASP . . . 79.49 -40.97 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.487 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 61.2 mtp180 -40.87 152.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -71.65 114.26 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -53.99 25.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.57 36.83 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.453 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.541 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.534 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.541 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.432 ' HG3' ' CG2' ' A' ' 229' ' ' ILE . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.527 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.471 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.453 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 119.92 36.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.38 177.2 5.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -111.38 100.1 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.62 115.67 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.6 t -169.62 142.05 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.7 m -57.23 176.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.96 96.46 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.84 166.72 28.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 77.5 p -89.78 -10.95 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.826 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.8 t -105.62 161.91 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.2 t -62.19 -54.56 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 147.24 162.73 10.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.482 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.0 m -51.84 111.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.1 m -157.57 128.88 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.43 75.79 1.09 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.58 143.44 10.79 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.919 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.01 82.62 2.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 46.1 mt -139.42 154.04 71.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.583 0.706 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.96 134.0 10.82 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.429 ' CG2' ' HG3' ' A' ' 283' ' ' PRO . 90.2 mt -49.04 127.02 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -79.69 139.08 54.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.74 -52.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.37 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.467 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.466 ' CG1' HD22 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.433 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t60 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.453 HG11 ' N ' ' A' ' 260' ' ' ASP . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.453 ' N ' HG11 ' A' ' 259' ' ' VAL . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . 0.422 ' C ' HG23 ' A' ' 262' ' ' VAL . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.422 HG23 ' C ' ' A' ' 261' ' ' ALA . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -144.23 172.74 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.03 -175.68 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.53 ' C ' ' CD2' ' A' ' 268' ' ' HIS . 0.7 OUTLIER -50.41 -55.07 17.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.86 -31.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 130.14 47.06 0.15 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -102.44 150.92 22.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.94 54.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -37.31 -35.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 106.69 48.4 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.481 ' O ' ' CG2' ' A' ' 278' ' ' VAL . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 280' ' ' PHE . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.429 ' HG3' ' CG2' ' A' ' 229' ' ' ILE . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.433 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.466 HD22 ' CG1' ' A' ' 236' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.403 HD22 ' CD1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.403 ' CD1' HD22 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.416 HG13 ' C ' ' A' ' 289' ' ' ALA . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.431 ' O ' ' N ' ' A' ' 311' ' ' GLN . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 308' ' ' THR . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.476 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 311' ' ' GLN . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.04 29.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -65.47 -157.44 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -170.46 116.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 110.827 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.54 141.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 10.4 t -172.92 145.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.193 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 97.0 p -73.19 156.14 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.73 90.1 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.66 -21.51 12.8 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.712 2.274 . . . . 0.0 112.369 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 17.1 t 45.48 41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.835 -179.849 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.0 t -171.54 158.37 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 31.8 p -166.44 142.95 4.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.76 115.88 1.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 24.0 m -161.67 134.03 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 t -171.0 149.06 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 147.56 159.28 8.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -141.75 142.99 27.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.99 89.42 1.37 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.1 mt -135.66 155.79 77.97 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.661 0.743 . . . . 0.0 110.925 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.33 143.64 5.24 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 mt -76.61 130.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -95.9 109.05 44.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.86 -56.07 3.13 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.55 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.458 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.436 ' O ' ' CE ' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.436 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.54 ' CD1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 260' ' ' ASP . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 259' ' ' VAL . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.423 HG11 ' N ' ' A' ' 263' ' ' HIS . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.423 ' N ' HG11 ' A' ' 262' ' ' VAL . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -121.35 154.27 36.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -102.54 -174.61 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.476 ' C ' ' CD2' ' A' ' 268' ' ' HIS . 1.6 t-160 -33.69 -66.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 32.4 m -76.35 -44.02 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 148.25 -17.51 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.5 ' N ' ' OD1' ' A' ' 267' ' ' ASP . 61.6 mtp180 -52.6 138.88 27.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -54.65 84.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 271' ' ' ARG . 7.7 p-10 -38.41 -54.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.55 37.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.473 HG13 ' CZ ' ' A' ' 280' ' ' PHE . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.55 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.473 ' CZ ' HG13 ' A' ' 278' ' ' VAL . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.429 HG21 ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.429 ' N ' HG21 ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.471 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.471 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 301' ' ' TYR . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' MET . . . . . 0.424 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.409 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.447 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.28 43.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.65 179.38 53.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -122.53 41.87 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.69 -7.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 28.1 m -134.63 126.54 29.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.9 p -134.51 148.49 50.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 118.88 145.92 7.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.56 40.4 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.678 2.252 . . . . 0.0 112.354 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 70.3 m -57.91 -49.13 77.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.3 t -150.36 152.16 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.1 m -155.25 150.17 26.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.54 -179.79 17.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -154.94 165.2 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.8 t -139.03 154.5 48.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.824 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.25 -145.95 4.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -60.09 153.02 58.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.92 113.78 3.79 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.9 mt -133.03 156.71 79.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' ILE . 72.0 Cg_exo -44.91 151.74 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' PRO . 49.5 mm -35.71 121.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.43 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 12.1 t-20 -67.94 112.58 11.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo -52.56 -51.59 10.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.491 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.463 ' CG1' HD22 ' A' ' 290' ' ' LEU . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.459 ' O ' ' CE ' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.459 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.441 ' CG1' HG12 ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.559 ' CD1' ' HB2' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . 0.421 ' CD2' ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.415 HG12 ' N ' ' A' ' 260' ' ' ASP . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.426 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.441 HG12 ' CG1' ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.402 ' N ' HG11 ' A' ' 262' ' ' VAL . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 273' ' ' ASN . 21.3 mmtp -134.3 177.39 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 271' ' ' ARG . 9.6 t0 -82.98 173.68 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -45.95 -37.44 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.439 HG22 ' N ' ' A' ' 270' ' ' GLY . 32.6 m -85.82 -44.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.439 ' N ' HG22 ' A' ' 269' ' ' VAL . . . 139.82 38.87 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 267' ' ' ASP . 67.1 mtt180 -122.24 146.49 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.72 100.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.403 ' ND2' ' C ' ' A' ' 266' ' ' LYS . 2.8 p30 -82.95 -44.07 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 139.02 45.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.412 ' CA ' ' HE1' ' A' ' 241' ' ' MET . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.559 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.491 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.559 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.426 ' CD2' ' HB2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.453 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.559 ' HB2' ' CD1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.463 HD22 ' CG1' ' A' ' 236' ' ' VAL . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.453 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.444 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.444 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.422 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.439 ' HB2' ' CD2' ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.47 47.81 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -79.42 -177.57 50.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -119.78 44.01 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 2.6 pp -88.83 165.28 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 19.7 m -163.93 148.98 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.3 m -95.93 42.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -121.9 90.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.447 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.14 150.02 28.95 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.646 2.23 . . . . 0.0 112.315 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.7 t -141.27 159.48 42.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 97.1 p -88.64 166.05 14.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.847 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.3 m -134.81 154.11 51.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -128.75 114.82 1.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -171.71 107.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.3 m -155.25 167.18 31.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.78 -83.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.462 ' HE3' ' N ' ' A' ' 225' ' ' LYS . 0.2 OUTLIER -55.15 162.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.937 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 140.21 21.76 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.35 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 158.72 55.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.66 129.59 9.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.716 2.278 . . . . 0.0 112.352 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 82.9 mt -76.11 126.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.54 102.54 19.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.625 0.726 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -41.89 -58.82 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.409 HD11 ' NZ ' ' A' ' 279' ' ' LYS . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.451 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.535 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.42 HG21 ' NH1' ' A' ' 251' ' ' ARG . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.523 ' CD2' ' HB1' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 154.86 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 268' ' ' HIS . 9.9 t70 -86.16 57.0 4.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' A' ' 267' ' ' ASP . 41.0 p-80 46.3 30.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.71 -31.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.08 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -138.29 144.15 40.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 15.0 m120 -63.36 115.81 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -100.65 -52.34 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 145.61 57.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.455 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.409 ' NZ ' HD11 ' A' ' 234' ' ' LEU . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CD1' ' N ' ' A' ' 280' ' ' PHE . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.535 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.417 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.551 HD22 ' CE1' ' A' ' 301' ' ' TYR . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' MET . . . . . 0.444 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.551 ' CE1' HD22 ' A' ' 296' ' ' LEU . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.451 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.523 ' HB1' ' CD2' ' A' ' 263' ' ' HIS . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 136.48 36.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.5 51.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -128.16 83.47 2.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 28.9 pt -152.86 152.18 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 47.0 p -74.7 116.82 15.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.9 p -85.89 -61.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.42 90.69 2.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.14 -174.35 2.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.4 t -147.59 155.08 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.3 t -161.55 166.17 27.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.2 m -165.76 166.03 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 128.46 173.25 13.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.4 t -127.4 147.96 50.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.9 m -94.61 159.05 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -167.15 48.82 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . 0.468 ' CD ' ' HD2' ' A' ' 226' ' ' PRO . 0.1 OUTLIER -130.0 137.68 31.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.854 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . 0.468 ' HD2' ' CD ' ' A' ' 225' ' ' LYS . 62.3 Cg_endo -77.08 107.17 2.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.27 . . . . 0.0 112.327 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.45 154.55 66.06 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' ILE . 61.0 Cg_endo -75.28 156.88 41.82 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.346 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 67.6 mt -37.22 134.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -84.66 112.95 46.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo -45.53 -49.71 10.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.638 2.225 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.509 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.401 ' O ' ' CE ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.401 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.442 ' C ' ' O ' ' A' ' 246' ' ' MET . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.455 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.447 ' CE1' ' HB3' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . 0.422 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . 0.446 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.457 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -134.61 176.4 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -80.45 179.82 7.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 9.3 p-80 -47.29 -42.76 21.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 270' ' ' GLY . 28.1 m -77.62 -42.37 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.126 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.411 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 131.11 38.49 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -115.13 123.5 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -51.02 112.83 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.457 ' H ' ' ND2' ' A' ' 273' ' ' ASN . 0.6 OUTLIER -91.48 -57.27 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 158.43 46.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.432 ' ND2' ' OD1' ' A' ' 273' ' ' ASN . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.46 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.567 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.509 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.567 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . 0.422 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.447 ' HB3' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.466 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.463 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.568 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.489 ' O ' ' CG ' ' A' ' 299' ' ' GLN . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.568 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . 0.466 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.06 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -67.83 -177.76 12.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 0.492 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 39.6 t60 -124.96 84.39 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 17.2 pt -123.72 166.45 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -155.98 169.86 23.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.2 t -110.68 95.24 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 166.43 166.35 25.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.439 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.83 116.94 4.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.636 2.224 . . . . 0.0 112.309 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.9 m -94.68 -59.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 57.5 p -128.72 -43.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 33.0 p -130.51 83.27 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.77 -142.15 7.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.7 p -174.87 130.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.846 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.9 p -111.34 141.41 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.98 -163.67 19.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -105.93 156.62 36.36 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.539 0.685 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.78 99.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.627 2.218 . . . . 0.0 112.338 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.66 157.59 51.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.863 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 155.32 37.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.6 mm -48.97 125.93 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 42.0 t-20 -89.77 111.36 45.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.621 0.724 . . . . 0.0 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo -44.37 -39.86 12.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.321 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD1' ' CG ' ' A' ' 230' ' ' ASN . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.516 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . . . . . . . . . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 272' ' ' ASN . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.459 ' O ' ' ND2' ' A' ' 272' ' ' ASN . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . 0.419 ' CG2' HG12 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.551 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . 0.419 HG12 ' CG2' ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -121.36 165.89 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 271' ' ' ARG . 1.0 OUTLIER -66.16 -175.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.911 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.566 ' CD2' HG12 ' A' ' 269' ' ' VAL . 25.9 p-80 -61.32 -32.17 72.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.566 HG12 ' CD2' ' A' ' 268' ' ' HIS . 34.7 m -87.41 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.452 ' N ' HG21 ' A' ' 269' ' ' VAL . . . 139.49 41.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.459 ' HG2' ' CG2' ' A' ' 269' ' ' VAL . 5.1 ptt85 -128.82 125.3 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.574 ' O ' ' CE1' ' A' ' 243' ' ' PHE . 21.4 t-20 -38.21 143.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -118.69 -45.88 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.32 35.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.414 ' C ' HG23 ' A' ' 278' ' ' VAL . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.414 HG23 ' C ' ' A' ' 277' ' ' LEU . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.516 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.485 HD11 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.485 ' CE1' HD11 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.551 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.402 ' CE3' HD12 ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.08 42.4 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -83.95 154.94 31.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -104.95 121.63 44.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.727 0.298 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.75 133.93 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 27.9 m -165.16 128.51 2.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 75.7 m -143.46 176.28 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.91 -152.03 20.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.29 -11.64 17.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.694 2.262 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.4 m -84.75 167.62 15.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 t -125.43 171.21 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.2 m -123.95 -58.36 1.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.17 109.93 2.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 223' ' ' SER . 89.2 p -171.54 169.99 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 222' ' ' SER . 37.7 t -38.16 147.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.65 159.46 10.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -69.6 160.28 80.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.96 87.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.258 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.37 157.35 50.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.62 137.77 8.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.631 2.22 . . . . 0.0 112.409 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 87.5 mt -38.64 150.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -96.88 109.13 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo -47.85 -48.97 14.66 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.707 2.272 . . . . 0.0 112.32 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.492 ' O ' ' N ' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.569 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -123.94 150.54 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.468 ' CG ' ' N ' ' A' ' 268' ' ' HIS . 8.1 t70 -66.16 168.48 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.468 ' N ' ' CG ' ' A' ' 267' ' ' ASP . 3.7 p80 -51.44 -21.55 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 32.7 m -78.68 -45.75 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 125.06 30.01 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -128.73 165.07 21.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.16 128.2 35.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 267' ' ' ASP . 0.4 OUTLIER -100.06 -48.1 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 142.83 47.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.411 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.44 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.569 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.412 HG22 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.492 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.484 ' CD1' HG23 ' A' ' 319' ' ' ILE . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.7 30.83 0.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.44 126.04 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.492 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -37.21 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.605 ' CD1' ' C ' ' A' ' 319' ' ' ILE . 0.0 OUTLIER -42.14 121.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.458 ' N ' HD12 ' A' ' 319' ' ' ILE . 14.2 t -152.2 151.91 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.6 m -61.49 110.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 171.45 88.61 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.85 121.32 5.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 82.9 p -120.3 148.57 43.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.821 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.798 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 7.6 t -113.2 88.29 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.8 m -143.43 170.73 15.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -166.41 -126.66 0.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.2 p -161.99 151.17 15.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.8 p -163.55 164.35 24.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.39 60.83 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 42.3 mttt -127.08 144.23 49.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.597 0.713 . . . . 0.0 110.908 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 90.51 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.246 . . . . 0.0 112.325 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 5.9 mp -110.1 154.2 42.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 0.0 110.892 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.19 158.15 33.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 25.0 mt -75.04 134.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -86.73 112.46 47.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.617 0.723 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -45.31 -30.27 5.26 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.561 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.46 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.504 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.458 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.457 ' CE1' ' HB2' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.436 ' CD1' ' OD1' ' A' ' 275' ' ' ASN . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.436 ' HB3' ' N ' ' A' ' 271' ' ' ARG . 32.9 mttp -120.51 167.16 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.439 ' OD2' ' ND1' ' A' ' 268' ' ' HIS . 16.8 t0 -65.86 166.35 11.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.439 ' ND1' ' OD2' ' A' ' 267' ' ' ASP . 13.3 p-80 -48.52 -29.34 4.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 8.6 m -86.13 -28.15 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 118.13 41.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' A' ' 272' ' ' ASN . 20.4 mmt180 -122.75 114.19 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.906 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 271' ' ' ARG . 23.8 t-20 -35.32 108.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.518 HD21 ' ND2' ' A' ' 275' ' ' ASN . 0.6 OUTLIER -76.71 -41.01 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . 154.21 -48.06 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . 0.518 ' ND2' HD21 ' A' ' 273' ' ' ASN . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.409 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.46 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 279' ' ' LYS . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.561 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.444 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.444 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' MET . . . . . 0.458 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.532 ' CD1' ' HA3' ' A' ' 317' ' ' GLY . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . 0.4 ' CB ' HD23 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 141.61 39.06 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . 0.532 ' HA3' ' CD1' ' A' ' 312' ' ' TRP . . . -69.32 136.68 28.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.515 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 0.421 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 28.9 t60 -95.89 89.6 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 23.5 pt -125.58 147.02 30.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.2 p -90.33 171.87 9.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 t -102.63 -58.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.59 162.63 35.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.5 119.93 2.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.2 m -125.7 103.11 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.3 m -88.49 134.58 33.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -85.72 -25.06 26.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 120.94 148.59 8.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.2 p -154.88 150.47 27.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.875 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 28.6 m -136.76 153.34 50.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.827 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.26 -73.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.456 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 153.44 49.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.84 146.58 26.45 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.404 HD13 ' C ' ' A' ' 227' ' ' LEU . 4.1 pp -78.42 153.33 79.01 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.0 143.24 28.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.233 . . . . 0.0 112.338 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.68 130.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -93.49 110.92 49.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo -48.09 -47.05 20.45 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.712 2.275 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.544 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.453 ' HB2' ' CD2' ' A' ' 277' ' ' LEU . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.477 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.413 HG13 ' N ' ' A' ' 260' ' ' ASP . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.413 ' N ' HG13 ' A' ' 259' ' ' VAL . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -125.08 170.37 11.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.01 174.87 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -45.29 -37.9 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 35.3 m -81.97 -45.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 137.91 32.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 21.3 mtt-85 -119.96 130.67 54.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.849 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -41.55 136.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.3 -47.75 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.83 40.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.491 HD13 ' CE3' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . 0.455 ' N ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.442 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . . . . . . . . . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.457 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.457 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.477 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.491 ' CE3' HD13 ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 129.25 49.74 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.62 120.37 9.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 319' ' ' ILE . 7.7 m170 -38.7 -45.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 318' ' ' HIS . 41.1 pt -34.11 149.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.7 m -160.62 124.32 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 9.6 t -67.74 145.8 54.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 144.3 102.62 0.39 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 106.94 2.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.359 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.0 t -89.63 111.34 22.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.2 t -140.95 124.55 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.6 t -100.13 131.46 46.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 116.39 148.58 9.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.0 m -117.96 127.31 53.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 56.9 m -64.36 167.54 6.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -140.07 -124.35 2.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 143.05 81.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.573 0.702 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.45 141.61 10.41 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 0.0 112.322 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.25 157.2 77.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.16 154.05 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 85.3 mt -37.55 127.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -71.22 136.68 84.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.65 -50.23 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' SER . . . . . 0.408 ' CB ' HD21 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.646 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t60 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.412 ' HB3' ' C ' ' A' ' 270' ' ' GLY . 15.5 mmtp -136.5 168.87 18.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.12 -176.53 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -36.6 67.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.71 -18.01 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . 0.412 ' C ' ' HB3' ' A' ' 266' ' ' LYS . . . 109.9 43.01 1.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -121.56 133.91 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -51.89 124.72 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -112.18 -44.65 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.36 40.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.408 HD21 ' CB ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.572 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.572 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.47 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.646 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.47 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . 0.443 ' ND2' ' HE ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.443 ' HE ' ' ND2' ' A' ' 293' ' ' ASN . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.461 ' O ' ' CG ' ' A' ' 299' ' ' GLN . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.478 ' CE1' HD13 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . . . . . . . . . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -179.86 -41.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 76.34 78.57 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . 0.474 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 22.6 t60 -103.03 41.06 1.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.05 139.28 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 23.3 m -110.02 -54.06 2.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.0 t -62.67 103.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -132.96 61.86 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.44 143.47 21.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 83.5 p -112.23 -11.77 13.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 -179.802 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.1 t -119.91 86.04 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t 56.59 42.87 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -167.93 92.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.4 m -147.2 168.64 21.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.7 m -125.57 167.47 15.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -169.05 134.61 3.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 122.69 0.37 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.05 92.79 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 0.0 112.365 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 71.0 mt -124.61 155.78 68.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.29 135.36 18.45 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.659 2.239 . . . . 0.0 112.303 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.8 mt -63.37 135.63 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' ND2' ' OD1' ' A' ' 232' ' ' ASP . 28.9 t30 -100.11 106.46 41.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.668 0.747 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -46.1 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ASP . . . . . 0.451 ' OD1' ' ND2' ' A' ' 230' ' ' ASN . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' VAL . . . . . 0.496 ' O ' ' CE ' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' MET . . . . . 0.496 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' PHE . . . . . 0.474 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.409 HG13 ' N ' ' A' ' 260' ' ' ASP . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 259' ' ' VAL . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -129.68 -175.83 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.417 ' CG ' ' HB3' ' A' ' 273' ' ' ASN . 4.8 m-20 -116.31 -60.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' HIS . . . . . 0.423 ' CE1' HG12 ' A' ' 269' ' ' VAL . 0.4 OUTLIER -131.77 -75.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.423 HG12 ' CE1' ' A' ' 268' ' ' HIS . 27.4 m -103.84 43.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 81.32 37.85 16.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -98.47 122.1 41.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -49.46 116.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ASN . . . . . 0.417 ' HB3' ' CG ' ' A' ' 267' ' ' ASP . 9.8 p-10 -88.99 -43.64 10.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 131.5 40.9 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.445 ' N ' ' HE3' ' A' ' 241' ' ' MET . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . 0.47 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' VAL . . . . . 0.564 HG12 ' CE2' ' A' ' 280' ' ' PHE . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' PHE . . . . . 0.564 ' CE2' HG12 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.488 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' PHE . . . . . 0.528 ' CD1' ' C ' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.444 ' O ' ' C ' ' A' ' 289' ' ' ALA . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.579 ' CB ' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.461 ' HA ' ' CG1' ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' LEU . . . . . 0.514 HD23 ' CE1' ' A' ' 301' ' ' TYR . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' ILE . . . . . 0.421 ' O ' ' CG2' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' TYR . . . . . 0.514 ' CE1' HD23 ' A' ' 296' ' ' LEU . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.474 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.461 ' CG1' ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' TRP . . . . . 0.47 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 173.92 -40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 78.77 109.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.545 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -109.13 -45.85 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 320' ' ' THR . 20.5 pt -39.9 -34.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.462 ' N ' HG13 ' A' ' 319' ' ' ILE . 69.4 p 33.97 41.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.7 p -63.76 153.41 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 134.08 161.97 9.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.69 168.92 22.76 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.314 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 80.1 p -128.1 -36.14 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.827 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.779 0.241 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.763 ' O ' ' HE3' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.763 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 315' ' ' ALA . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.628 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.628 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.453 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 298' ' ' ILE . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.487 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.465 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.453 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.767 0.236 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.511 ' O ' HG21 ' A' ' 286' ' ' THR . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.542 ' HA ' HD23 ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.681 ' O ' ' HE3' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.681 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.514 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.484 ' OD1' ' ND2' ' A' ' 248' ' ' ASN . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 264' ' ' LEU . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 250' ' ' VAL . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.01 HD21 ' HB1' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.537 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 306' ' ' PRO . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 298' ' ' ILE . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.507 ' CE1' HD12 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 313' ' ' VAL . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 309' ' ' GLU . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 1.01 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.811 0.254 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.534 ' O ' ' HE3' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.534 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 245' ' ' ALA . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.416 ' HB2' ' CD ' ' A' ' 242' ' ' PRO . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.464 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 264' ' ' LEU . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.599 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 250' ' ' VAL . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 277' ' ' LEU . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.446 ' N ' ' HD3' ' A' ' 279' ' ' LYS . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.599 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.514 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 298' ' ' ILE . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.454 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.781 0.242 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.523 ' OD1' HG22 ' A' ' 308' ' ' THR . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 283' ' ' PRO . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.604 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 250' ' ' VAL . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.003 HD21 ' HB1' ' A' ' 315' ' ' ALA . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 234' ' ' LEU . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.426 ' HD3' HD21 ' A' ' 234' ' ' LEU . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.542 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.604 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.599 HD22 ' HD3' ' A' ' 306' ' ' PRO . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.599 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 232' ' ' ASP . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.474 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 1.003 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.2 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.787 0.244 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.527 ' O ' ' HE1' ' A' ' 241' ' ' MET . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.527 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.807 ' HA ' HD11 ' A' ' 264' ' ' LEU . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 264' ' ' LEU . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.538 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.807 HD11 ' HA ' ' A' ' 247' ' ' GLU . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 315' ' ' ALA . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.536 ' HB3' HD12 ' A' ' 265' ' ' LEU . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.574 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 298' ' ' ILE . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 289' ' ' ALA . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.471 ' HD3' HD22 ' A' ' 290' ' ' LEU . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.446 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.774 0.239 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 264' ' ' LEU . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.583 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 250' ' ' VAL . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.797 HD21 ' HB1' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 261' ' ' ALA . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.519 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.492 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.583 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.482 HD22 ' HD3' ' A' ' 306' ' ' PRO . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.492 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 298' ' ' ILE . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.482 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.468 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.797 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.783 0.243 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.464 ' CG1' HD21 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.415 ' HB3' HD12 ' A' ' 281' ' ' LEU . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 315' ' ' ALA . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.438 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 258' ' ' ARG . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.438 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 306' ' ' PRO . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 296' ' ' LEU . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.416 HG12 HD23 ' A' ' 290' ' ' LEU . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.791 0.246 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 302' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.714 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.706 HD11 ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.666 HD21 ' HB1' ' A' ' 315' ' ' ALA . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 264' ' ' LEU . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 312' ' ' TRP . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.455 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.459 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.714 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.4 HD22 ' HD3' ' A' ' 306' ' ' PRO . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 298' ' ' ILE . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 241' ' ' MET . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.4 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.632 ' HA ' HD13 ' A' ' 277' ' ' LEU . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.666 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.23 0.117 0 CA-C-O 120.829 0.262 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.639 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 264' ' ' LEU . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 247' ' ' GLU . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.404 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.449 HD22 ' HD3' ' A' ' 306' ' ' PRO . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.404 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 298' ' ' ILE . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 241' ' ' MET . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 289' ' ' ALA . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.449 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.568 ' HA ' HD13 ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.827 0.261 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.533 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.443 ' HA ' HD23 ' A' ' 277' ' ' LEU . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.415 ' O ' ' HE1' ' A' ' 241' ' ' MET . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.415 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.476 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 16.1 t-80 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 260' ' ' ASP . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.692 HD21 ' HB1' ' A' ' 315' ' ' ALA . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.574 HD23 HG12 ' A' ' 304' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.574 HG12 HD23 ' A' ' 290' ' ' LEU . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.435 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 232' ' ' ASP . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 313' ' ' VAL . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 309' ' ' GLU . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.692 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.753 0.231 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.7 ' O ' ' HE3' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.7 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.7 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.403 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.851 HD21 ' HB1' ' A' ' 315' ' ' ALA . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.4 ' N ' ' CG2' ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.851 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.735 0.223 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.503 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.71 ' O ' ' HE3' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.71 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.555 ' OD2' HD23 ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.59 ' CG1' HG11 ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 250' ' ' VAL . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.966 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.599 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.599 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' OD2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 257' ' ' LEU . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.658 HD22 ' HD3' ' A' ' 306' ' ' PRO . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.461 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.461 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 253' ' ' PHE . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.658 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.428 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.966 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' A' ' 234' ' ' LEU . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.81 0.254 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 231' ' ' PRO . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.642 ' HA ' HD23 ' A' ' 277' ' ' LEU . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.407 HG12 ' SD ' ' A' ' 241' ' ' MET . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.496 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.421 ' HE2' ' C ' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.719 HD21 ' HB1' ' A' ' 315' ' ' ALA . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 237' ' ' SER . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.439 ' O ' HD22 ' A' ' 234' ' ' LEU . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 298' ' ' ILE . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 232' ' ' ASP . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' GLU . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.719 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.813 0.256 . . . . 0.0 112.397 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' HE1' ' A' ' 280' ' ' PHE . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.603 ' HA ' HD23 ' A' ' 277' ' ' LEU . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.667 HG12 ' SD ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.667 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 264' ' ' LEU . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.465 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 247' ' ' GLU . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 315' ' ' ALA . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 237' ' ' SER . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.412 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' N ' ' HG3' ' A' ' 279' ' ' LYS . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' ASP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.621 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.483 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.621 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 313' ' ' VAL . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 309' ' ' GLU . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.805 0.252 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 231' ' ' PRO . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 307' ' ' ALA . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.551 ' O ' ' HE3' ' A' ' 241' ' ' MET . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.551 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.562 ' HD2' HD12 ' A' ' 281' ' ' LEU . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.496 ' O ' HD23 ' A' ' 264' ' ' LEU . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 263' ' ' HIS . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.45 ' H ' ' HE3' ' A' ' 241' ' ' MET . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 258' ' ' ARG . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' MET . . . . . 0.434 ' SD ' HG11 ' A' ' 302' ' ' VAL . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.508 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.712 ' HB2' ' OG ' ' A' ' 237' ' ' SER . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.756 0.232 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.588 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.983 HD21 ' HB1' ' A' ' 315' ' ' ALA . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 280' ' ' PHE . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.404 HD22 ' HD3' ' A' ' 306' ' ' PRO . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 298' ' ' ILE . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.404 ' HD3' HD22 ' A' ' 290' ' ' LEU . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.433 ' CE3' ' HB3' ' A' ' 277' ' ' LEU . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.983 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.802 0.251 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 231' ' ' PRO . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.584 ' HA ' HD23 ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 276' ' ' GLY . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.583 HH12 HG11 ' A' ' 259' ' ' VAL . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.517 ' HB3' HD12 ' A' ' 281' ' ' LEU . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.583 HG11 HH12 ' A' ' 251' ' ' ARG . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.402 ' O ' HD23 ' A' ' 264' ' ' LEU . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 263' ' ' HIS . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 315' ' ' ALA . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.529 ' OD1' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 276' ' ' GLY . . . . . 0.535 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 258' ' ' ARG . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 287' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' MET . . . . . 0.503 ' SD ' HG11 ' A' ' 302' ' ' VAL . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' A' ' 297' ' ' MET . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.4 HG12 HD23 ' A' ' 290' ' ' LEU . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.452 ' HD3' HD22 ' A' ' 290' ' ' LEU . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.747 0.228 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.44 HG22 ' HE1' ' A' ' 280' ' ' PHE . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 239' ' ' HIS . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 237' ' ' SER . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 250' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 264' ' ' LEU . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 288' ' ' GLU . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 250' ' ' VAL . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' HD22 ' A' ' 234' ' ' LEU . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.467 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.572 ' CD ' HD21 ' A' ' 257' ' ' LEU . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.404 ' C ' HG11 ' A' ' 304' ' ' VAL . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.467 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 298' ' ' ILE . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 289' ' ' ALA . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 306' ' ' PRO . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 305' ' ' SER . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.748 0.228 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.785 ' HA ' HD23 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.819 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t-80 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 315' ' ' ALA . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ASN . . . . . 0.41 ' HB2' HD12 ' A' ' 265' ' ' LEU . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.523 ' O ' ' ND2' ' A' ' 293' ' ' ASN . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 290' ' ' LEU . 20.1 p30 -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.539 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 298' ' ' ILE . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.431 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.8 0.25 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 231' ' ' PRO . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 277' ' ' LEU . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' VAL . . . . . 0.55 ' O ' ' HE3' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' MET . . . . . 0.55 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ASP . . . . . 0.533 ' OD1' HD11 ' A' ' 298' ' ' ILE . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 254' ' ' PHE . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PHE . . . . . 0.891 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 255' ' ' HIS . 1.2 p-80 -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 288' ' ' GLU . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.697 HD21 ' HB1' ' A' ' 315' ' ' ALA . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 237' ' ' SER . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' CG2' ' A' ' 236' ' ' VAL . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 283' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 286' ' ' THR . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' PHE . . . . . 0.642 ' N ' HG23 ' A' ' 286' ' ' THR . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.459 ' OE1' HD21 ' A' ' 257' ' ' LEU . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' ALA . . . . . 0.891 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.679 ' HA ' HG12 ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' PRO . . . . . 0.607 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' TRP . . . . . 0.477 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ALA . . . . . 0.697 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 47.8 t -170.45 146.13 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 110.825 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 8.6 t -169.44 146.0 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -94.07 161.78 24.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.8 m -115.32 96.82 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.9 t -119.9 96.34 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -126.59 177.62 17.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -139.03 153.49 71.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.689 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.31 98.7 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 pp -122.81 153.93 63.71 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 229' ' ' ILE . 60.5 Cg_endo -74.35 147.79 37.52 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.729 2.286 . . . . 0.0 112.32 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 228' ' ' PRO . 45.8 mm -34.09 126.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -93.99 130.24 35.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo -46.04 -45.93 16.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.763 ' O ' ' HE3' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.763 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 315' ' ' ALA . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -134.21 177.45 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 269' ' ' VAL . 21.6 p30 -111.72 -175.05 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.67 ' CE1' HG13 ' A' ' 269' ' ' VAL . 18.5 p-80 -52.16 -40.84 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.67 HG13 ' CE1' ' A' ' 268' ' ' HIS . 34.0 m -81.85 16.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 49.62 48.03 36.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.403 ' HG3' HG23 ' A' ' 269' ' ' VAL . 51.4 mtt180 -121.95 139.81 53.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.83 86.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -55.2 -52.48 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.96 55.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.628 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.628 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.453 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 298' ' ' ILE . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.487 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.465 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.453 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.44 46.35 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -94.48 -169.73 37.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -166.77 131.32 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.0 pt -145.24 151.71 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.6 p -96.39 109.39 21.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -59.79 -59.11 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.19 71.03 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.74 99.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.68 2.254 . . . . 0.0 112.371 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.6 t -111.37 152.66 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.8 m 61.37 43.37 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.0 m -90.17 148.13 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.58 144.98 8.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.9 m -137.38 157.03 47.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -87.41 161.18 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.406 ' C ' ' HD2' ' A' ' 225' ' ' LYS . . . -150.87 47.31 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.529 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.406 ' HD2' ' C ' ' A' ' 224' ' ' GLY . 10.9 mptt -135.26 146.08 56.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.39 92.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.264 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 pp -121.31 154.95 59.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.8 149.54 33.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.0 mt -53.52 136.34 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -89.82 111.63 47.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -45.71 -62.87 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.64 2.226 . . . . 0.0 112.326 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.511 ' O ' HG21 ' A' ' 286' ' ' THR . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.542 ' HA ' HD23 ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.681 ' O ' ' HE3' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.681 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.514 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.484 ' OD1' ' ND2' ' A' ' 248' ' ' ASN . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 264' ' ' LEU . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 250' ' ' VAL . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.01 HD21 ' HB1' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -132.63 138.17 47.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -49.75 169.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -46.76 -35.14 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 271' ' ' ARG . 19.0 m -85.03 -35.66 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 125.43 30.8 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.466 ' HG3' HG23 ' A' ' 269' ' ' VAL . 31.5 mtp180 -101.6 128.58 47.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.905 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -54.45 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 271' ' ' ARG . 12.6 p-10 -59.01 -38.48 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 129.24 47.73 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.462 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.537 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 306' ' ' PRO . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 298' ' ' ILE . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.507 ' CE1' HD12 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 313' ' ' VAL . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 309' ' ' GLU . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 1.01 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 124.12 48.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.39 -162.6 3.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 318' ' ' HIS . 0.0 OUTLIER -126.7 61.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.794 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.2 OUTLIER -132.39 25.42 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 53.0 m -137.62 129.53 28.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.6 p -116.94 158.32 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -147.77 61.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.6 154.85 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.721 2.28 . . . . 0.0 112.302 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.0 m -139.95 169.63 17.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.1 m -131.23 -59.04 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.833 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.0 p -61.44 85.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.23 18.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.7 p -90.77 140.24 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.1 p -128.3 153.28 47.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.39 53.87 40.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -136.75 156.55 76.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.584 0.707 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.55 84.67 1.7 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 0.0 112.388 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.38 156.98 57.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.39 160.08 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 283' ' ' PRO . 37.8 mm -84.32 122.77 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 231' ' ' PRO . 24.7 t-20 -72.9 137.01 79.64 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.63 0.729 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.476 ' HD2' ' ND2' ' A' ' 230' ' ' ASN . 61.4 Cg_endo -77.46 -50.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.534 ' O ' ' HE3' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.534 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 245' ' ' ALA . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.464 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 264' ' ' LEU . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.599 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 250' ' ' VAL . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -117.79 154.19 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.42 -176.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -58.58 -29.98 66.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.34 -19.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.93 1.51 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -125.72 122.94 37.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 0.7 OUTLIER -63.87 90.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -56.58 -47.36 79.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 157.48 55.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 277' ' ' LEU . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.446 ' N ' ' HD3' ' A' ' 279' ' ' LYS . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 229' ' ' ILE . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.599 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.514 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 4.3 p30 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 298' ' ' ILE . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.454 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 118.06 39.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -58.66 -155.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.463 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 10.5 t-80 -169.81 106.16 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.747 0.308 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.5 pt -133.3 127.72 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.7 p -140.43 145.18 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 49.3 m 51.74 43.27 30.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -97.13 -176.38 34.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.9 117.98 4.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.622 2.215 . . . . 0.0 112.342 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -87.14 137.14 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.1 t 45.85 42.56 9.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.885 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.9 t -126.51 108.26 11.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 150.29 67.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.7 m -127.27 103.62 7.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.1 m -127.12 121.89 32.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.09 135.12 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.06 141.02 4.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.86 137.47 16.29 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 151.93 70.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.39 130.96 11.81 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.699 HG23 ' HG3' ' A' ' 283' ' ' PRO . 33.7 mt -51.67 144.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -100.42 106.37 42.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo -47.22 -52.5 7.76 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.523 ' OD1' HG22 ' A' ' 308' ' ' THR . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 283' ' ' PRO . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' HIS . . . . . 0.47 ' HB3' ' ND2' ' A' ' 275' ' ' ASN . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.604 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 26.2 t-80 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 250' ' ' VAL . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.003 HD21 ' HB1' ' A' ' 315' ' ' ALA . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -136.6 -175.04 3.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.27 -75.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.502 ' CD2' HG13 ' A' ' 269' ' ' VAL . 5.1 p-80 -133.17 -56.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 268' ' ' HIS . 19.2 m -91.46 -34.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 143.3 52.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -110.2 148.02 32.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.05 87.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -59.41 -49.13 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 136.01 33.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.47 ' ND2' ' HB3' ' A' ' 239' ' ' HIS . 20.8 m120 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 234' ' ' LEU . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.699 ' HG3' HG23 ' A' ' 229' ' ' ILE . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.542 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.604 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.599 HD22 ' HD3' ' A' ' 306' ' ' PRO . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.599 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 232' ' ' ASP . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.474 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 1.003 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.66 41.33 0.5 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -93.54 173.57 34.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -159.27 118.41 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.728 0.299 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.676 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.2 OUTLIER -133.76 156.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 321' ' ' SER . 9.1 t -99.52 45.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 320' ' ' THR . 24.3 t 36.96 46.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.37 160.96 30.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.67 148.0 2.68 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.7 m -57.66 -58.98 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 44.4 p -174.86 132.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 92.6 p -168.65 149.84 4.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -144.03 -174.02 15.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.6 t -74.01 152.36 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 87.8 p -139.71 164.32 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -133.45 -80.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -109.73 162.43 20.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.62 0.724 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.57 138.12 11.09 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.371 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.51 153.51 44.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.57 144.94 25.78 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 231' ' ' PRO . 79.8 mt -41.79 146.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -100.42 103.48 23.92 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 229' ' ' ILE . 73.2 Cg_exo -42.72 -50.07 6.2 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.235 . . . . 0.0 112.381 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.527 ' O ' ' HE1' ' A' ' 241' ' ' MET . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.527 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.807 ' HA ' HD11 ' A' ' 264' ' ' LEU . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 264' ' ' LEU . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.538 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.807 HD11 ' HA ' ' A' ' 247' ' ' GLU . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 315' ' ' ALA . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -133.39 159.57 39.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.81 -175.04 0.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.654 ' CE1' HG13 ' A' ' 269' ' ' VAL . 1.9 p-80 -59.7 -30.54 68.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.654 HG13 ' CE1' ' A' ' 268' ' ' HIS . 25.6 m -91.9 -24.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 111.38 46.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.518 ' HG3' HG23 ' A' ' 269' ' ' VAL . 91.3 mtt-85 -112.29 139.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -64.58 81.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -61.07 -53.43 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.24 43.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.526 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.536 ' HB3' HD12 ' A' ' 265' ' ' LEU . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.574 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 298' ' ' ILE . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 289' ' ' ALA . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.471 ' HD3' HD22 ' A' ' 290' ' ' LEU . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.517 ' HE1' HG23 ' A' ' 319' ' ' ILE . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.83 41.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -109.45 122.39 6.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -111.91 96.86 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -100.06 147.86 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 12.7 p -123.07 -4.63 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 95.2 p -90.03 112.97 24.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.83 88.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.2 -16.66 17.51 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.674 2.25 . . . . 0.0 112.341 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.2 t -75.69 124.56 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.0 m 51.06 36.31 15.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.4 p -73.79 165.78 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 132.1 -117.34 2.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.3 m 52.3 44.61 29.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 80.0 p -103.9 118.49 36.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.82 -47.65 0.8 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -134.37 146.51 59.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.03 108.65 2.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.82 152.3 74.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.731 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 163.48 37.41 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.6 mt -72.42 137.69 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 232' ' ' ASP . 24.0 t30 -82.9 139.88 43.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.853 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo -79.56 -46.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 264' ' ' LEU . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.583 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 250' ' ' VAL . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.797 HD21 ' HB1' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -119.14 167.86 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.39 -177.06 4.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -61.84 -20.48 63.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.3 m -97.26 -8.25 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.102 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 86.51 41.42 6.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.9 ptt85 -127.22 142.19 51.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.912 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -58.53 123.6 16.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.25 -40.33 10.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . 135.05 46.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.46 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 261' ' ' ALA . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.519 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.492 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.583 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.482 HD22 ' HD3' ' A' ' 306' ' ' PRO . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.492 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 298' ' ' ILE . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.482 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.468 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.797 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.04 38.17 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.55 152.82 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.85 110.55 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 320' ' ' THR . 2.2 pp -133.52 -40.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.718 ' N ' HD12 ' A' ' 319' ' ' ILE . 0.5 OUTLIER 32.92 54.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.8 t -122.26 103.81 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 177.23 140.2 3.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 126.23 11.72 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.728 2.285 . . . . 0.0 112.31 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 18.7 t -123.06 79.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.5 m -152.84 144.24 23.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.4 m -153.8 117.6 4.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.817 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.46 129.11 3.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.1 m -166.26 172.02 11.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.853 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -144.31 152.04 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -117.71 55.81 0.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -138.21 158.81 70.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 102.47 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.248 . . . . 0.0 112.344 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.8 mt -121.13 154.07 58.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.667 0.746 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.63 160.47 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.369 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 234' ' ' LEU . 27.1 mt -58.42 133.54 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -94.11 110.74 49.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.74 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.64 -47.16 21.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.71 2.273 . . . . 0.0 112.37 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 229' ' ' ILE . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.464 ' CG1' HD21 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.415 ' HB3' HD12 ' A' ' 281' ' ' LEU . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 315' ' ' ALA . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -125.64 168.02 14.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.78 -175.76 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.549 ' CE1' HG13 ' A' ' 269' ' ' VAL . 0.1 OUTLIER -54.15 -33.21 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.549 HG13 ' CE1' ' A' ' 268' ' ' HIS . 17.6 m -95.77 21.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 60.75 40.4 98.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.517 ' CG ' HG23 ' A' ' 269' ' ' VAL . 14.1 mmt180 -123.52 137.71 54.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.67 119.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.2 -44.72 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.72 41.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.438 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 258' ' ' ARG . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.438 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 306' ' ' PRO . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 296' ' ' LEU . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.416 HG12 HD23 ' A' ' 290' ' ' LEU . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.7 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.11 178.45 53.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.521 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -129.81 92.6 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -140.57 161.09 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.08 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.2 m -129.84 145.65 51.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 46.0 t -93.02 142.35 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.18 144.8 13.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.83 116.57 3.77 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.308 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 53.7 p -110.3 121.7 45.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 51.1 p -101.38 104.63 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 t 38.66 45.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.53 51.15 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.5 m -138.67 131.35 29.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.7 m -120.38 139.09 53.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 225' ' ' LYS . . . 103.6 -114.05 4.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.467 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 224' ' ' GLY . 55.3 mttp -33.55 96.9 0.11 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 224' ' ' GLY . 61.2 Cg_endo -75.43 79.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -52.15 153.23 5.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.729 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 148.26 33.77 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.346 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 234' ' ' LEU . 19.6 mt -40.14 137.83 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -94.62 108.67 38.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -43.51 -48.1 8.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.361 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 229' ' ' ILE . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 302' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.714 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.706 HD11 ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.666 HD21 ' HB1' ' A' ' 315' ' ' ALA . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.439 ' O ' ' ND2' ' A' ' 273' ' ' ASN . 10.6 mmtp -115.39 -177.52 3.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -117.38 -179.82 3.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.406 ' CD2' HG13 ' A' ' 269' ' ' VAL . 5.8 p-80 -45.93 -48.63 16.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 268' ' ' HIS . 16.1 m -74.94 -17.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.09 30.28 6.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -121.74 146.02 47.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -51.44 113.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 266' ' ' LYS . 4.5 p30 -87.78 -51.35 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 151.48 46.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.532 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 264' ' ' LEU . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 312' ' ' TRP . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.455 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.459 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.714 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.4 HD22 ' HD3' ' A' ' 306' ' ' PRO . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 298' ' ' ILE . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 241' ' ' MET . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.4 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.632 ' HA ' HD13 ' A' ' 277' ' ' LEU . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.666 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 132.95 39.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -92.81 -173.22 41.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.469 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -143.64 111.02 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.55 144.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 15.1 t -154.47 149.44 26.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.9 t -111.32 92.51 4.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 160.91 145.89 4.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.52 -51.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 63.8 m -143.28 175.64 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 36.5 m -157.0 150.41 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 110.906 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -164.34 156.65 16.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 151.99 137.62 2.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.0 t -163.36 149.98 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.4 p -170.75 146.61 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.41 24.64 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -90.0 155.0 47.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.46 105.66 2.12 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.6 mt -146.29 158.5 47.5 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.91 145.46 2.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 283' ' ' PRO . 55.3 mt -48.87 121.69 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -81.49 124.21 80.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.23 -25.35 4.46 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.639 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 264' ' ' LEU . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 38.8 t-80 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 247' ' ' GLU . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -105.72 165.54 11.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.644 ' OD2' HG22 ' A' ' 269' ' ' VAL . 6.6 p-10 -104.45 -174.9 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -54.55 -25.84 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.644 HG22 ' OD2' ' A' ' 267' ' ' ASP . 27.7 m -115.22 25.03 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 267' ' ' ASP . . . 79.49 -40.97 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.569 ' HG3' HG23 ' A' ' 269' ' ' VAL . 61.2 mtp180 -40.87 152.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.43 HD21 HD22 ' A' ' 264' ' ' LEU . 21.7 t-20 -71.65 114.26 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.22 -53.99 25.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.57 36.83 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.417 ' OD1' ' N ' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.687 ' HG3' HD13 ' A' ' 229' ' ' ILE . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.404 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.449 HD22 ' HD3' ' A' ' 306' ' ' PRO . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.404 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 298' ' ' ILE . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 241' ' ' MET . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 289' ' ' ALA . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.449 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.568 ' HA ' HD13 ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 119.92 36.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.38 177.2 5.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -111.38 100.1 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.62 115.67 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.6 t -169.62 142.05 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.7 m -57.23 176.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.96 96.46 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.84 166.72 28.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 77.5 p -89.78 -10.95 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.826 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.8 t -105.62 161.91 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.2 t -62.19 -54.56 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 147.24 162.73 10.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.482 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.0 m -51.84 111.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.1 m -157.57 128.88 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.43 75.79 1.09 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -159.58 143.44 10.79 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.919 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.01 82.62 2.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 46.1 mt -139.42 154.04 71.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.583 0.706 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.96 134.0 10.82 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.667 HG23 ' HG3' ' A' ' 283' ' ' PRO . 90.2 mt -49.04 127.02 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -79.69 139.08 54.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.74 -52.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.37 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.533 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.443 ' HA ' HD23 ' A' ' 277' ' ' LEU . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.415 ' O ' ' HE1' ' A' ' 241' ' ' MET . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.415 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.476 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 16.1 t-80 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.43 ' C ' ' OD1' ' A' ' 260' ' ' ASP . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.692 HD21 ' HB1' ' A' ' 315' ' ' ALA . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -144.23 172.74 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.03 -175.68 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -50.41 -55.07 17.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.86 -31.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 130.14 47.06 0.15 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -102.44 150.92 22.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.94 54.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -37.31 -35.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 106.69 48.4 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 229' ' ' ILE . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.574 HD23 HG12 ' A' ' 304' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.574 HG12 HD23 ' A' ' 290' ' ' LEU . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.435 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 232' ' ' ASP . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 313' ' ' VAL . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 309' ' ' GLU . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.692 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.04 29.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -65.47 -157.44 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -170.46 116.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 110.827 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.54 141.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 10.4 t -172.92 145.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.193 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 97.0 p -73.19 156.14 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.73 90.1 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.66 -21.51 12.8 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.712 2.274 . . . . 0.0 112.369 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 17.1 t 45.48 41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.835 -179.849 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.0 t -171.54 158.37 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 31.8 p -166.44 142.95 4.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.76 115.88 1.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 24.0 m -161.67 134.03 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 t -171.0 149.06 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 147.56 159.28 8.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -141.75 142.99 27.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.99 89.42 1.37 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.1 mt -135.66 155.79 77.97 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.661 0.743 . . . . 0.0 110.925 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.33 143.64 5.24 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 234' ' ' LEU . 43.0 mt -76.61 130.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -95.9 109.05 44.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.86 -56.07 3.13 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 229' ' ' ILE . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.7 ' O ' ' HE3' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.7 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.7 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.403 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.851 HD21 ' HB1' ' A' ' 315' ' ' ALA . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -121.35 154.27 36.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -102.54 -174.61 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.453 ' C ' ' O ' ' A' ' 267' ' ' ASP . 0.1 OUTLIER -33.69 -66.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 271' ' ' ARG . 32.4 m -76.35 -44.02 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 148.25 -17.51 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.525 ' H ' HG23 ' A' ' 269' ' ' VAL . 61.6 mtp180 -52.6 138.88 27.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -54.65 84.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 271' ' ' ARG . 7.7 p-10 -38.41 -54.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.55 37.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.4 ' N ' ' CG2' ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.851 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.28 43.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.65 179.38 53.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -122.53 41.87 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.69 -7.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 28.1 m -134.63 126.54 29.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.9 p -134.51 148.49 50.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 118.88 145.92 7.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.56 40.4 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.678 2.252 . . . . 0.0 112.354 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 70.3 m -57.91 -49.13 77.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.3 t -150.36 152.16 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.1 m -155.25 150.17 26.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.54 -179.79 17.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -154.94 165.2 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.8 t -139.03 154.5 48.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.824 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.25 -145.95 4.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -60.09 153.02 58.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.92 113.78 3.79 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.9 mt -133.03 156.71 79.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' ILE . 72.0 Cg_exo -44.91 151.74 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' PRO . 49.5 mm -35.71 121.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.43 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 12.1 t-20 -67.94 112.58 11.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo -52.56 -51.59 10.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.503 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.71 ' O ' ' HE3' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.71 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.555 ' OD2' HD23 ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.59 ' CG1' HG11 ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 250' ' ' VAL . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.966 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp -134.3 177.39 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 271' ' ' ARG . 9.6 t0 -82.98 173.68 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -45.95 -37.44 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 270' ' ' GLY . 32.6 m -85.82 -44.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 139.82 38.87 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 267' ' ' ASP . 67.1 mtt180 -122.24 146.49 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.72 100.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -82.95 -44.07 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 139.02 45.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.599 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.599 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' OD2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 257' ' ' LEU . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.658 HD22 ' HD3' ' A' ' 306' ' ' PRO . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.461 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.461 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 253' ' ' PHE . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.658 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.547 ' HE1' HG23 ' A' ' 319' ' ' ILE . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 319' ' ' ILE . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.966 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.47 47.81 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -79.42 -177.57 50.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -119.78 44.01 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.547 HG23 ' HE1' ' A' ' 312' ' ' TRP . 2.6 pp -88.83 165.28 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 19.7 m -163.93 148.98 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.3 m -95.93 42.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -121.9 90.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.447 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.14 150.02 28.95 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.646 2.23 . . . . 0.0 112.315 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.7 t -141.27 159.48 42.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 97.1 p -88.64 166.05 14.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.847 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.3 m -134.81 154.11 51.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -128.75 114.82 1.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -171.71 107.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.3 m -155.25 167.18 31.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.78 -83.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.46 ' N ' ' HE3' ' A' ' 225' ' ' LYS . 0.2 OUTLIER -55.15 162.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.937 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 140.21 21.76 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.35 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 158.72 55.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.66 129.59 9.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.716 2.278 . . . . 0.0 112.352 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 231' ' ' PRO . 82.9 mt -76.11 126.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.54 102.54 19.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.625 0.726 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' A' ' 234' ' ' LEU . 70.9 Cg_exo -41.89 -58.82 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 231' ' ' PRO . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.642 ' HA ' HD23 ' A' ' 277' ' ' LEU . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.407 HG12 ' SD ' ' A' ' 241' ' ' MET . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.496 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.421 ' HE2' ' C ' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.719 HD21 ' HB1' ' A' ' 315' ' ' ALA . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 154.86 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 268' ' ' HIS . 9.9 t70 -86.16 57.0 4.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' A' ' 267' ' ' ASP . 41.0 p-80 46.3 30.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.71 -31.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.08 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -138.29 144.15 40.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 15.0 m120 -63.36 115.81 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -100.65 -52.34 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 145.61 57.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 237' ' ' SER . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.439 ' O ' HD22 ' A' ' 234' ' ' LEU . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 298' ' ' ILE . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 232' ' ' ASP . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' GLU . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.719 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 136.48 36.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.5 51.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -128.16 83.47 2.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 28.9 pt -152.86 152.18 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 47.0 p -74.7 116.82 15.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.9 p -85.89 -61.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.42 90.69 2.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.14 -174.35 2.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.4 t -147.59 155.08 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.3 t -161.55 166.17 27.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.2 m -165.76 166.03 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 128.46 173.25 13.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.4 t -127.4 147.96 50.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.9 m -94.61 159.05 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -167.15 48.82 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.457 ' CD ' ' HD2' ' A' ' 226' ' ' PRO . 0.1 OUTLIER -130.0 137.68 31.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.854 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' PRO . . . . . 0.457 ' HD2' ' CD ' ' A' ' 225' ' ' LYS . 62.3 Cg_endo -77.08 107.17 2.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.27 . . . . 0.0 112.327 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.45 154.55 66.06 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' ILE . 61.0 Cg_endo -75.28 156.88 41.82 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.346 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 67.6 mt -37.22 134.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -84.66 112.95 46.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo -45.53 -49.71 10.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.638 2.225 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' HE1' ' A' ' 280' ' ' PHE . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.603 ' HA ' HD23 ' A' ' 277' ' ' LEU . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.667 HG12 ' SD ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.667 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 264' ' ' LEU . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 19.2 t-20 -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.427 ' C ' ' OD1' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.465 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 247' ' ' GLU . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 315' ' ' ALA . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -134.61 176.4 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -80.45 179.82 7.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.427 ' CD2' HG13 ' A' ' 269' ' ' VAL . 9.3 p-80 -47.29 -42.76 21.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 270' ' ' GLY . 28.1 m -77.62 -42.37 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.126 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 131.11 38.49 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -115.13 123.5 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -51.02 112.83 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.524 ' H ' ' ND2' ' A' ' 273' ' ' ASN . 0.6 OUTLIER -91.48 -57.27 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 158.43 46.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.432 ' ND2' ' OD1' ' A' ' 273' ' ' ASN . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 237' ' ' SER . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.412 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' N ' ' HG3' ' A' ' 279' ' ' LYS . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' ASP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.621 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.483 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.621 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 313' ' ' VAL . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 309' ' ' GLU . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.06 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -67.83 -177.76 12.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 20.7 t-80 -124.96 84.39 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 17.2 pt -123.72 166.45 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -155.98 169.86 23.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.2 t -110.68 95.24 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 166.43 166.35 25.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.439 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.83 116.94 4.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.636 2.224 . . . . 0.0 112.309 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.9 m -94.68 -59.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 57.5 p -128.72 -43.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 33.0 p -130.51 83.27 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.77 -142.15 7.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.7 p -174.87 130.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.846 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.9 p -111.34 141.41 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.98 -163.67 19.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -105.93 156.62 36.36 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.539 0.685 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.78 99.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.627 2.218 . . . . 0.0 112.338 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.66 157.59 51.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.863 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 155.32 37.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.6 mm -48.97 125.93 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 42.0 t-20 -89.77 111.36 45.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.621 0.724 . . . . 0.0 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo -44.37 -39.86 12.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.321 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD1' ' CG ' ' A' ' 230' ' ' ASN . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 307' ' ' ALA . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.551 ' O ' ' HE3' ' A' ' 241' ' ' MET . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.551 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 272' ' ' ASN . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.459 ' O ' ' ND2' ' A' ' 272' ' ' ASN . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.562 ' HD2' HD12 ' A' ' 281' ' ' LEU . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.496 ' O ' HD23 ' A' ' 264' ' ' LEU . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 263' ' ' HIS . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -121.36 165.89 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 271' ' ' ARG . 1.0 OUTLIER -66.16 -175.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.911 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.564 ' CD2' HG13 ' A' ' 269' ' ' VAL . 25.9 p-80 -61.32 -32.17 72.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 268' ' ' HIS . 34.7 m -87.41 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 139.49 41.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.459 ' HG2' ' CG2' ' A' ' 269' ' ' VAL . 5.1 ptt85 -128.82 125.3 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.574 ' O ' ' CE1' ' A' ' 243' ' ' PHE . 21.4 t-20 -38.21 143.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -118.69 -45.88 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.32 35.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.45 ' H ' ' HE3' ' A' ' 241' ' ' MET . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 258' ' ' ARG . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' MET . . . . . 0.434 ' SD ' HG11 ' A' ' 302' ' ' VAL . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.712 ' HB2' ' OG ' ' A' ' 237' ' ' SER . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.08 42.4 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -83.95 154.94 31.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -104.95 121.63 44.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.727 0.298 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.75 133.93 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 27.9 m -165.16 128.51 2.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 75.7 m -143.46 176.28 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.91 -152.03 20.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.29 -11.64 17.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.694 2.262 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.4 m -84.75 167.62 15.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 t -125.43 171.21 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.2 m -123.95 -58.36 1.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.17 109.93 2.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 223' ' ' SER . 89.2 p -171.54 169.99 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 222' ' ' SER . 37.7 t -38.16 147.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.65 159.46 10.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -69.6 160.28 80.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.96 87.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.258 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.37 157.35 50.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.62 137.77 8.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.631 2.22 . . . . 0.0 112.409 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 87.5 mt -38.64 150.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -96.88 109.13 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo -47.85 -48.97 14.66 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.707 2.272 . . . . 0.0 112.32 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.588 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.983 HD21 ' HB1' ' A' ' 315' ' ' ALA . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -123.94 150.54 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.503 ' OD2' HG13 ' A' ' 269' ' ' VAL . 8.1 t70 -66.16 168.48 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.468 ' N ' ' CG ' ' A' ' 267' ' ' ASP . 3.7 p80 -51.44 -21.55 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 270' ' ' GLY . 32.7 m -78.68 -45.75 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.51 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 125.06 30.01 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -128.73 165.07 21.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.16 128.2 35.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 267' ' ' ASP . 0.4 OUTLIER -100.06 -48.1 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 142.83 47.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 280' ' ' PHE . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.404 HD22 ' HD3' ' A' ' 306' ' ' PRO . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 298' ' ' ILE . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.404 ' HD3' HD22 ' A' ' 290' ' ' LEU . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.433 ' CE3' ' HB3' ' A' ' 277' ' ' LEU . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.983 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.7 30.83 0.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.44 126.04 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.492 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -37.21 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 320' ' ' THR . 0.0 OUTLIER -42.14 121.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.849 ' N ' HD13 ' A' ' 319' ' ' ILE . 14.2 t -152.2 151.91 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.6 m -61.49 110.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 171.45 88.61 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.85 121.32 5.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 82.9 p -120.3 148.57 43.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.821 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.798 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 7.6 t -113.2 88.29 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.8 m -143.43 170.73 15.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -166.41 -126.66 0.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.2 p -161.99 151.17 15.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.8 p -163.55 164.35 24.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.39 60.83 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' LYS . . . . . 0.534 ' O ' HD12 ' A' ' 227' ' ' LEU . 42.3 mttt -127.08 144.23 49.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.597 0.713 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 90.51 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.246 . . . . 0.0 112.325 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 225' ' ' LYS . 5.9 mp -110.1 154.2 42.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.19 158.15 33.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' ' 283' ' ' PRO . 25.0 mt -75.04 134.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -86.73 112.46 47.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.617 0.723 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -45.31 -30.27 5.26 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 231' ' ' PRO . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.584 ' HA ' HD23 ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 276' ' ' GLY . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.583 HH12 HG11 ' A' ' 259' ' ' VAL . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.517 ' HB3' HD12 ' A' ' 281' ' ' LEU . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.583 HG11 HH12 ' A' ' 251' ' ' ARG . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.402 ' O ' HD23 ' A' ' 264' ' ' LEU . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 263' ' ' HIS . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 315' ' ' ALA . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 271' ' ' ARG . 32.9 mttp -120.51 167.16 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.662 ' OD2' HG22 ' A' ' 269' ' ' VAL . 16.8 t0 -65.86 166.35 11.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.582 ' CE1' HG13 ' A' ' 269' ' ' VAL . 13.3 p-80 -48.52 -29.34 4.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.662 HG22 ' OD2' ' A' ' 267' ' ' ASP . 8.6 m -86.13 -28.15 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 118.13 41.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' A' ' 269' ' ' VAL . 20.4 mmt180 -122.75 114.19 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.906 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 271' ' ' ARG . 23.8 t-20 -35.32 108.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.56 HD22 ' ND2' ' A' ' 275' ' ' ASN . 0.6 OUTLIER -76.71 -41.01 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . 154.21 -48.06 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.56 ' ND2' HD22 ' A' ' 273' ' ' ASN . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.535 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 258' ' ' ARG . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' ' 229' ' ' ILE . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 287' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' MET . . . . . 0.503 ' SD ' HG11 ' A' ' 302' ' ' VAL . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' A' ' 297' ' ' MET . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.4 HG12 HD23 ' A' ' 290' ' ' LEU . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.452 ' HD3' HD22 ' A' ' 290' ' ' LEU . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.549 ' CD1' ' HA3' ' A' ' 317' ' ' GLY . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 141.61 39.06 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' GLY . . . . . 0.549 ' HA3' ' CD1' ' A' ' 312' ' ' TRP . . . -69.32 136.68 28.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.515 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 21.4 t-80 -95.89 89.6 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 110.856 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 23.5 pt -125.58 147.02 30.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.2 p -90.33 171.87 9.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 t -102.63 -58.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.59 162.63 35.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.5 119.93 2.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.2 m -125.7 103.11 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.3 m -88.49 134.58 33.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -85.72 -25.06 26.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 120.94 148.59 8.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.2 p -154.88 150.47 27.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.875 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 28.6 m -136.76 153.34 50.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.827 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.26 -73.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.456 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 153.44 49.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.84 146.58 26.45 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.42 153.33 79.01 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.0 143.24 28.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.233 . . . . 0.0 112.338 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.68 130.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -93.49 110.92 49.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo -48.09 -47.05 20.45 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.712 2.275 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.44 HG22 ' HE1' ' A' ' 280' ' ' PHE . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 239' ' ' HIS . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 237' ' ' SER . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 250' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 264' ' ' LEU . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 288' ' ' GLU . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 250' ' ' VAL . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -125.08 170.37 11.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.01 174.87 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -45.29 -37.9 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 270' ' ' GLY . 35.3 m -81.97 -45.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 137.91 32.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 269' ' ' VAL . 21.3 mtt-85 -119.96 130.67 54.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.849 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -41.55 136.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -116.3 -47.75 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.516 ' O ' ' ND2' ' A' ' 275' ' ' ASN . . . 143.83 40.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.497 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 274' ' ' GLY . 24.8 m120 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' HD22 ' A' ' 234' ' ' LEU . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.467 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.572 ' CD ' HD21 ' A' ' 257' ' ' LEU . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.404 ' C ' HG11 ' A' ' 304' ' ' VAL . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.467 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 298' ' ' ILE . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 289' ' ' ALA . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 306' ' ' PRO . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 305' ' ' SER . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 129.25 49.74 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.62 120.37 9.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 319' ' ' ILE . 7.7 m170 -38.7 -45.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 318' ' ' HIS . 41.1 pt -34.11 149.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.7 m -160.62 124.32 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 9.6 t -67.74 145.8 54.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 144.3 102.62 0.39 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 106.94 2.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.359 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.0 t -89.63 111.34 22.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.2 t -140.95 124.55 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.6 t -100.13 131.46 46.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 116.39 148.58 9.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.0 m -117.96 127.31 53.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 56.9 m -64.36 167.54 6.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -140.07 -124.35 2.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 143.05 81.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.573 0.702 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.45 141.61 10.41 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 0.0 112.322 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.25 157.2 77.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.16 154.05 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.73 HG23 ' HG3' ' A' ' 283' ' ' PRO . 85.3 mt -37.55 127.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -71.22 136.68 84.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.65 -50.23 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.785 ' HA ' HD23 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.819 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t-80 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 315' ' ' ALA . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HB3' ' C ' ' A' ' 270' ' ' GLY . 15.5 mmtp -136.5 168.87 18.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.12 -176.53 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' HIS . . . . . 0.415 ' CE1' HG13 ' A' ' 269' ' ' VAL . 2.1 p-80 -55.8 -36.6 67.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.415 HG13 ' CE1' ' A' ' 268' ' ' HIS . 16.6 m -89.71 -18.01 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' GLY . . . . . 0.423 ' C ' ' HB3' ' A' ' 266' ' ' LYS . . . 109.9 43.01 1.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -121.56 133.91 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -51.89 124.72 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -112.18 -44.65 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.36 40.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASN . . . . . 0.41 ' HB2' HD12 ' A' ' 265' ' ' LEU . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.73 ' HG3' HG23 ' A' ' 229' ' ' ILE . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.523 ' O ' ' ND2' ' A' ' 293' ' ' ASN . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' ASN . . . . . 0.523 ' ND2' ' O ' ' A' ' 290' ' ' LEU . 20.1 p30 -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.43 ' HD3' ' N ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.539 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 298' ' ' ILE . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.431 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -179.86 -41.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 76.34 78.57 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 59.2 t-80 -103.03 41.06 1.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.05 139.28 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 23.3 m -110.02 -54.06 2.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.0 t -62.67 103.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -132.96 61.86 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.44 143.47 21.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 83.5 p -112.23 -11.77 13.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 -179.802 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.1 t -119.91 86.04 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t 56.59 42.87 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -167.93 92.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.4 m -147.2 168.64 21.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.7 m -125.57 167.47 15.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -169.05 134.61 3.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 122.69 0.37 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.05 92.79 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 0.0 112.365 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 71.0 mt -124.61 155.78 68.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.29 135.36 18.45 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.659 2.239 . . . . 0.0 112.303 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.8 mt -63.37 135.63 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' ND2' ' OD1' ' A' ' 232' ' ' ASP . 28.9 t30 -100.11 106.46 41.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.668 0.747 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -46.1 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ASP . . . . . 0.451 ' OD1' ' ND2' ' A' ' 230' ' ' ASN . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 277' ' ' LEU . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' VAL . . . . . 0.55 ' O ' ' HE3' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' MET . . . . . 0.55 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ASP . . . . . 0.533 ' OD1' HD11 ' A' ' 298' ' ' ILE . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 254' ' ' PHE . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PHE . . . . . 0.891 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 255' ' ' HIS . 1.2 p-80 -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 288' ' ' GLU . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.697 HD21 ' HB1' ' A' ' 315' ' ' ALA . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -129.68 -175.83 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 273' ' ' ASN . 4.8 m-20 -116.31 -60.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.77 -75.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.84 43.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 81.32 37.85 16.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -98.47 122.1 41.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -49.46 116.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ASN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 267' ' ' ASP . 9.8 p-10 -88.99 -43.64 10.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 131.5 40.9 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 237' ' ' SER . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' CG2' ' A' ' 236' ' ' VAL . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 283' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 286' ' ' THR . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' PHE . . . . . 0.642 ' N ' HG23 ' A' ' 286' ' ' THR . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.459 ' OE1' HD21 ' A' ' 257' ' ' LEU . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.891 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.679 ' HA ' HG12 ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' PRO . . . . . 0.607 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' TRP . . . . . 0.477 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ALA . . . . . 0.697 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 173.92 -40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 78.77 109.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.545 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -109.13 -45.85 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 320' ' ' THR . 20.5 pt -39.9 -34.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.474 ' N ' HG13 ' A' ' 319' ' ' ILE . 69.4 p 33.97 41.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.7 p -63.76 153.41 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 134.08 161.97 9.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.69 168.92 22.76 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.314 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 80.1 p -128.1 -36.14 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.827 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo . . . . . 0 C--O 1.231 0.161 0 CA-C-O 120.779 0.241 . . . . 0.0 112.315 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.763 ' O ' ' HE3' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.763 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 315' ' ' ALA . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.496 -0.242 . . . . 0.0 112.496 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.628 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.628 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.453 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 298' ' ' ILE . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.487 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.465 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.453 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.767 0.236 . . . . 0.0 112.326 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.511 ' O ' HG21 ' A' ' 286' ' ' THR . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.542 ' HA ' HD23 ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.681 ' O ' ' HE3' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.681 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.405 ' O ' HG23 ' A' ' 250' ' ' VAL . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 248' ' ' ASN . 0.2 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 264' ' ' LEU . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 250' ' ' VAL . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.01 HD21 ' HB1' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.537 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 306' ' ' PRO . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 298' ' ' ILE . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.507 ' CE1' HD12 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 313' ' ' VAL . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 309' ' ' GLU . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 1.01 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo . . . . . 0 C--O 1.231 0.166 0 CA-C-O 120.811 0.254 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.534 ' O ' ' HE3' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.534 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 245' ' ' ALA . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.416 ' HB2' ' CD ' ' A' ' 242' ' ' PRO . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.464 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 264' ' ' LEU . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.599 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 250' ' ' VAL . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.463 -0.255 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 277' ' ' LEU . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.446 ' N ' ' HD3' ' A' ' 279' ' ' LYS . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.599 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.514 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 298' ' ' ILE . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.454 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.781 0.242 . . . . 0.0 112.327 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.523 ' OD1' HG22 ' A' ' 308' ' ' THR . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 283' ' ' PRO . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.604 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 250' ' ' VAL . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.003 HD21 ' HB1' ' A' ' 315' ' ' ALA . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 234' ' ' LEU . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.426 ' HD3' HD21 ' A' ' 234' ' ' LEU . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.542 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.604 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.599 HD22 ' HD3' ' A' ' 306' ' ' PRO . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.599 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 232' ' ' ASP . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.474 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 1.003 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.2 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.787 0.244 . . . . 0.0 112.381 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.527 ' O ' ' HE1' ' A' ' 241' ' ' MET . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.527 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.807 ' HA ' HD11 ' A' ' 264' ' ' LEU . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 264' ' ' LEU . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.538 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.807 HD11 ' HA ' ' A' ' 247' ' ' GLU . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 315' ' ' ALA . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.301 0 N-CA-C 112.526 -0.23 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.536 ' HB3' HD12 ' A' ' 265' ' ' LEU . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.574 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 298' ' ' ILE . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 289' ' ' ALA . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.471 ' HD3' HD22 ' A' ' 290' ' ' LEU . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.446 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.136 0 CA-C-O 120.774 0.239 . . . . 0.0 112.317 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 264' ' ' LEU . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.583 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 250' ' ' VAL . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.797 HD21 ' HB1' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.316 0 N-CA-C 112.46 -0.256 . . . . 0.0 112.46 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 261' ' ' ALA . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.519 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.492 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.583 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.482 HD22 ' HD3' ' A' ' 306' ' ' PRO . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.492 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 298' ' ' ILE . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.482 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.468 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.797 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo . . . . . 0 C--O 1.231 0.153 0 CA-C-O 120.783 0.243 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.464 ' CG1' HD21 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.415 ' HB3' HD12 ' A' ' 281' ' ' LEU . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 315' ' ' ALA . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.438 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 258' ' ' ARG . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.438 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 306' ' ' PRO . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 296' ' ' LEU . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.416 HG12 HD23 ' A' ' 290' ' ' LEU . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.791 0.246 . . . . 0.0 112.361 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 302' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.714 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.706 HD11 ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.666 HD21 ' HB1' ' A' ' 315' ' ' ALA . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.6 mmtp . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 264' ' ' LEU . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 312' ' ' TRP . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.455 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.459 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.714 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.4 HD22 ' HD3' ' A' ' 306' ' ' PRO . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.416 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 1.3 p-10 -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.416 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 298' ' ' ILE . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 241' ' ' MET . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.4 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.632 ' HA ' HD13 ' A' ' 277' ' ' LEU . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.666 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo . . . . . 0 C--O 1.23 0.117 0 CA-C-O 120.829 0.262 . . . . 0.0 112.334 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.639 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 264' ' ' LEU . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 247' ' ' GLU . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.352 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.404 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.449 HD22 ' HD3' ' A' ' 306' ' ' PRO . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.404 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 298' ' ' ILE . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 241' ' ' MET . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 289' ' ' ALA . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.449 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.568 ' HA ' HD13 ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo . . . . . 0 C--O 1.231 0.157 0 CA-C-O 120.827 0.261 . . . . 0.0 112.37 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.533 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.443 ' HA ' HD23 ' A' ' 277' ' ' LEU . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.415 ' O ' ' HE1' ' A' ' 241' ' ' MET . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.415 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.476 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t60 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.692 HD21 ' HB1' ' A' ' 315' ' ' ALA . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.521 -0.232 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.574 HD23 HG12 ' A' ' 304' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.574 HG12 HD23 ' A' ' 290' ' ' LEU . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.435 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 232' ' ' ASP . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 313' ' ' VAL . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 309' ' ' GLU . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.692 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo . . . . . 0 C--O 1.232 0.196 0 CA-C-O 120.753 0.231 . . . . 0.0 112.358 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.7 ' O ' ' HE3' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.7 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.7 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.403 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.851 HD21 ' HB1' ' A' ' 315' ' ' ALA . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.4 ' N ' ' CG2' ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.851 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo . . . . . 0 C--O 1.231 0.174 0 CA-C-O 120.735 0.223 . . . . 0.0 112.332 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.503 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.71 ' O ' ' HE3' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.71 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.555 ' OD2' HD23 ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.59 ' CG1' HG11 ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 250' ' ' VAL . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.966 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.3 mmtp . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 N-CA-C 112.488 -0.245 . . . . 0.0 112.488 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.599 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.599 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' OD2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 257' ' ' LEU . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.658 HD22 ' HD3' ' A' ' 306' ' ' PRO . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.461 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.461 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 253' ' ' PHE . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.658 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.428 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.966 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' A' ' 234' ' ' LEU . 70.9 Cg_exo . . . . . 0 C--O 1.231 0.168 0 CA-C-O 120.81 0.254 . . . . 0.0 112.4 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 231' ' ' PRO . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.642 ' HA ' HD23 ' A' ' 277' ' ' LEU . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.407 HG12 ' SD ' ' A' ' 241' ' ' MET . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.496 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.421 ' HE2' ' C ' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.719 HD21 ' HB1' ' A' ' 315' ' ' ALA . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.447 -0.261 . . . . 0.0 112.447 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 237' ' ' SER . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.439 ' O ' HD22 ' A' ' 234' ' ' LEU . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 298' ' ' ILE . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 232' ' ' ASP . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' GLU . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.719 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo . . . . . 0 N--CA 1.466 -0.144 0 CA-C-O 120.813 0.256 . . . . 0.0 112.397 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' HE1' ' A' ' 280' ' ' PHE . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.603 ' HA ' HD23 ' A' ' 277' ' ' LEU . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.667 HG12 ' SD ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.667 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 264' ' ' LEU . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.465 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 247' ' ' GLU . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 315' ' ' ALA . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 237' ' ' SER . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.412 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.449 ' N ' ' HG3' ' A' ' 279' ' ' LYS . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.621 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.483 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.621 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 313' ' ' VAL . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 309' ' ' GLU . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo . . . . . 0 N--CA 1.466 -0.141 0 CA-C-O 120.805 0.252 . . . . 0.0 112.321 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 231' ' ' PRO . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 307' ' ' ALA . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.551 ' O ' ' HE3' ' A' ' 241' ' ' MET . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.551 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.562 ' HD2' HD12 ' A' ' 281' ' ' LEU . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.496 ' O ' HD23 ' A' ' 264' ' ' LEU . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 263' ' ' HIS . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 N-CA-C 112.475 -0.25 . . . . 0.0 112.475 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.45 ' H ' ' HE3' ' A' ' 241' ' ' MET . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 258' ' ' ARG . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . 0.434 ' SD ' HG11 ' A' ' 302' ' ' VAL . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.508 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.712 ' HB2' ' OG ' ' A' ' 237' ' ' SER . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo . . . . . 0 C--O 1.232 0.207 0 CA-C-O 120.756 0.232 . . . . 0.0 112.32 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.588 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.983 HD21 ' HB1' ' A' ' 315' ' ' ALA . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 280' ' ' PHE . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.404 HD22 ' HD3' ' A' ' 306' ' ' PRO . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 298' ' ' ILE . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.404 ' HD3' HD22 ' A' ' 290' ' ' LEU . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.433 ' CE3' ' HB3' ' A' ' 277' ' ' LEU . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.983 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.802 0.251 . . . . 0.0 112.34 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 231' ' ' PRO . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.584 ' HA ' HD23 ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 276' ' ' GLY . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.583 HH12 HG11 ' A' ' 259' ' ' VAL . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.517 ' HB3' HD12 ' A' ' 281' ' ' LEU . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.583 HG11 HH12 ' A' ' 251' ' ' ARG . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.402 ' O ' HD23 ' A' ' 264' ' ' LEU . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 263' ' ' HIS . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 315' ' ' ALA . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.9 mttp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . . . . . . 0 N--CA 1.452 -0.271 0 N-CA-C 112.508 -0.237 . . . . 0.0 112.508 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.529 ' OD1' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . 0.535 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 258' ' ' ARG . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 287' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . 0.503 ' SD ' HG11 ' A' ' 302' ' ' VAL . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' A' ' 297' ' ' MET . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.4 HG12 HD23 ' A' ' 290' ' ' LEU . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.452 ' HD3' HD22 ' A' ' 290' ' ' LEU . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.424 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo . . . . . 0 C--O 1.231 0.154 0 CA-C-O 120.747 0.228 . . . . 0.0 112.3 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.44 HG22 ' HE1' ' A' ' 280' ' ' PHE . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 239' ' ' HIS . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 237' ' ' SER . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 264' ' ' LEU . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 288' ' ' GLU . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 250' ' ' VAL . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' HD22 ' A' ' 234' ' ' LEU . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.467 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.572 ' CD ' HD21 ' A' ' 257' ' ' LEU . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.404 ' C ' HG11 ' A' ' 304' ' ' VAL . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.467 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 298' ' ' ILE . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 289' ' ' ALA . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 306' ' ' PRO . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 305' ' ' SER . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo . . . . . 0 C--O 1.231 0.17 0 CA-C-O 120.748 0.228 . . . . 0.0 112.313 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.785 ' HA ' HD23 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.819 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t60 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 315' ' ' ALA . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.5 mmtp . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . 0.41 ' HB2' HD12 ' A' ' 265' ' ' LEU . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 306' ' ' PRO . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . 0.469 ' ND2' ' HE ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.469 ' HE ' ' ND2' ' A' ' 293' ' ' ASN . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.539 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 298' ' ' ILE . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.431 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo . . . . . 0 C--O 1.231 0.147 0 CA-C-O 120.8 0.25 . . . . 0.0 112.347 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 231' ' ' PRO . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 277' ' ' LEU . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' VAL . . . . . 0.55 ' O ' ' HE3' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' MET . . . . . 0.55 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ASP . . . . . 0.533 ' OD1' HD11 ' A' ' 298' ' ' ILE . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 254' ' ' PHE . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PHE . . . . . 0.891 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 288' ' ' GLU . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.697 HD21 ' HB1' ' A' ' 315' ' ' ALA . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 237' ' ' SER . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' CG2' ' A' ' 236' ' ' VAL . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 286' ' ' THR . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' PHE . . . . . 0.642 ' N ' HG23 ' A' ' 286' ' ' THR . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.459 ' OE1' HD21 ' A' ' 257' ' ' LEU . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' ALA . . . . . 0.891 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.679 ' HA ' HG12 ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' PRO . . . . . 0.607 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' TRP . . . . . 0.477 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ALA . . . . . 0.697 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.539 -0.224 . . . . 0.0 112.539 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 47.8 t -170.45 146.13 2.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.861 0.363 . . . . 0.0 110.825 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 8.6 t -169.44 146.0 3.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.853 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -94.07 161.78 24.66 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.496 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 14.8 m -115.32 96.82 5.84 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.851 0.357 . . . . 0.0 110.887 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.9 t -119.9 96.34 5.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -126.59 177.62 17.17 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.489 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 7.7 ptpp? -139.03 153.49 71.65 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.546 0.689 . . . . 0.0 110.907 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.31 98.7 1.04 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.665 2.243 . . . . 0.0 112.338 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.7 pp -122.81 153.93 63.71 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.605 0.717 . . . . 0.0 110.907 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.438 ' O ' ' C ' ' A' ' 229' ' ' ILE . 60.5 Cg_endo -74.35 147.79 37.52 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.729 2.286 . . . . 0.0 112.32 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.438 ' C ' ' O ' ' A' ' 228' ' ' PRO . 45.8 mm -34.09 126.44 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.095 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -93.99 130.24 35.13 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.654 0.74 . . . . 0.0 110.86 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.444 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.5 Cg_exo -46.04 -45.93 16.92 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.7 2.267 . . . . 0.0 112.315 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -34.76 -41.61 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.88 179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.407 ' N ' ' OD1' ' A' ' 232' ' ' ASP . 4.3 m-20 -68.03 -61.71 1.74 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.885 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.7 mt -52.48 -28.38 20.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.519 ' CE2' ' HG3' ' A' ' 279' ' ' LYS . 7.4 m-85 -101.11 101.67 12.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.966 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.1 m -113.71 165.32 8.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.176 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.414 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 68.0 p -122.23 142.79 50.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.858 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.763 ' O ' ' HE3' ' A' ' 241' ' ' MET . 11.7 t -123.35 115.45 45.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.147 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 38.8 m-70 -117.92 124.89 49.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.822 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 118.81 53.18 0.29 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.763 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -120.82 143.22 36.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.58 0.705 . . . . 0.0 110.885 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.27 157.44 0.25 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.687 2.258 . . . . 0.0 112.36 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -70.26 -14.71 62.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.896 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 87.6 p -98.42 -16.6 19.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.872 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -44.15 132.78 5.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.106 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 18.1 ptm -138.8 169.02 18.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.9 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 5.1 tt0 -36.34 -38.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -66.99 -64.8 0.78 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.901 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -38.39 -46.66 1.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 84.6 t -46.5 -53.35 2.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.161 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.9 mtp85 -43.1 -60.63 1.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 251' ' ' ARG . 34.3 t70 -34.93 -38.44 0.08 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.886 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.465 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 22.5 t80 -71.92 -62.04 1.57 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.882 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.49 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 55.4 m-85 -96.99 41.81 1.1 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.866 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.545 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 3.6 p-80 -83.05 110.06 17.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 131.99 -17.82 4.84 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.512 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 17.6 mt -100.75 165.0 11.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.908 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 84.7 mtt180 -66.8 102.3 0.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.873 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.7 t -99.96 122.06 51.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.165 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -101.02 -49.14 4.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.866 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.25 157.12 36.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.124 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 98.7 t -139.81 113.93 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.155 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.48 136.05 37.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.852 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 72.8 mt -126.23 125.35 42.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.793 HD21 ' HB1' ' A' ' 315' ' ' ALA . 30.1 mt -87.54 150.13 23.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 29.8 mttp -134.21 177.45 7.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.478 ' OD1' HG22 ' A' ' 269' ' ' VAL . 21.6 p30 -111.72 -175.05 2.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.889 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.81 ' CE1' HG13 ' A' ' 269' ' ' VAL . 4.2 p80 -52.16 -40.84 62.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.809 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.81 HG13 ' CE1' ' A' ' 268' ' ' HIS . 34.0 m -81.85 16.83 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.133 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 49.62 48.03 36.33 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.514 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.403 ' HG3' HG23 ' A' ' 269' ' ' VAL . 51.4 mtt180 -121.95 139.81 53.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.841 0.353 . . . . 0.0 110.871 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -68.83 86.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -55.2 -52.48 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.912 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.96 55.56 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.496 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -162.75 132.72 4.48 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -160.1 -179.52 34.94 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 23.1 mt -135.11 146.09 48.5 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.851 0.357 . . . . 0.0 110.953 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.628 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 8.4 t -123.92 141.48 44.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.119 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.519 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.84 111.84 14.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.914 179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.628 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 3.2 m-85 -104.58 139.25 39.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.891 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 20.0 mt -48.51 -63.79 0.98 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.951 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 48.7 m -100.13 156.18 35.58 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.641 0.734 . . . . 0.0 110.869 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.488 ' O ' ' N ' ' A' ' 285' ' ' ASP . 61.4 Cg_endo -75.95 -49.77 0.12 Allowed 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.702 2.268 . . . . 0.0 112.347 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -38.8 -26.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.913 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 283' ' ' PRO . 24.1 m-20 -77.75 -59.43 2.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.506 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -51.96 -44.08 63.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.092 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.506 ' N ' ' CG2' ' A' ' 286' ' ' THR . 17.7 t80 -38.0 -35.84 0.17 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -67.28 -47.22 71.3 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.886 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.49 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.33 -42.19 61.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.453 ' CD2' ' HD3' ' A' ' 306' ' ' PRO . 77.7 mt -53.95 -30.34 46.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.501 ' HE3' ' CD2' ' A' ' 287' ' ' PHE . 0.1 OUTLIER -76.76 -20.8 56.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.928 179.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 41.6 mtp85 -93.52 22.19 5.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.903 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -75.1 141.3 43.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 30.7 mmt180 59.4 50.02 8.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.855 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 6.8 mtt -107.76 178.9 4.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.871 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.487 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.9 tp -94.07 120.87 34.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.1 ttm -137.59 113.94 10.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.612 HG22 ' O ' ' A' ' 298' ' ' ILE . 34.6 mt 46.38 47.24 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.143 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 63.12 26.39 15.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.944 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 41.1 mmt-85 -138.07 133.72 33.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.487 ' CE1' HD12 ' A' ' 296' ' ' LEU . 22.3 m-85 -82.38 124.38 29.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.891 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.465 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 28.0 m -99.95 141.74 16.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -110.03 101.97 10.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 42.8 t -94.65 110.65 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.121 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 60.6 p -145.41 142.16 17.87 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.69 0.757 . . . . 0.0 110.822 -179.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.453 ' HD3' ' CD2' ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.81 153.2 3.84 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.728 2.285 . . . . 0.0 112.322 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -126.14 175.08 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 309' ' ' GLU . 21.5 p -117.58 137.26 52.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.1 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 308' ' ' THR . 14.1 tt0 -37.31 -44.9 0.63 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 78.3 mtt180 -50.92 -52.76 38.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 18.2 mt-30 -56.84 -46.03 81.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.945 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 65.2 t-105 -53.77 -44.52 70.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.942 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 94.4 t -67.86 -59.51 3.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.147 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.84 -51.82 27.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.147 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.793 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.99 -41.77 26.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.112 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.44 46.35 0.21 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.52 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -94.48 -169.73 37.38 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -166.77 131.32 2.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.741 0.305 . . . . 0.0 110.893 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.0 pt -145.24 151.71 14.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.1 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.6 p -96.39 109.39 21.93 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.7 t -59.79 -59.11 5.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.849 -179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.19 71.03 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.43 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.74 99.04 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.68 2.254 . . . . 0.0 112.371 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.6 t -111.37 152.66 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.829 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.861 -179.804 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.33 0 N-CA-C 112.478 -0.249 . . . . 0.0 112.478 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 50.8 m 61.37 43.37 10.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.907 0.384 . . . . 0.0 110.897 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.0 m -90.17 148.13 23.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.86 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -172.58 144.98 8.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.462 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 7.9 m -137.38 157.03 47.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.841 0.353 . . . . 0.0 110.852 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 58.8 m -87.41 161.18 18.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.827 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.406 ' C ' ' HD2' ' A' ' 225' ' ' LYS . . . -150.87 47.31 0.59 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.529 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.406 ' HD2' ' C ' ' A' ' 224' ' ' GLY . 10.9 mptt -135.26 146.08 56.6 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.631 0.729 . . . . 0.0 110.866 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.39 92.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.695 2.264 . . . . 0.0 112.348 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 2.7 pp -121.31 154.95 59.17 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.595 0.712 . . . . 0.0 110.912 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.8 149.54 33.66 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.661 2.241 . . . . 0.0 112.32 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 77.0 mt -53.52 136.34 14.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.143 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -89.82 111.63 47.37 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.613 0.72 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.429 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -45.71 -62.87 0.38 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.64 2.226 . . . . 0.0 112.326 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 231' ' ' PRO . 5.7 m-20 -34.33 -45.49 0.22 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.511 ' O ' HG21 ' A' ' 286' ' ' THR . 7.2 t0 -49.61 -53.06 26.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.922 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 11.8 mt -68.82 -30.67 69.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.575 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 2.5 m-85 -99.93 95.32 6.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.943 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.8 m -110.44 165.85 5.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.093 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.542 ' HA ' HD23 ' A' ' 277' ' ' LEU . 66.9 p -125.38 143.07 51.15 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.681 ' O ' ' HE3' ' A' ' 241' ' ' MET . 9.9 t -122.6 117.46 52.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . 0.436 ' ND1' ' OD1' ' A' ' 275' ' ' ASN . 13.8 m-70 -119.4 123.41 44.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 119.38 53.95 0.27 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.5 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.681 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -119.29 142.58 32.64 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.545 0.688 . . . . 0.0 110.884 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -48.25 -177.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.35 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -86.01 -21.67 27.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.848 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 17.6 t -96.66 -17.26 20.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -43.52 98.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.405 ' O ' HG23 ' A' ' 250' ' ' VAL . 11.8 ptp -102.84 -177.64 3.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -48.93 -69.11 0.13 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.931 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.495 ' H ' ' ND2' ' A' ' 248' ' ' ASN . 0.2 OUTLIER -42.85 -46.49 5.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -52.55 -41.79 63.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.855 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.508 HG21 HD21 ' A' ' 264' ' ' LEU . 88.5 t -53.62 -53.41 25.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.135 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.405 ' O ' ' N ' ' A' ' 255' ' ' HIS . 48.7 mtt85 -41.66 -52.84 3.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.842 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.401 ' C ' ' O ' ' A' ' 251' ' ' ARG . 30.3 t70 -37.32 -39.43 0.28 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.834 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.1 t80 -71.49 -57.06 4.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.681 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.6 m-85 -100.07 43.6 1.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.405 ' N ' ' O ' ' A' ' 251' ' ' ARG . 10.4 t60 -87.37 104.44 16.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.868 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 138.62 -14.21 3.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.453 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.2 mt -104.24 172.21 6.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.842 0.353 . . . . 0.0 110.872 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 61.4 mtt180 -72.78 97.89 2.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 87.7 t -90.85 137.06 22.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.108 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.28 -49.29 2.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.883 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -153.21 164.31 38.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.083 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.9 t -146.09 123.86 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 66.1 t60 -119.63 141.48 49.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.857 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.508 HD21 HG21 ' A' ' 250' ' ' VAL . 12.4 mt -140.07 109.36 6.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.01 HD21 ' HB1' ' A' ' 315' ' ' ALA . 90.7 mt -51.27 142.18 13.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.89 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 4.7 mmmm -132.63 138.17 47.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.897 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -49.75 169.89 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.882 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.413 ' CD2' ' H ' ' A' ' 269' ' ' VAL . 0.3 OUTLIER -46.76 -35.14 5.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.902 179.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.466 HG23 ' HG3' ' A' ' 271' ' ' ARG . 19.0 m -85.03 -35.66 10.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.168 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 125.43 30.8 0.88 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.466 ' HG3' HG23 ' A' ' 269' ' ' VAL . 31.5 mtp180 -101.6 128.58 47.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.785 0.326 . . . . 0.0 110.905 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -54.45 89.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.883 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.406 ' N ' ' O ' ' A' ' 271' ' ' ARG . 12.6 p-10 -59.01 -38.48 79.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.89 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 129.24 47.73 0.15 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.462 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.436 ' OD1' ' ND1' ' A' ' 239' ' ' HIS . 71.1 m-20 -164.78 136.64 4.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.905 0.383 . . . . 0.0 110.889 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -161.16 179.0 36.88 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.542 HD23 ' HA ' ' A' ' 237' ' ' SER . 14.9 mt -136.6 150.36 48.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.866 0.365 . . . . 0.0 110.939 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 40.4 t -121.69 149.84 24.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.106 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.575 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -124.89 144.47 50.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.855 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.537 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 90.9 m-85 -135.53 147.2 48.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.874 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 23.7 mt -62.15 -62.11 2.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.901 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.0 m -99.93 158.75 31.51 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.654 0.74 . . . . 0.0 110.843 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.72 -19.63 11.11 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.615 2.21 . . . . 0.0 112.332 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -70.62 -44.13 67.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -59.49 -56.04 26.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.846 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.537 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 0.9 OUTLIER -55.02 -39.57 69.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.119 -179.871 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.439 ' N ' ' CG2' ' A' ' 286' ' ' THR . 38.7 t80 -40.27 -34.79 0.35 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.868 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -69.71 -51.81 31.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.681 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -48.31 -39.6 22.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.092 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.497 HD22 ' HD3' ' A' ' 306' ' ' PRO . 34.8 mt -62.9 -27.1 69.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.929 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 16.2 mtmm -81.02 -20.75 41.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 68.3 mtt180 -91.84 21.72 4.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -72.86 148.35 44.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.0 mmm180 60.43 47.29 8.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.908 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 1.9 mmt -105.27 -179.18 3.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.902 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.507 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.9 tp -99.13 119.59 38.1 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.907 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.8 ttm -134.61 110.86 9.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 298' ' ' ILE . 41.3 mt 48.67 46.29 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.104 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 65.23 28.98 11.94 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.915 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpt180 -139.26 139.22 37.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.854 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.507 ' CE1' HD12 ' A' ' 296' ' ' LEU . 41.8 m-85 -90.35 122.81 33.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.881 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 23.8 m -101.34 142.17 16.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.133 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -109.57 101.2 10.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.889 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 40.1 t -95.2 116.3 36.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.149 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 59.0 p -152.26 148.81 21.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.633 0.73 . . . . 0.0 110.872 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.497 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.3 Cg_exo -49.17 158.89 1.26 Allowed 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.716 2.277 . . . . 0.0 112.361 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.51 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.84 -177.85 4.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.133 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.5 p -126.54 138.87 53.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.123 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.401 ' O ' HG23 ' A' ' 313' ' ' VAL . 6.6 tp10 -39.4 -48.48 1.93 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.926 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.6 mmt85 -49.04 -41.41 34.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.898 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 15.0 mm-40 -68.37 -45.53 72.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.427 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 53.7 t-105 -58.62 -38.5 78.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.923 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 309' ' ' GLU . 61.4 t -72.08 -51.83 28.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.116 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -55.51 -47.06 76.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.113 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 1.01 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -53.95 -40.34 66.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 124.12 48.67 0.22 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.491 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.39 -162.6 3.21 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.53 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.552 ' CG ' ' O ' ' A' ' 318' ' ' HIS . 0.5 OUTLIER -126.7 61.61 1.32 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.778 0.323 . . . . 0.0 110.886 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.794 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.2 OUTLIER -132.39 25.42 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.1 179.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 53.0 m -137.62 129.53 28.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.184 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 94.6 p -116.94 158.32 24.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.891 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -147.77 61.94 0.44 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.488 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -45.6 154.85 0.54 Allowed 'Trans proline' 0 N--CA 1.465 -0.152 0 C-N-CA 122.721 2.28 . . . . 0.0 112.302 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.0 m -139.95 169.63 17.35 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.819 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 14.8 t . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.816 -179.792 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.299 0 N-CA-C 112.494 -0.243 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.1 m -131.23 -59.04 0.99 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.868 0.366 . . . . 0.0 110.833 -179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 63.0 p -61.44 85.84 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -90.66 -147.23 18.21 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.493 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 60.7 p -90.77 140.24 29.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.858 0.361 . . . . 0.0 110.884 -179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 79.1 p -128.3 153.28 47.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.844 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 61.39 53.87 40.74 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.471 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -136.75 156.55 76.02 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.584 0.707 . . . . 0.0 110.924 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.55 84.67 1.7 Allowed 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.69 2.26 . . . . 0.0 112.388 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.0 mt -121.38 156.98 57.31 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.59 0.71 . . . . 0.0 110.905 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.39 160.08 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.723 2.282 . . . . 0.0 112.367 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.405 HG23 ' HG3' ' A' ' 283' ' ' PRO . 37.8 mm -84.32 122.77 38.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.096 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 231' ' ' PRO . 24.7 t-20 -72.9 137.01 79.64 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.63 0.729 . . . . 0.0 110.86 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.476 ' HD2' ' ND2' ' A' ' 230' ' ' ASN . 61.4 Cg_endo -77.46 -50.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.72 2.28 . . . . 0.0 112.307 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -39.45 -40.49 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -65.3 -58.7 5.27 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.882 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 21.8 mt -57.56 -28.68 63.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.559 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 93.2 m-85 -102.24 100.55 10.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.926 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.09 167.96 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.102 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 38.9 p -125.24 144.61 50.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.857 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.534 ' O ' ' HE3' ' A' ' 241' ' ' MET . 22.0 t -121.63 110.04 26.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.123 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -113.71 118.7 35.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.877 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.9 53.52 0.16 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.534 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.2 mpp? -115.7 153.79 47.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.537 0.684 . . . . 0.0 110.903 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.416 ' CD ' ' HB2' ' A' ' 245' ' ' ALA . 72.4 Cg_exo -44.54 147.71 1.59 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.699 2.266 . . . . 0.0 112.343 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -53.01 -28.65 25.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 9.5 m -116.31 23.1 12.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.849 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.441 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -56.21 135.99 53.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.097 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.464 ' HG3' ' ND2' ' A' ' 248' ' ' ASN . 9.5 ptp -130.54 -175.25 3.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.883 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -48.28 -61.01 2.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.875 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.464 ' ND2' ' HG3' ' A' ' 246' ' ' MET . 0.8 OUTLIER -44.83 -43.94 9.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.91 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 248' ' ' ASN . 1.2 m-20 -57.28 -39.44 75.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.827 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.679 HG21 HD21 ' A' ' 264' ' ' LEU . 88.2 t -71.94 -57.8 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.13 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 255' ' ' HIS . 29.2 mtp180 -45.04 -47.57 11.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.897 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -45.53 -35.96 4.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.93 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.422 ' O ' ' NH1' ' A' ' 292' ' ' ARG . 26.1 t80 -78.7 -47.78 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.908 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.599 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 36.4 m-85 -98.98 37.11 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.41 ' N ' ' O ' ' A' ' 251' ' ' ARG . 27.9 t-80 -84.98 109.8 18.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.801 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 119.85 15.07 5.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.502 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 67.2 mt -125.53 -179.83 4.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.807 0.337 . . . . 0.0 110.899 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 38.9 mtt180 -84.05 80.02 9.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.828 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.3 t -82.48 127.49 39.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.113 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -105.57 -43.25 4.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -159.06 155.22 26.98 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.096 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 91.6 t -136.81 113.46 12.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.089 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -98.76 138.08 36.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.679 HD21 HG21 ' A' ' 250' ' ' VAL . 60.9 mt -134.67 111.38 9.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.903 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.013 HD21 ' HB1' ' A' ' 315' ' ' ALA . 15.5 mt -68.33 142.47 55.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 38.1 mttt -117.79 154.19 32.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.871 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -67.42 -176.8 0.63 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.89 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -58.58 -29.98 66.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.861 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 3.2 m -90.34 -19.18 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 108.78 40.93 1.51 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -125.72 122.94 37.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.838 0.352 . . . . 0.0 110.896 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.441 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 0.7 OUTLIER -63.87 90.21 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -56.58 -47.36 79.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 157.48 55.81 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 59.3 m-20 -161.82 123.42 2.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.852 0.358 . . . . 0.0 110.917 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.412 ' O ' HD23 ' A' ' 277' ' ' LEU . . . -156.68 179.52 32.44 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.506 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.454 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 35.0 mt -130.5 171.68 12.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.848 0.356 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.0 t -150.4 138.56 14.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.099 179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 5.6 tmtm? -119.23 144.22 46.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.446 ' N ' ' HD3' ' A' ' 279' ' ' LYS . 55.9 m-85 -130.18 162.08 29.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.9 mt -77.38 -63.24 1.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.888 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.92 144.87 29.18 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.642 0.734 . . . . 0.0 110.889 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.405 ' HG3' HG23 ' A' ' 229' ' ' ILE . 60.7 Cg_endo -74.17 -4.5 15.51 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.647 2.231 . . . . 0.0 112.346 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -80.49 -41.83 23.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.961 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -67.49 -48.28 67.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.867 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.1 t -54.35 -42.15 69.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.514 ' CD2' ' HD2' ' A' ' 291' ' ' LYS . 42.4 t80 -42.27 -30.26 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.888 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -72.71 -41.4 65.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.891 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.599 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.61 -46.44 82.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.097 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 77.9 mt -56.57 -35.12 67.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.952 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.514 ' HD2' ' CD2' ' A' ' 287' ' ' PHE . 21.2 mtpp -71.58 -18.63 62.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.848 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.422 ' NH1' ' O ' ' A' ' 253' ' ' PHE . 77.9 mtt180 -91.58 15.43 12.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.837 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -63.53 146.54 53.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.422 ' HB3' ' NH1' ' A' ' 294' ' ' ARG . 5.4 mmm180 64.27 42.15 5.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.1 mtt -106.4 -179.09 3.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.843 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.4 mt -96.38 152.24 18.79 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.894 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.2 ttm -161.29 105.18 1.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.43 HG22 ' O ' ' A' ' 298' ' ' ILE . 15.1 mt 51.63 45.03 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.113 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 25.1 mm-40 69.06 25.67 5.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 16.4 tpt180 -140.06 131.16 26.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -79.16 130.94 36.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.952 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.4 m -107.77 143.53 18.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.146 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -111.25 97.31 6.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.11 118.27 39.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.135 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 50.2 m -153.89 153.93 29.35 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.672 0.749 . . . . 0.0 110.872 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_exo -52.82 150.34 23.02 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.65 2.234 . . . . 0.0 112.293 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -128.84 -176.98 4.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.111 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -134.02 141.44 47.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.113 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -38.67 -45.18 1.07 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 27.0 mtp180 -46.03 -57.48 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.888 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -57.19 -45.47 83.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.454 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 58.8 t-105 -53.75 -54.02 43.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.923 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 91.8 t -57.24 -57.16 11.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.148 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.82 -51.31 52.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.126 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 1.013 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.01 -42.27 48.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.093 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 118.06 39.07 0.77 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.491 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -58.66 -155.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.463 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -169.81 106.16 0.35 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.747 0.308 . . . . 0.0 110.878 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.5 pt -133.3 127.72 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.129 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 63.7 p -140.43 145.18 36.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.16 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 49.3 m 51.74 43.27 30.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -97.13 -176.38 34.73 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.442 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.9 117.98 4.65 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.622 2.215 . . . . 0.0 112.342 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.7 t -87.14 137.14 32.6 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.877 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.7 p . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.857 -179.794 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.474 -0.25 . . . . 0.0 112.474 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 9.1 t 45.85 42.56 9.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.893 0.378 . . . . 0.0 110.885 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.9 t -126.51 108.26 11.0 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 150.29 67.97 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 36.7 m -127.27 103.62 7.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.842 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 67.1 m -127.12 121.89 32.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.867 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 102.09 135.12 8.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.471 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.06 141.02 4.73 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.582 0.706 . . . . 0.0 110.872 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.86 137.47 16.29 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.648 2.232 . . . . 0.0 112.36 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 13.4 mt -60.73 151.93 70.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 0.0 110.934 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.39 130.96 11.81 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.699 HG23 ' HG3' ' A' ' 283' ' ' PRO . 33.7 mt -51.67 144.57 2.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.157 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -100.42 106.37 42.21 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.673 0.749 . . . . 0.0 110.845 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.423 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.7 Cg_exo -47.22 -52.5 7.76 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.698 2.265 . . . . 0.0 112.327 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.523 ' OD1' HG22 ' A' ' 308' ' ' THR . 17.0 m-20 -34.1 -49.08 0.34 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -58.95 -62.87 1.56 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.426 HD21 ' HD3' ' A' ' 283' ' ' PRO . 16.1 mt -47.38 -32.1 4.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.912 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.445 ' O ' ' N ' ' A' ' 307' ' ' ALA . 93.3 m-85 -99.88 94.98 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.954 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.09 176.74 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.111 179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 66.3 p -133.66 144.72 49.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.451 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.6 t -129.99 109.38 17.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.149 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 45.4 m-70 -121.33 118.52 29.69 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 132.81 48.65 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.466 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.451 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -116.93 142.66 30.19 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.593 0.711 . . . . 0.0 110.879 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_exo -47.16 174.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.705 2.27 . . . . 0.0 112.341 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -81.94 -12.31 58.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 54.3 p -102.83 -7.25 21.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.841 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -64.83 117.54 7.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.052 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.416 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.4 ptt? -121.8 173.84 7.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.869 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 246' ' ' MET . 3.3 tt0 -36.5 -37.1 0.12 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.867 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -69.07 -51.16 41.7 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -51.4 -46.39 62.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.89 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.491 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -51.9 -55.82 8.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.145 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' N ' ' A' ' 255' ' ' HIS . 32.5 mtt85 -40.68 -55.75 2.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.833 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -38.6 -37.73 0.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.456 ' CD1' ' SD ' ' A' ' 297' ' ' MET . 13.7 t80 -72.4 -60.07 2.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.878 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.604 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 25.7 m-85 -99.69 43.46 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.866 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.436 ' N ' ' O ' ' A' ' 251' ' ' ARG . 85.0 t60 -83.67 -37.48 22.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.73 22.64 5.52 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.469 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 20.6 mt -135.15 172.48 12.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.771 0.319 . . . . 0.0 110.938 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.409 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 46.6 mtt180 -81.04 102.95 10.53 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.878 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 88.8 t -93.94 140.28 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.159 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.407 ' HB2' ' CD2' ' A' ' 281' ' ' LEU . 19.3 t70 -119.13 -48.58 2.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.862 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -150.53 147.9 28.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.054 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 95.1 t -133.15 118.87 33.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.152 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 78.5 t60 -108.45 140.7 41.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.491 HD21 HG21 ' A' ' 250' ' ' VAL . 23.5 mt -136.34 119.12 16.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.889 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.003 HD21 ' HB1' ' A' ' 315' ' ' ALA . 62.3 mt -66.07 179.21 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.925 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -136.6 -175.04 3.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.856 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -105.27 -75.05 0.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.502 ' CD2' HG13 ' A' ' 269' ' ' VAL . 5.1 p-80 -133.17 -56.97 0.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.841 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.502 HG13 ' CD2' ' A' ' 268' ' ' HIS . 19.2 m -91.46 -34.63 6.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.108 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 143.3 52.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.487 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -110.2 148.02 32.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.789 0.328 . . . . 0.0 110.902 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -72.05 87.16 1.05 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.857 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 -59.41 -49.13 78.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 136.01 33.75 0.25 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.52 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 46.5 m-80 -152.04 129.85 11.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.888 0.375 . . . . 0.0 110.88 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.4 -176.87 31.94 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.535 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.474 ' HB2' ' CZ3' ' A' ' 312' ' ' TRP . 17.5 mt -127.53 162.43 26.46 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.85 0.357 . . . . 0.0 110.932 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.0 t -140.38 133.54 33.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 14.3 tttt -114.05 136.68 52.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 69.3 m-85 -114.68 175.99 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.847 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.425 ' O ' HD22 ' A' ' 234' ' ' LEU . 30.8 mt -89.53 -66.75 0.89 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.899 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 60.6 p -100.24 135.88 20.2 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.617 0.722 . . . . 0.0 110.874 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.699 ' HG3' HG23 ' A' ' 229' ' ' ILE . 76.4 Cg_exo -49.1 -24.71 8.11 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.67 2.246 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -63.7 -68.47 0.34 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 6.9 m-20 -41.26 -43.11 2.32 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 287' ' ' PHE . 99.6 m -53.08 -57.58 9.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.133 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.542 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 1.8 t80 -34.7 -52.71 0.53 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.895 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -41.14 -50.23 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.829 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.604 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -64.12 -50.96 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.089 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.599 HD22 ' HD3' ' A' ' 306' ' ' PRO . 35.7 mt -51.99 -21.46 3.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.933 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 63.0 mttt -80.37 -29.81 37.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.918 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 30.4 mtt180 -84.69 20.36 1.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.39 137.71 58.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 61.99 40.97 11.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.0 mmt -102.56 176.43 5.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.847 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.1 mt -98.42 151.93 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . 0.456 ' SD ' ' CD1' ' A' ' 253' ' ' PHE . 3.2 ttp -172.45 105.43 0.17 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.564 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.1 mt 69.47 39.14 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 21.2 mm-40 65.17 26.43 12.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -139.98 146.8 39.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -93.83 126.4 39.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.951 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.2 m -102.06 146.44 10.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.144 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -111.82 99.25 7.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.928 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 84.3 t -96.48 117.76 41.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 94.3 p -155.79 146.16 15.98 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.619 0.724 . . . . 0.0 110.874 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.599 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.3 Cg_exo -48.3 159.33 0.76 Allowed 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.683 2.256 . . . . 0.0 112.333 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.06 166.9 23.29 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.143 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.523 HG22 ' OD1' ' A' ' 232' ' ' ASP . 40.4 p -119.44 136.71 54.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.129 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 308' ' ' THR . 33.7 tt0 -36.42 -45.56 0.49 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.928 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 57.6 mtt180 -47.19 -46.86 24.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.892 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -68.67 -42.96 77.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.912 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.474 ' CZ3' ' HB2' ' A' ' 277' ' ' LEU . 37.6 t-105 -56.62 -36.33 69.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 96.3 t -81.65 -51.61 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.152 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.17 -48.03 71.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.111 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 1.003 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -54.27 -38.82 66.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.66 41.33 0.5 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.43 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -93.54 173.57 34.05 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.508 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 48.7 t60 -159.27 118.41 2.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.728 0.299 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.676 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.2 OUTLIER -133.76 156.96 41.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.099 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 321' ' ' SER . 9.1 t -99.52 45.79 0.99 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.137 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 320' ' ' THR . 24.3 t 36.96 46.51 0.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.861 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 83.37 160.96 30.57 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.506 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -45.67 148.0 2.68 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.684 2.256 . . . . 0.0 112.378 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 8.7 m -57.66 -58.98 5.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.878 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 37.7 t . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.867 -179.84 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 44.4 p -174.86 132.28 0.33 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.921 0.391 . . . . 0.0 110.833 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 92.6 p -168.65 149.84 4.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.824 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -144.03 -174.02 15.95 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 8.6 t -74.01 152.36 40.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.899 0.381 . . . . 0.0 110.836 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 87.8 p -139.71 164.32 30.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.883 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -133.45 -80.1 0.15 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -109.73 162.43 20.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.62 0.724 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.57 138.12 11.09 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.648 2.232 . . . . 0.0 112.371 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 3.6 mp -111.51 153.51 44.18 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.646 0.736 . . . . 0.0 110.933 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.57 144.94 25.78 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.635 2.224 . . . . 0.0 112.365 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.42 ' O ' ' HD3' ' A' ' 231' ' ' PRO . 79.8 mt -41.79 146.46 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.137 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -100.42 103.48 23.92 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 0.0 110.842 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 229' ' ' ILE . 73.2 Cg_exo -42.72 -50.07 6.2 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.652 2.235 . . . . 0.0 112.381 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 6.1 t0 -37.4 -43.5 0.57 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -63.15 -63.52 1.17 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.911 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 20.4 mt -47.41 -33.78 6.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.918 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.551 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 68.4 m-85 -99.83 94.63 6.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.937 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.2 m -104.61 175.95 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.148 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 81.5 p -132.57 145.11 50.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.527 ' O ' ' HE1' ' A' ' 241' ' ' MET . 12.1 t -122.05 114.65 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.136 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 11.8 m-70 -124.19 124.99 43.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.53 47.62 0.25 Allowed Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.475 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.527 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.5 mpp? -117.2 138.61 25.05 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.582 0.706 . . . . 0.0 110.87 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -47.38 171.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.696 2.264 . . . . 0.0 112.322 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 11.6 t80 -70.87 -32.84 69.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.858 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 7.2 t -79.2 -23.78 43.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.882 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -38.17 129.66 1.27 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.7 ptt? -137.89 173.89 11.16 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.849 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.807 ' HA ' HD11 ' A' ' 264' ' ' LEU . 9.3 tt0 -42.54 -54.66 3.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.889 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 32.3 t-20 -48.52 -54.06 15.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -46.78 -51.19 16.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.549 HG21 HD21 ' A' ' 264' ' ' LEU . 94.9 t -43.71 -57.97 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.111 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -42.23 -53.12 4.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -41.28 -36.88 0.86 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 21.5 t80 -73.02 -58.98 2.93 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.538 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 52.4 m-85 -96.02 41.05 1.11 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.875 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -86.48 99.28 11.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.813 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 144.86 -16.66 1.97 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.514 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -102.2 179.14 4.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.807 0.337 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.5 mtt85 -80.29 98.54 7.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.0 t -92.13 124.35 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.118 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -100.62 -47.29 4.91 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.856 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.36 160.4 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.111 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 71.6 t -144.98 125.33 7.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.167 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -110.49 142.54 42.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.857 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.807 HD11 ' HA ' ' A' ' 247' ' ' GLU . 36.5 mt -133.0 118.44 18.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.87 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.893 HD21 ' HB1' ' A' ' 315' ' ' ALA . 24.2 mt -71.84 153.85 41.64 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 25.6 mttp -133.39 159.57 39.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.894 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.6 t0 -64.81 -175.04 0.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.895 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.454 ' NE2' HG13 ' A' ' 269' ' ' VAL . 0.3 OUTLIER -59.7 -30.54 68.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.868 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.518 HG23 ' HG3' ' A' ' 271' ' ' ARG . 25.6 m -91.9 -24.82 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.094 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 111.38 46.73 0.78 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.491 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.518 ' HG3' HG23 ' A' ' 269' ' ' VAL . 91.3 mtt-85 -112.29 139.3 47.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.79 0.329 . . . . 0.0 110.867 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -64.58 81.85 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -61.07 -53.43 57.22 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.24 43.08 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.526 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.536 ' HB3' HD12 ' A' ' 265' ' ' LEU . 87.8 m-20 -147.26 130.76 16.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.877 0.37 . . . . 0.0 110.885 -179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.49 164.79 37.91 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.481 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 21.6 mt -114.11 168.25 9.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.897 0.38 . . . . 0.0 110.899 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.552 HG12 ' CZ ' ' A' ' 280' ' ' PHE . 80.5 t -143.95 137.9 24.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.096 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.551 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 12.2 tttt -126.73 155.75 42.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.552 ' CZ ' HG12 ' A' ' 278' ' ' VAL . 1.1 m-85 -140.01 -179.37 5.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.906 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.3 mt -87.39 -61.88 1.62 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.867 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.0 m -98.06 151.09 37.37 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.665 0.745 . . . . 0.0 110.887 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.31 -25.55 11.29 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.632 2.222 . . . . 0.0 112.326 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -59.61 -47.79 84.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -66.84 -40.07 87.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.883 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 289' ' ' ALA . 77.8 m -59.11 -53.86 53.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.148 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.574 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -34.44 -47.04 0.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.873 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -48.71 -47.12 41.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.888 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.18 -45.0 79.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.119 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.7 mt -64.77 -17.27 64.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.883 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.574 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 33.0 mttm -87.19 -23.98 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -91.65 20.72 5.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.892 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -68.3 158.37 33.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.1 mmm180 54.1 40.89 32.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 12.5 mtt -103.41 178.62 4.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.898 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -99.88 151.74 20.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.925 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 5.4 ttm -164.75 105.71 0.83 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.928 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 298' ' ' ILE . 37.3 mt 58.66 45.82 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.137 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 64.93 26.9 12.8 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.896 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.7 tpp180 -138.85 148.09 43.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.868 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -93.44 129.03 39.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.924 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.8 m -106.26 140.37 24.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.13 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.67 110.88 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.871 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.443 HG11 ' O ' ' A' ' 289' ' ' ALA . 30.6 t -106.53 110.53 31.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.173 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 9.1 m -146.51 153.8 47.96 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.686 0.755 . . . . 0.0 110.855 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.471 ' HD3' HD22 ' A' ' 290' ' ' LEU . 68.6 Cg_exo -52.15 156.86 7.07 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.675 2.25 . . . . 0.0 112.366 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -136.2 178.73 6.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.096 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.422 ' O ' ' C ' ' A' ' 309' ' ' GLU . 18.5 p -127.23 134.8 50.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.156 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 308' ' ' THR . 16.0 tt0 -36.09 -46.74 0.51 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.833 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 37.9 mtp180 -44.52 -47.44 10.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.856 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -66.34 -45.29 80.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.517 ' HE1' HG23 ' A' ' 319' ' ' ILE . 35.5 t-105 -56.23 -49.96 72.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 89.4 t -58.58 -57.71 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.105 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -52.48 -49.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.115 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.893 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.93 -39.19 54.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.112 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 121.83 41.42 0.49 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.47 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -109.45 122.39 6.44 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 -179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -111.91 96.86 6.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.802 0.334 . . . . 0.0 110.88 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.578 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -100.06 147.86 7.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.145 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 12.7 p -123.07 -4.63 8.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.172 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 95.2 p -90.03 112.97 24.57 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 -179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.83 88.07 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.2 -16.66 17.51 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.674 2.25 . . . . 0.0 112.341 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 3.2 t -75.69 124.56 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.875 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 47.4 t . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.48 -0.248 . . . . 0.0 112.48 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.0 m 51.06 36.31 15.05 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.814 0.34 . . . . 0.0 110.814 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 77.4 p -73.79 165.78 24.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.843 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 132.1 -117.34 2.03 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.437 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 40.3 m 52.3 44.61 29.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 80.0 p -103.9 118.49 36.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.891 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 142.82 -47.65 0.8 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.447 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 38.1 mttp -134.37 146.51 59.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.635 0.731 . . . . 0.0 110.879 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.03 108.65 2.68 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.668 2.245 . . . . 0.0 112.326 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 18.2 mt -79.82 152.3 74.6 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.636 0.731 . . . . 0.0 110.903 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 163.48 37.41 Favored 'Trans proline' 0 C--O 1.232 0.205 0 C-N-CA 122.687 2.258 . . . . 0.0 112.345 179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 30.6 mt -72.42 137.69 23.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.101 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.43 ' ND2' ' HB3' ' A' ' 232' ' ' ASP . 24.0 t30 -82.9 139.88 43.21 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.601 0.715 . . . . 0.0 110.853 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.432 ' O ' ' C ' ' A' ' 232' ' ' ASP . 61.5 Cg_endo -79.56 -46.89 0.09 OUTLIER 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.658 2.239 . . . . 0.0 112.317 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.1 OUTLIER -34.34 -47.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.859 179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -65.65 -68.42 0.37 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.86 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 18.3 mt -44.2 -29.02 0.58 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.569 ' CE1' ' HD3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.57 99.36 9.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.951 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.92 177.29 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 17.5 p -134.43 142.77 47.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.873 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.42 ' O ' ' CE ' ' A' ' 241' ' ' MET . 15.9 t -122.38 118.63 55.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.151 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -122.9 123.27 40.58 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.872 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 124.34 41.45 0.39 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.462 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.42 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.9 mpp? -111.45 140.67 23.29 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.546 0.689 . . . . 0.0 110.865 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -47.52 176.05 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.715 2.277 . . . . 0.0 112.343 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -82.97 -25.72 32.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 32.3 p -88.6 -15.73 34.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.844 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -49.26 128.62 17.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.068 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -129.58 178.69 6.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.473 ' HA ' HD11 ' A' ' 264' ' ' LEU . 35.4 tt0 -41.72 -60.58 1.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -44.67 -53.19 7.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.904 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.25 -52.18 16.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.83 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.655 HG21 HD21 ' A' ' 264' ' ' LEU . 92.9 t -50.66 -56.31 4.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -41.87 -55.32 3.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.865 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -38.41 -37.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.881 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.461 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 10.3 t80 -69.76 -63.01 1.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.583 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 22.5 m-85 -100.02 45.87 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.896 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -84.08 -46.48 11.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.875 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -57.87 -10.33 6.5 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.501 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.7 mt -109.53 173.08 6.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.977 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -80.99 116.48 20.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -99.83 132.77 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.132 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.8 -47.95 3.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.908 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.617 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -149.94 156.24 41.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.123 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.4 t -145.4 130.05 12.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.122 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -120.94 145.24 47.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.655 HD21 HG21 ' A' ' 250' ' ' VAL . 25.1 mt -139.26 123.7 18.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.797 HD21 ' HB1' ' A' ' 315' ' ' ALA . 41.8 mt -77.21 139.49 39.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.907 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.9 mttm -119.14 167.86 11.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.905 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -91.39 -177.06 4.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.82 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.544 ' CE1' HG13 ' A' ' 269' ' ' VAL . 6.8 p80 -61.84 -20.48 63.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.843 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.544 HG13 ' CE1' ' A' ' 268' ' ' HIS . 3.3 m -97.26 -8.25 9.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.102 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 86.51 41.42 6.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.52 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.9 ptt85 -127.22 142.19 51.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.912 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -58.53 123.6 16.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.906 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.25 -40.33 10.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.407 ' O ' ' CG ' ' A' ' 275' ' ' ASN . . . 135.05 46.4 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.46 179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.407 ' CG ' ' O ' ' A' ' 274' ' ' GLY . 78.1 m-20 -163.6 123.62 2.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.846 0.355 . . . . 0.0 110.886 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -153.25 173.17 32.13 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.513 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 44.8 mt -124.18 155.28 38.78 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.802 0.334 . . . . 0.0 110.917 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.468 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.6 t -129.77 149.53 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.118 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 261' ' ' ALA . 23.5 tptp -133.94 144.23 48.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.519 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 8.3 m-85 -133.62 171.16 14.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 26.6 mt -78.65 -63.99 1.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.911 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 39.6 m -100.04 152.52 37.85 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.65 0.738 . . . . 0.0 110.84 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 -8.49 18.8 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.632 2.221 . . . . 0.0 112.32 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 1.3 tp-100 -74.29 -50.27 19.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -62.71 -43.09 99.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.847 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.519 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 53.8 m -54.64 -52.66 61.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.128 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.492 ' CD2' ' HE2' ' A' ' 291' ' ' LYS . 2.4 t80 -36.39 -48.65 0.67 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.853 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -48.24 -44.43 33.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.876 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.583 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -58.62 -52.28 66.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.104 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.482 HD22 ' HD3' ' A' ' 306' ' ' PRO . 24.7 mt -54.79 -23.92 20.29 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.911 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.492 ' HE2' ' CD2' ' A' ' 287' ' ' PHE . 46.3 mttm -80.33 -24.36 39.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.922 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.441 ' O ' ' CG ' ' A' ' 295' ' ' MET . 25.6 mtt180 -88.42 14.0 10.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -58.84 149.9 25.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.883 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.6 mmm-85 61.34 39.45 15.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.858 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.441 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 3.2 mmt -101.05 178.11 4.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.9 mt -98.86 156.38 16.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.899 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 4.9 ttm -168.97 105.67 0.41 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.831 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.568 HG22 ' O ' ' A' ' 298' ' ' ILE . 28.7 mt 59.92 42.97 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 66.62 25.5 9.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.934 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -140.02 137.93 35.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.898 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -81.28 135.96 35.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.913 -179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 3.1 m -113.58 143.53 23.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.14 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -110.65 109.31 19.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.902 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 58.1 t -102.57 120.59 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.127 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.8 p -154.66 147.57 18.01 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.623 0.725 . . . . 0.0 110.875 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.482 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.9 Cg_exo -48.95 157.89 1.48 Allowed 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.713 2.275 . . . . 0.0 112.327 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -134.25 178.33 7.06 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.091 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 20.7 p -128.46 139.26 52.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.135 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -39.77 -46.69 1.96 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.869 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 81.5 mtt180 -47.46 -53.2 14.79 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.829 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -61.33 -36.13 79.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.468 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 42.9 t-105 -63.91 -47.83 79.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.952 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 92.6 t -60.0 -56.61 16.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.144 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -51.61 -46.77 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.134 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.797 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -50.14 -40.12 45.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.122 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.04 38.17 0.51 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.464 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -99.55 152.82 19.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.476 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -100.85 110.55 22.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.805 0.336 . . . . 0.0 110.847 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.718 HD12 ' N ' ' A' ' 320' ' ' THR . 2.2 pp -133.52 -40.33 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.145 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.718 ' N ' HD12 ' A' ' 319' ' ' ILE . 0.5 OUTLIER 32.92 54.96 0.42 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.145 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.8 t -122.26 103.81 9.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.87 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 177.23 140.2 3.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.496 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 126.23 11.72 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.728 2.285 . . . . 0.0 112.31 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 18.7 t -123.06 79.43 1.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.864 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.6 p . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 -179.782 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.307 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 28.5 m -152.84 144.24 23.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.901 0.382 . . . . 0.0 110.853 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 15.4 m -153.8 117.6 4.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.817 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 130.46 129.11 3.06 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.476 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.1 m -166.26 172.02 11.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.909 0.385 . . . . 0.0 110.853 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 15.6 m -144.31 152.04 40.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -117.71 55.81 0.56 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.508 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 11.8 mtmm -138.21 158.81 70.25 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.572 0.701 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.95 102.47 1.62 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.673 2.248 . . . . 0.0 112.344 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 57.8 mt -121.13 154.07 58.19 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.667 0.746 . . . . 0.0 110.877 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_exo -45.63 160.47 0.16 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.369 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 234' ' ' LEU . 27.1 mt -58.42 133.54 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.11 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -94.11 110.74 49.95 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.655 0.74 . . . . 0.0 110.877 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.64 -47.16 21.59 Favored 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.71 2.273 . . . . 0.0 112.37 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.05 -32.92 3.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.25 -66.57 0.58 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.424 HD11 HG21 ' A' ' 229' ' ' ILE . 36.1 mt -45.48 -27.64 0.76 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.937 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.422 ' O ' ' N ' ' A' ' 307' ' ' ALA . 55.3 m-85 -99.95 101.0 11.98 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.925 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.464 ' CG1' HD21 ' A' ' 290' ' ' LEU . 9.2 m -116.11 172.29 4.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.108 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 72.8 p -130.47 151.58 50.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.848 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.473 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.2 t -128.69 115.47 37.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -120.24 128.03 52.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 117.5 49.47 0.39 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.481 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.473 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.3 mpp? -119.26 140.62 29.23 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.572 0.701 . . . . 0.0 110.884 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.26 153.69 1.68 Allowed 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.694 2.263 . . . . 0.0 112.313 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -58.18 -35.72 72.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.446 ' O ' ' C ' ' A' ' 245' ' ' ALA . 4.5 m -77.17 -23.52 51.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.872 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -34.17 130.2 0.34 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.109 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 6.6 ptp -133.44 179.86 5.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.24 -53.74 32.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.847 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -50.15 -43.83 52.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.897 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -57.33 -44.29 84.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.865 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.0 t -51.85 -59.42 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.115 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 252' ' ' ASP . 16.2 mtp85 -41.23 -58.1 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.868 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.8 t70 -34.82 -39.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.843 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.518 ' CE2' HG21 ' A' ' 302' ' ' VAL . 19.5 t80 -68.19 -66.45 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.69 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 31.1 m-85 -92.39 42.0 1.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.888 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -86.32 31.81 0.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.905 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -144.72 19.76 2.01 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.491 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 18.8 mt -137.17 -175.3 4.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.415 ' HB3' HD12 ' A' ' 281' ' ' LEU . 47.4 mtm180 -86.96 90.93 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.862 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 86.1 t -82.01 133.32 29.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.063 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -109.91 -46.33 3.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.868 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -155.61 160.08 40.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.087 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 89.5 t -140.44 131.9 30.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.166 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 22.1 t60 -123.19 140.85 52.59 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.845 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 51.1 mt -135.92 130.68 34.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.886 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.885 HD21 ' HB1' ' A' ' 315' ' ' ALA . 70.6 mt -80.41 156.52 26.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.949 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -125.64 168.02 14.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.891 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.78 -175.76 3.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.823 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.512 ' CD2' HG13 ' A' ' 269' ' ' VAL . 0.3 OUTLIER -54.15 -33.21 57.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.517 HG23 ' CG ' ' A' ' 271' ' ' ARG . 17.6 m -95.77 21.67 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.134 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 60.75 40.4 98.05 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.512 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.517 ' CG ' HG23 ' A' ' 269' ' ' VAL . 14.1 mmt180 -123.52 137.71 54.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.826 0.346 . . . . 0.0 110.85 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -60.67 119.93 9.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.93 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -86.2 -44.72 11.96 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.898 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 146.72 41.34 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.476 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -155.77 124.39 5.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.888 0.375 . . . . 0.0 110.876 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -148.45 177.65 26.56 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.467 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' A' ' 312' ' ' TRP . 35.6 mt -129.24 152.92 48.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.858 0.361 . . . . 0.0 110.907 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 14.4 t -133.53 145.56 33.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.151 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 24.7 tttm -123.36 147.49 47.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.862 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.438 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 36.9 m-85 -132.0 173.19 11.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.912 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 258' ' ' ARG . 31.2 mt -83.49 -63.77 1.29 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.875 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 2.8 m -100.04 154.36 37.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 0.0 110.87 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.02 -6.47 18.57 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.687 2.258 . . . . 0.0 112.329 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -77.77 -65.87 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.875 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -46.01 -45.97 16.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.901 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.438 ' OG1' ' CD2' ' A' ' 280' ' ' PHE . 59.5 m -47.8 -51.36 22.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -46.5 -48.06 19.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.908 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.463 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 59.6 mm-40 -46.48 -32.81 3.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.69 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -80.33 -48.74 12.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.056 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' HD3' ' A' ' 306' ' ' PRO . 49.5 mt -53.87 -32.57 53.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.905 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.463 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 0.3 OUTLIER -76.12 -17.44 59.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 179.862 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 295' ' ' MET . 85.0 mtt180 -89.92 14.09 13.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.9 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 7.8 p-10 -59.17 157.49 10.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.0 mmt180 58.45 40.38 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.881 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.418 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 7.4 mmt -101.14 174.54 5.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.863 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 296' ' ' LEU . 11.9 mt -98.29 150.05 21.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.926 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -162.61 105.58 1.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . . . . . . . . . 7.4 mt 56.63 50.6 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.105 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.5 mt-30 60.98 26.96 16.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 15.3 tpp180 -138.44 145.77 41.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -91.74 127.22 37.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.939 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.518 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.2 m -104.49 142.71 17.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.155 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -112.39 109.06 18.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.91 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.416 HG12 HD23 ' A' ' 290' ' ' LEU . 55.4 t -101.15 119.82 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.0 m -153.17 147.5 18.97 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.821 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.519 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.4 Cg_exo -48.95 160.61 0.66 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.702 2.268 . . . . 0.0 112.359 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.8 159.57 41.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.114 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 19.3 p -106.15 140.58 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.158 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -40.41 -47.84 2.64 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 20.1 mtp180 -46.87 -40.77 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -70.65 -39.39 73.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.499 ' HA ' HD13 ' A' ' 277' ' ' LEU . 50.8 t-105 -63.99 -41.66 97.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.917 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 93.9 t -72.09 -55.97 11.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.142 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.86 -38.8 73.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.149 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.885 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -57.93 -38.87 76.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.7 0.31 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.11 178.45 53.84 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.521 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 3.1 t-80 -129.81 92.6 3.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.842 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.796 HD13 ' H ' ' A' ' 319' ' ' ILE . 0.1 OUTLIER -140.57 161.09 24.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.08 -179.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 59.2 m -129.84 145.65 51.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.164 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 46.0 t -93.02 142.35 27.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.842 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 104.18 144.8 13.67 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.532 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.83 116.57 3.77 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.722 2.281 . . . . 0.0 112.308 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 53.7 p -110.3 121.7 45.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.827 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.9 m . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.865 -179.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 51.1 p -101.38 104.63 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.9 0.381 . . . . 0.0 110.851 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 2.7 t 38.66 45.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.85 -179.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.53 51.15 0.73 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.428 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 11.5 m -138.67 131.35 29.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.86 -179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 12.7 m -120.38 139.09 53.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.461 ' O ' ' C ' ' A' ' 225' ' ' LYS . . . 103.6 -114.05 4.68 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.467 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 224' ' ' GLY . 55.3 mttp -33.55 96.9 0.11 Allowed Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.606 0.717 . . . . 0.0 110.864 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.422 ' N ' ' O ' ' A' ' 224' ' ' GLY . 61.2 Cg_endo -75.43 79.87 2.66 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.665 2.243 . . . . 0.0 112.337 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -52.15 153.23 5.01 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.632 0.729 . . . . 0.0 110.886 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.34 148.26 33.77 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.639 2.226 . . . . 0.0 112.346 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.444 HG21 HD11 ' A' ' 234' ' ' LEU . 19.6 mt -40.14 137.83 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.137 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -94.62 108.67 38.69 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.614 0.721 . . . . 0.0 110.916 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -43.51 -48.1 8.78 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.655 2.237 . . . . 0.0 112.361 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -36.99 -42.37 0.4 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.86 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -65.39 -54.32 30.36 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.444 HD11 HG21 ' A' ' 229' ' ' ILE . 13.1 mt -64.04 -19.55 65.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.92 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.6 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 4.0 m-85 -108.28 99.64 9.03 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.942 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 3.8 m -118.8 156.63 20.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.113 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 6.5 t -111.65 155.0 24.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.858 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.467 ' O ' ' HE1' ' A' ' 241' ' ' MET . 15.4 t -128.89 114.12 31.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.17 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -119.26 124.7 47.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 122.11 49.67 0.25 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.5 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.546 ' HG3' HG12 ' A' ' 302' ' ' VAL . 2.8 mpp? -120.11 142.43 33.49 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.579 0.704 . . . . 0.0 110.882 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.92 156.9 0.6 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.373 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -67.11 -9.61 41.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.868 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 41.2 m -103.29 -11.8 17.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.85 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -55.19 136.79 48.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.115 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 8.2 ptp -137.3 173.12 12.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.853 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.706 ' N ' HD11 ' A' ' 264' ' ' LEU . 11.9 tt0 -43.57 -40.97 4.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -60.06 -59.75 4.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.879 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -46.54 -47.09 19.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.854 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 93.8 t -46.44 -58.96 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.084 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 252' ' ' ASP . 36.2 mtt180 -40.24 -54.59 2.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.875 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.429 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.0 t70 -35.13 -40.2 0.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -67.22 -64.14 0.92 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.714 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 11.2 m-85 -99.93 46.82 0.95 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 13.3 p-80 -85.69 -33.56 21.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -83.2 26.04 4.59 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.48 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 56.4 mt -137.03 175.78 9.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.864 0.364 . . . . 0.0 110.888 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 15.0 mtt-85 -77.38 96.56 4.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.864 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 98.7 t -88.52 135.76 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.136 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.422 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.1 OUTLIER -110.25 -49.89 3.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -154.34 162.06 41.39 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.112 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 75.1 t -141.43 127.0 18.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -121.12 146.32 46.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.92 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.706 HD11 ' N ' ' A' ' 247' ' ' GLU . 59.1 mt -135.03 155.16 51.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.907 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.666 HD21 ' HB1' ' A' ' 315' ' ' ALA . 52.5 mt -111.51 165.18 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.958 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.439 ' O ' ' ND2' ' A' ' 273' ' ' ASN . 10.6 mmtp -115.39 -177.52 3.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.932 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -117.38 -179.82 3.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.85 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.406 ' CD2' HG13 ' A' ' 269' ' ' VAL . 5.8 p-80 -45.93 -48.63 16.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 268' ' ' HIS . 16.1 m -74.94 -17.87 16.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.092 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 99.09 30.28 6.77 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.489 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 17.4 ptt180 -121.74 146.02 47.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.851 0.358 . . . . 0.0 110.885 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -51.44 113.45 0.96 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.93 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.439 ' ND2' ' O ' ' A' ' 266' ' ' LYS . 4.5 p30 -87.78 -51.35 5.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 151.48 46.61 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.532 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 7.0 m-80 -149.53 119.61 7.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.854 0.359 . . . . 0.0 110.9 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.492 ' HA3' HD23 ' A' ' 264' ' ' LEU . . . -146.89 157.98 27.58 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.496 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.632 HD13 ' HA ' ' A' ' 312' ' ' TRP . 19.8 mt -114.57 136.53 52.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.851 0.358 . . . . 0.0 110.904 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 61.1 t -114.39 144.5 21.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 280' ' ' PHE . 10.2 tmtt? -126.97 140.61 52.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.881 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.455 ' CD2' ' OG1' ' A' ' 286' ' ' THR . 53.3 m-85 -126.63 165.28 19.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.8 mt -79.65 -67.77 0.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.929 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 67.6 m -94.8 154.59 39.84 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.629 0.728 . . . . 0.0 110.894 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.67 -14.01 17.81 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.675 2.25 . . . . 0.0 112.359 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 53.6 mm-40 -71.49 -47.01 58.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.867 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 26.4 m-20 -65.31 -54.27 31.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.842 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.53 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.4 t -52.28 -46.66 65.97 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.145 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.53 ' N ' ' CG2' ' A' ' 286' ' ' THR . 13.2 t80 -41.35 -31.21 0.22 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.459 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 21.3 mt-10 -69.35 -45.64 68.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.941 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.714 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -56.16 -41.23 75.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.157 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.4 HD22 ' HD3' ' A' ' 306' ' ' PRO . 83.1 mt -60.85 -27.08 67.83 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.91 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.459 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 47.6 mtmt -83.97 -7.24 59.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.85 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 29.5 mtp85 -100.9 14.26 32.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.416 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 1.3 p-10 -64.95 155.38 34.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.891 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.416 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 15.0 mmm180 58.79 36.08 24.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.856 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.7 mtt -100.19 178.9 4.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.6 mt -99.55 157.4 16.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.884 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 10.7 ttm -169.28 107.52 0.42 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.854 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.628 HG22 ' O ' ' A' ' 298' ' ' ILE . 25.6 mt 59.52 41.76 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.157 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.3 mm-40 69.36 25.95 5.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.936 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 14.3 tpp180 -139.06 152.23 47.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.907 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.6 m-85 -96.91 128.06 43.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.546 HG12 ' HG3' ' A' ' 241' ' ' MET . 3.5 m -104.06 146.21 11.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.159 179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -113.0 99.82 8.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.9 t -95.53 113.81 30.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.154 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 83.1 p -144.01 150.5 49.51 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.619 0.723 . . . . 0.0 110.876 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.4 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.1 Cg_exo -51.63 157.44 5.24 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.667 2.245 . . . . 0.0 112.358 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.6 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -131.93 -177.14 4.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.107 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 11.0 p -132.08 151.25 51.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.114 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -46.37 -39.98 11.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.888 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -61.25 -50.84 71.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.86 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -58.61 -38.53 78.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.946 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.632 ' HA ' HD13 ' A' ' 277' ' ' LEU . 58.0 t-105 -64.22 -48.52 75.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.1 t -64.15 -54.04 36.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.131 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -48.22 -53.56 16.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.129 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.666 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -46.73 -42.61 17.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 132.95 39.48 0.21 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.434 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -92.81 -173.22 41.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.469 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -143.64 111.02 5.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.842 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 9.1 pt -131.55 144.43 37.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.081 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 15.1 t -154.47 149.44 26.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.072 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 11.9 t -111.32 92.51 4.07 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 160.91 145.89 4.44 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.52 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -78.52 -51.44 0.07 OUTLIER 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.703 2.268 . . . . 0.0 112.336 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 63.8 m -143.28 175.64 9.74 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.87 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 64.7 p . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.869 -179.847 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 36.5 m -157.0 150.41 24.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.863 0.364 . . . . 0.0 110.906 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.9 m -164.34 156.65 16.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.905 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 151.99 137.62 2.63 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 25.0 t -163.36 149.98 12.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 110.887 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 59.4 p -170.75 146.61 2.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.846 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.76 168.41 24.64 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.469 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -90.0 155.0 47.6 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.556 0.693 . . . . 0.0 110.912 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -75.46 105.66 2.12 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.676 2.251 . . . . 0.0 112.344 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.6 mt -146.29 158.5 47.5 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.608 0.718 . . . . 0.0 110.909 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.91 145.46 2.97 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.671 2.247 . . . . 0.0 112.368 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.687 HD13 ' HG3' ' A' ' 283' ' ' PRO . 55.3 mt -48.87 121.69 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 45.5 t-20 -81.49 124.21 80.37 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.604 0.716 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.23 -25.35 4.46 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.699 2.266 . . . . 0.0 112.334 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' CG ' ' N ' ' A' ' 233' ' ' ASP . 0.4 OUTLIER -40.01 -47.18 2.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.879 179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.409 ' N ' ' CG ' ' A' ' 232' ' ' ASP . 5.0 t70 -66.52 -67.04 0.48 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.847 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 15.4 mt -43.44 -31.81 0.76 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.939 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.639 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 69.3 m-85 -99.82 96.83 7.85 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.989 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 13.6 m -110.27 178.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.092 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 75.3 p -134.95 142.96 46.63 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.844 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.464 ' O ' ' CE ' ' A' ' 241' ' ' MET . 13.4 t -120.32 112.08 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.162 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 70.8 m-70 -118.59 123.87 46.08 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.867 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.94 48.95 0.22 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.491 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.464 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -121.88 140.86 32.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.542 0.687 . . . . 0.0 110.909 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -47.25 165.57 0.1 Allowed 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.647 2.232 . . . . 0.0 112.333 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -67.69 -32.77 73.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.898 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.428 ' O ' ' C ' ' A' ' 245' ' ' ALA . 67.6 m -79.52 -24.39 42.26 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.807 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.428 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.87 114.38 0.27 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.137 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.6 ptp -114.26 -178.9 3.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.864 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.498 ' HA ' HD11 ' A' ' 264' ' ' LEU . 6.1 tt0 -51.15 -55.67 16.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t30 -45.78 -52.11 11.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.895 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -46.94 -46.73 21.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 90.5 t -49.9 -57.86 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.11 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.4 OUTLIER -49.45 -42.91 44.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -46.08 -37.52 6.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.882 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -75.01 -60.16 2.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.872 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.561 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 49.0 m-85 -91.01 35.32 0.91 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.457 ' N ' ' O ' ' A' ' 251' ' ' ARG . 25.1 t60 -82.82 100.47 10.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.848 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 141.31 -11.78 2.77 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.467 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 26.2 mt -102.84 -174.85 2.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.919 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.8 mtt85 -83.71 94.34 8.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.832 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.23 132.1 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -110.22 -39.57 4.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -169.78 158.65 7.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.124 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.1 t -141.47 133.47 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -118.4 147.24 43.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.834 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.498 HD11 ' HA ' ' A' ' 247' ' ' GLU . 50.8 mt -134.27 129.97 36.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.927 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 41.1 mt -79.15 147.5 32.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.904 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 6.6 mmpt? -105.72 165.54 11.1 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.644 ' OD2' HG22 ' A' ' 269' ' ' VAL . 6.6 p-10 -104.45 -174.9 2.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -25.84 28.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.894 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.644 HG22 ' OD2' ' A' ' 267' ' ' ASP . 27.7 m -115.22 25.03 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.102 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.498 ' N ' ' OD1' ' A' ' 267' ' ' ASP . . . 79.49 -40.97 2.25 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.49 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.569 ' HG3' HG23 ' A' ' 269' ' ' VAL . 61.2 mtp180 -40.87 152.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.886 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.43 HD21 HD22 ' A' ' 264' ' ' LEU . 21.7 t-20 -71.65 114.26 9.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.916 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.22 -53.99 25.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.57 36.83 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.505 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 275' ' ' ASN . 6.8 p-10 -152.29 128.91 10.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.893 0.378 . . . . 0.0 110.881 -179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.05 162.65 28.61 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.512 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.568 HD13 ' HA ' ' A' ' 312' ' ' TRP . 55.2 mt -117.59 142.26 47.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.837 0.351 . . . . 0.0 110.899 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.401 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 43.1 t -119.55 145.25 26.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.101 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.559 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 5.0 tmtt? -134.42 135.39 42.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.401 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 4.5 m-85 -122.97 -176.88 3.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 29.6 mt -88.84 -63.59 1.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.7 m -99.59 151.39 37.43 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.652 0.739 . . . . 0.0 110.839 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.687 ' HG3' HD13 ' A' ' 229' ' ' ILE . 61.4 Cg_endo -75.56 -11.95 20.47 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.674 2.25 . . . . 0.0 112.36 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -71.85 -50.67 27.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.62 -40.48 97.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.811 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 287' ' ' PHE . 53.1 m -56.76 -50.59 71.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.12 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.437 ' C ' ' O ' ' A' ' 286' ' ' THR . 14.1 t80 -35.24 -50.27 0.53 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.908 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.404 ' HA ' ' CE ' ' A' ' 291' ' ' LYS . 25.2 mm-40 -45.92 -51.06 13.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.85 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.561 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -52.44 -44.36 65.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.098 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.449 HD22 ' HD3' ' A' ' 306' ' ' PRO . 63.0 mt -58.06 -35.15 70.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.897 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.404 ' CE ' ' HA ' ' A' ' 288' ' ' GLU . 35.8 mtmt -70.96 -28.48 64.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.857 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 58.1 mtt-85 -81.79 16.2 1.91 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.46 152.43 41.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.899 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 15.0 mmt85 55.66 42.25 29.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.844 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.5 mmt -101.27 177.94 4.79 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.0 mt -97.01 150.63 20.57 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.3 ttm -165.15 105.15 0.77 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.922 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.646 HG22 ' O ' ' A' ' 298' ' ' ILE . 46.1 mt 57.58 45.84 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.142 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 64.39 28.64 13.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.939 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 1.2 tpm_? -139.73 147.52 41.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.861 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -92.04 125.6 36.79 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.434 HG12 ' HG3' ' A' ' 241' ' ' MET . 6.0 m -101.96 143.0 15.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.124 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.24 109.18 19.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.905 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 289' ' ' ALA . 44.2 t -100.73 111.22 29.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.075 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 96.6 p -145.6 148.2 35.93 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.691 0.758 . . . . 0.0 110.834 -179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.449 ' HD3' HD22 ' A' ' 290' ' ' LEU . 74.6 Cg_exo -48.76 158.68 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.633 2.222 . . . . 0.0 112.361 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -132.7 174.85 9.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.117 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 17.0 p -122.32 134.38 54.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.113 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -38.56 -49.76 1.54 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.917 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.8 mmm180 -44.96 -48.42 11.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.899 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -64.34 -44.25 92.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.568 ' HA ' HD13 ' A' ' 277' ' ' LEU . 49.7 t-105 -54.42 -39.81 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.896 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 97.6 t -71.63 -51.16 34.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.131 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -54.47 -47.38 73.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -51.33 -39.44 56.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.09 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 119.92 36.47 0.82 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.38 177.2 5.96 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.45 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 16.0 t60 -111.38 100.1 8.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.783 0.325 . . . . 0.0 110.851 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.62 115.67 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.177 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 9.6 t -169.62 142.05 2.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.193 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 18.7 m -57.23 176.1 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.875 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 141.96 96.46 0.26 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.459 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.84 166.72 28.66 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.666 2.244 . . . . 0.0 112.364 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 77.5 p -89.78 -10.95 43.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.869 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.8 t . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.88 -179.826 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 22.8 t -105.62 161.91 13.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.845 0.355 . . . . 0.0 110.891 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 16.2 t -62.19 -54.56 39.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.892 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 147.24 162.73 10.14 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.482 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 4.0 m -51.84 111.16 0.56 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.884 0.374 . . . . 0.0 110.872 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 38.1 m -157.57 128.88 6.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.871 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 103.43 75.79 1.09 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.4 ' N ' ' HD2' ' A' ' 225' ' ' LYS . 0.0 OUTLIER -159.58 143.44 10.79 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.606 0.717 . . . . 0.0 110.919 -179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -78.01 82.62 2.39 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.678 2.252 . . . . 0.0 112.331 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 46.1 mt -139.42 154.04 71.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.583 0.706 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -44.96 134.0 10.82 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.687 2.258 . . . . 0.0 112.359 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.667 HG23 ' HG3' ' A' ' 283' ' ' PRO . 90.2 mt -49.04 127.02 4.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.161 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -79.69 139.08 54.33 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.641 0.734 . . . . 0.0 110.926 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.74 -52.5 0.05 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.655 2.237 . . . . 0.0 112.37 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.533 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.5 t70 -44.54 -21.99 0.07 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 235' ' ' TYR . 3.6 m-20 -76.07 -64.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.848 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 54.5 mt -40.55 -27.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.932 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.485 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 1.6 m-85 -99.39 108.56 21.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.432 ' CG1' HD21 ' A' ' 290' ' ' LEU . 3.9 m -124.8 155.57 33.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.132 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.443 ' HA ' HD23 ' A' ' 277' ' ' LEU . 87.2 p -111.24 147.35 35.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.415 ' O ' ' HE1' ' A' ' 241' ' ' MET . 18.7 t -124.73 122.81 64.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.161 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -130.96 127.2 37.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.87 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 123.13 48.87 0.24 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.496 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.415 ' HE1' ' O ' ' A' ' 238' ' ' VAL . 2.6 mpp? -118.12 142.49 31.15 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 110.872 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 56.7 Cg_endo -71.7 170.66 18.13 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.666 2.244 . . . . 0.0 112.352 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -64.25 -33.83 76.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 81.9 p -71.99 -29.88 64.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.476 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -53.68 102.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.07 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.431 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.5 ptp -113.35 173.91 6.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.85 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.431 ' C ' ' O ' ' A' ' 246' ' ' MET . 8.6 tt0 -35.74 -40.98 0.2 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.897 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.61 -51.61 54.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.871 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -49.48 -55.07 14.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.868 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 96.4 t -42.38 -58.65 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.11 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 255' ' ' HIS . 42.7 mtt180 -43.45 -52.73 5.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.88 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 35.4 t70 -34.91 -40.63 0.12 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . . . . . . . . . 20.9 t80 -71.9 -60.45 2.23 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.501 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.2 m-85 -97.14 41.34 1.12 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.891 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.467 ' N ' ' O ' ' A' ' 251' ' ' ARG . 4.5 t60 -82.46 -40.05 21.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.85 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.07 26.34 3.86 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.491 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 28.3 mt -136.02 169.99 16.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.796 0.332 . . . . 0.0 110.895 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 73.8 mtt180 -78.3 99.41 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 58.5 t -93.65 139.25 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.131 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 11.3 t0 -119.27 -50.73 2.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -143.43 155.23 44.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.062 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 93.6 t -140.65 113.71 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.102 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -101.44 137.85 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.85 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 48.9 mt -129.02 130.16 46.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.928 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.692 HD21 ' HB1' ' A' ' 315' ' ' ALA . 27.4 mt -90.09 -177.59 5.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 32.1 mmtm -144.23 172.74 12.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -87.03 -175.68 5.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.53 ' C ' ' CD2' ' A' ' 268' ' ' HIS . 0.7 OUTLIER -50.41 -55.07 17.38 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.932 179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 18.5 m -81.86 -31.24 10.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 130.14 47.06 0.15 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.417 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 62.2 mtm180 -102.44 150.92 22.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.789 0.328 . . . . 0.0 110.863 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.94 54.89 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.881 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -37.31 -35.41 0.11 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 106.69 48.4 0.97 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.521 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 -142.84 137.63 29.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.376 . . . . 0.0 110.881 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -174.72 -175.98 42.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.498 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.483 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 14.8 mt -124.86 176.2 6.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.837 0.351 . . . . 0.0 110.912 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 277' ' ' LEU . 61.3 t -159.98 140.18 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 12.0 ttmt -115.56 161.98 17.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.882 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.482 ' N ' ' CG ' ' A' ' 279' ' ' LYS . 7.2 m-85 -143.34 151.02 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.9 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.9 mt -60.35 -66.76 0.47 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.941 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 6.5 m -97.84 154.51 37.8 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.653 0.739 . . . . 0.0 110.855 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.667 ' HG3' HG23 ' A' ' 229' ' ' ILE . 63.6 Cg_endo -76.69 -21.17 13.03 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.635 2.223 . . . . 0.0 112.366 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -63.08 -48.39 78.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.962 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.87 -34.11 77.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.423 ' O ' ' C ' ' A' ' 287' ' ' PHE . 52.1 m -62.13 -53.75 50.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.102 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.423 ' C ' ' O ' ' A' ' 286' ' ' THR . 7.5 t80 -35.71 -53.81 0.71 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.877 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -44.61 -47.58 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.912 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.501 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -54.17 -56.07 21.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.147 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.574 HD23 HG12 ' A' ' 304' ' ' VAL . 27.4 mt -56.44 -34.45 66.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.938 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt -70.46 -24.58 62.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.876 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -87.1 16.76 4.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.861 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.68 155.88 14.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.872 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 55.5 41.11 31.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.86 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.0 mmt -101.12 166.26 10.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.595 HD21 ' CE1' ' A' ' 301' ' ' TYR . 11.9 mt -99.42 150.28 22.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.952 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 22.4 ttp -170.84 109.94 0.34 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.661 HG22 ' O ' ' A' ' 298' ' ' ILE . 40.1 mt 69.07 34.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.125 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 69.28 25.09 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -140.06 142.92 36.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.894 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.595 ' CE1' HD21 ' A' ' 296' ' ' LEU . 90.3 m-85 -87.55 132.42 34.05 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.933 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.65 140.05 26.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.121 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -108.92 114.96 29.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.88 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.574 HG12 HD23 ' A' ' 290' ' ' LEU . 19.3 t -107.76 114.61 46.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.117 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 4.4 m -146.82 145.25 22.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.637 0.732 . . . . 0.0 110.877 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.435 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.9 Cg_exo -50.5 155.33 5.25 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -126.71 166.57 17.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.144 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.533 HG22 ' OD1' ' A' ' 232' ' ' ASP . 36.7 p -119.5 153.15 35.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.125 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.602 ' O ' HG23 ' A' ' 313' ' ' VAL . 18.6 tt0 -42.97 -33.44 0.8 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.863 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -67.94 -38.24 82.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.843 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 315' ' ' ALA . 14.8 mm100 -71.83 -37.74 70.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.889 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.483 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 65.1 t-105 -72.94 -46.58 51.75 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.896 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 309' ' ' GLU . 94.2 t -68.08 -50.71 56.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.114 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -62.38 -34.96 77.72 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.096 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.692 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -64.77 -34.45 78.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.04 29.85 1.31 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.513 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -65.47 -157.44 0.35 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.48 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -170.46 116.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.761 0.315 . . . . 0.0 110.827 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 8.3 pt -142.54 141.35 27.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.142 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 10.4 t -172.92 145.53 1.42 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.193 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 97.0 p -73.19 156.14 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 70.73 90.1 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.498 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -76.66 -21.51 12.8 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 122.712 2.274 . . . . 0.0 112.369 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 17.1 t 45.48 41.15 6.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.9 -179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.4 p . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.835 -179.849 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 10.0 t -171.54 158.37 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.909 0.385 . . . . 0.0 110.84 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 31.8 p -166.44 142.95 4.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.844 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 126.76 115.88 1.99 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.475 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 24.0 m -161.67 134.03 5.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.881 0.372 . . . . 0.0 110.884 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.4 t -171.0 149.06 2.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.87 -179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 147.56 159.28 8.29 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.462 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -141.75 142.99 27.26 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.885 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -78.99 89.42 1.37 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.689 2.259 . . . . 0.0 112.318 179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 33.1 mt -135.66 155.79 77.97 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.661 0.743 . . . . 0.0 110.925 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -45.33 143.64 5.24 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.704 2.269 . . . . 0.0 112.299 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.584 ' CG2' HD11 ' A' ' 234' ' ' LEU . 43.0 mt -76.61 130.6 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.155 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 18.9 t30 -95.9 109.05 44.48 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.63 0.729 . . . . 0.0 110.899 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -45.86 -56.07 3.13 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.631 2.221 . . . . 0.0 112.358 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -38.43 -50.73 1.54 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.73 -53.16 58.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.584 HD11 ' CG2' ' A' ' 229' ' ' ILE . 19.4 mt -61.47 -30.55 70.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.906 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 279' ' ' LYS . 68.1 m-85 -100.25 97.8 8.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.7 m -116.3 162.58 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.098 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.48 ' HB3' ' CD2' ' A' ' 277' ' ' LEU . 63.9 p -124.04 141.15 52.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.7 ' O ' ' HE3' ' A' ' 241' ' ' MET . 12.9 t -116.33 120.18 64.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.094 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 -119.17 119.69 34.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.824 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.73 49.5 0.18 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.482 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.7 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -121.28 141.29 32.84 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.572 0.701 . . . . 0.0 110.883 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.95 173.09 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -78.08 -33.34 50.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.88 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.0 p -82.4 -15.91 50.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -47.82 130.82 15.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.114 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 16.3 ptp -139.97 174.82 10.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -38.2 -49.35 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.912 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -52.35 -50.32 62.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.925 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -58.39 -61.78 2.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.85 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 94.9 t -40.72 -52.98 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.098 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.42 ' O ' ' C ' ' A' ' 252' ' ' ASP . 13.9 mtp85 -41.69 -56.1 2.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.838 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 251' ' ' ARG . 15.8 t0 -36.32 -38.93 0.17 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.492 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 6.4 t80 -68.54 -63.24 1.1 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.879 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.7 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 17.3 m-85 -99.74 46.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 10.1 t60 -85.45 -36.66 20.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.849 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.29 30.09 3.08 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 52.2 mt -139.89 178.43 7.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.802 0.334 . . . . 0.0 110.927 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.403 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 29.1 mtt85 -83.97 101.46 11.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.89 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 84.1 t -91.33 147.55 5.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.147 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -125.11 -36.91 2.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -172.4 156.64 3.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.093 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 97.4 t -140.15 134.64 36.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.13 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -119.43 143.55 47.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.834 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 43.9 mt -130.85 122.14 26.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.904 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.851 HD21 ' HB1' ' A' ' 315' ' ' ALA . 34.2 mt -68.82 163.74 23.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.922 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 8.8 mmtp -121.35 154.27 36.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.863 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.5 ' OD1' ' N ' ' A' ' 271' ' ' ARG . 0.2 OUTLIER -102.54 -174.61 2.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.882 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.476 ' C ' ' CD2' ' A' ' 268' ' ' HIS . 1.6 t-160 -33.69 -66.16 0.16 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.525 HG23 ' H ' ' A' ' 271' ' ' ARG . 32.4 m -76.35 -44.02 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.157 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.505 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 148.25 -17.51 1.34 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.515 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.525 ' H ' HG23 ' A' ' 269' ' ' VAL . 61.6 mtp180 -52.6 138.88 27.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.873 0.368 . . . . 0.0 110.873 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 6.3 m120 -54.65 84.37 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.893 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.476 ' N ' ' O ' ' A' ' 271' ' ' ARG . 7.7 p-10 -38.41 -54.51 1.46 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.55 37.53 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.501 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -151.11 133.62 15.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.887 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.88 169.77 33.06 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.482 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.48 ' CD2' ' HB3' ' A' ' 237' ' ' SER . 35.4 mt -120.14 162.41 19.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 110.93 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 47.4 t -143.28 135.36 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.127 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 235' ' ' TYR . 3.5 tmtm? -119.33 138.69 52.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.926 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -123.42 155.25 37.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.882 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.0 mt -67.23 -65.34 0.7 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.941 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.3 m -99.89 154.65 37.13 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.689 0.757 . . . . 0.0 110.86 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.36 -11.31 20.84 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.721 2.28 . . . . 0.0 112.384 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 8.0 mp0 -76.99 -15.52 59.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 45.2 m-20 -94.9 -45.85 7.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.4 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 0.8 OUTLIER -57.09 -37.87 72.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.138 -179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.4 ' N ' ' CG2' ' A' ' 286' ' ' THR . 29.1 t80 -55.1 -31.52 61.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.848 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 8.3 mm-40 -69.93 -22.86 63.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.896 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.7 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -84.43 -43.01 15.07 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.116 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 75.8 mt -59.86 -36.47 76.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.953 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.7 ptmt -70.13 -18.17 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.896 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.449 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.7 mtp85 -92.07 14.76 15.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.861 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.17 155.93 23.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.2 mmm-85 57.91 36.35 26.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.449 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 9.4 mmt -100.64 170.37 8.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.3 mt -91.57 157.91 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.927 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . 0.428 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 7.3 ttm -170.56 107.06 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.827 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.583 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.4 mt 60.51 41.23 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.113 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.2 mm100 68.35 26.81 6.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.884 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -140.05 146.22 38.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.849 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 90.3 m-85 -88.94 125.43 34.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.938 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 5.3 m -100.61 144.91 11.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.06 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.03 102.65 10.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.867 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 8.8 t -95.57 110.78 24.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.1 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 80.7 p -143.64 149.58 47.52 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.649 0.737 . . . . 0.0 110.898 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -50.92 155.15 6.16 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.647 2.231 . . . . 0.0 112.362 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.401 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -134.05 169.89 16.46 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 25.3 p -116.25 133.27 56.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.123 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -37.84 -47.79 1.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 68.7 mtt180 -44.06 -52.17 7.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.833 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -61.73 -41.67 97.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.919 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.455 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 24.2 t-105 -58.07 -39.68 79.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.909 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.4 t -78.04 -55.12 10.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.14 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.66 -51.49 48.67 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.851 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -47.44 -39.31 15.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.123 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.28 43.8 0.28 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.46 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -80.65 179.38 53.52 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -122.53 41.87 3.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.762 0.315 . . . . 0.0 110.883 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 14.1 tt -78.69 -7.89 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.151 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 28.1 m -134.63 126.54 29.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.156 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 54.9 p -134.51 148.49 50.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.874 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 118.88 145.92 7.82 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.466 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -78.56 40.4 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.678 2.252 . . . . 0.0 112.354 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 70.3 m -57.91 -49.13 77.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.835 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 39.7 m . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.896 -179.807 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.3 t -150.36 152.16 33.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.855 0.359 . . . . 0.0 110.871 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 3.1 m -155.25 150.17 26.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.845 -179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -137.54 -179.79 17.3 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.711 -0.756 . . . . 0.0 112.501 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.3 m -154.94 165.2 37.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.859 0.362 . . . . 0.0 110.838 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 3.8 t -139.03 154.5 48.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.824 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -141.25 -145.95 4.65 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.525 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -60.09 153.02 58.72 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.92 113.78 3.79 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.704 2.269 . . . . 0.0 112.336 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 17.9 mt -133.03 156.71 79.76 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.627 0.727 . . . . 0.0 110.919 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 229' ' ' ILE . 72.0 Cg_exo -44.91 151.74 0.63 Allowed 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.672 2.248 . . . . 0.0 112.359 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.427 ' C ' ' O ' ' A' ' 228' ' ' PRO . 49.5 mm -35.71 121.61 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.146 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.43 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 12.1 t-20 -67.94 112.58 11.02 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.648 0.737 . . . . 0.0 110.897 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 63.5 Cg_exo -52.56 -51.59 10.78 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.653 2.235 . . . . 0.0 112.332 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -33.78 -41.2 0.09 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.86 179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -66.19 -66.62 0.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.865 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 27.9 mt -49.79 -30.53 9.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.925 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.503 ' CE1' ' HE3' ' A' ' 279' ' ' LYS . 27.8 m-85 -99.59 99.63 10.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.929 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.9 m -113.57 169.92 4.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 24.9 p -127.73 140.91 51.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.887 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.71 ' O ' ' HE3' ' A' ' 241' ' ' MET . 21.2 t -121.99 114.7 43.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -117.65 120.73 38.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.843 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.09 48.69 0.2 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.482 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.71 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 3.0 mpp? -109.69 149.72 40.29 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.551 0.691 . . . . 0.0 110.861 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 59.5 Cg_endo -73.09 154.36 52.34 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.698 2.265 . . . . 0.0 112.336 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -53.25 -26.76 19.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 48.1 m -80.7 -24.5 38.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.879 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.585 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -40.98 110.45 0.16 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.134 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.4 ' SD ' ' OD1' ' A' ' 248' ' ' ASN . 12.3 ptp -122.36 -175.33 3.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.933 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -47.06 -61.58 1.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.867 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.468 ' ND2' ' OD1' ' A' ' 249' ' ' ASP . 1.8 p-10 -47.22 -48.48 24.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.927 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.485 ' OD2' ' CD1' ' A' ' 298' ' ' ILE . 7.2 m-20 -51.98 -50.43 61.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.875 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.59 HG11 ' CG1' ' A' ' 262' ' ' VAL . 74.4 t -52.83 -59.75 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.125 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . . . . . . . . . 16.4 mtp180 -54.54 -45.27 73.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -44.2 -36.98 2.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.838 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.528 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 4.6 t80 -68.72 -61.13 1.94 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.885 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.672 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 15.9 m-85 -100.27 48.26 0.92 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.893 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -86.93 -29.52 22.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.857 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -85.83 24.12 8.18 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.52 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.481 HD21 ' HG3' ' A' ' 288' ' ' GLU . 32.4 mt -138.04 176.28 8.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.809 0.338 . . . . 0.0 110.872 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 32.2 mtt85 -77.61 98.44 5.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 90.5 t -87.78 145.21 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.089 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.555 ' OD2' HD23 ' A' ' 281' ' ' LEU . 1.4 t70 -121.71 -46.99 2.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.842 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.91 163.73 36.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.106 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.59 ' CG1' HG11 ' A' ' 250' ' ' VAL . 81.9 t -139.82 136.39 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 77.1 t60 -128.71 135.0 48.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.854 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.515 HD21 HG21 ' A' ' 250' ' ' VAL . 44.3 mt -128.57 132.36 48.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.948 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.966 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.6 mt -95.63 177.18 5.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.927 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.403 ' C ' ' ND2' ' A' ' 273' ' ' ASN . 21.3 mmtp -134.3 177.39 7.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 271' ' ' ARG . 9.6 t0 -82.98 173.68 11.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.872 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -45.95 -37.44 6.47 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.856 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.492 HG23 ' N ' ' A' ' 270' ' ' GLY . 32.6 m -85.82 -44.7 16.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.083 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.492 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 139.82 38.87 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.446 ' O ' ' N ' ' A' ' 267' ' ' ASP . 67.1 mtt180 -122.24 146.49 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 110.845 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -62.72 100.7 0.21 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.894 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.403 ' ND2' ' C ' ' A' ' 266' ' ' LYS . 2.8 p30 -82.95 -44.07 15.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.916 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 139.02 45.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.488 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -143.37 122.22 12.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.829 0.347 . . . . 0.0 110.882 -179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -154.16 170.35 32.69 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.46 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.428 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 34.0 mt -125.2 161.14 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.87 0.367 . . . . 0.0 110.939 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.599 HG11 ' CZ ' ' A' ' 280' ' ' PHE . 88.6 t -136.01 139.57 45.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.503 ' HE3' ' CE1' ' A' ' 235' ' ' TYR . 0.2 OUTLIER -123.97 130.21 52.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.893 179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.599 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 34.6 m-85 -118.15 174.95 5.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.555 HD23 ' OD2' ' A' ' 260' ' ' ASP . 8.8 mt -89.53 -58.75 2.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 33.6 m -99.66 151.23 37.39 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.673 0.749 . . . . 0.0 110.827 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.68 -29.2 13.18 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.705 2.27 . . . . 0.0 112.364 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 -60.34 -57.99 10.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.888 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -58.5 -32.63 68.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.879 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 28.8 m -61.35 -47.69 84.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.178 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -49.96 -38.79 38.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.843 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 257' ' ' LEU . 53.3 mm-40 -51.6 -29.77 18.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.93 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.672 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -81.42 -48.44 11.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.094 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.658 HD22 ' HD3' ' A' ' 306' ' ' PRO . 48.2 mt -54.27 -30.4 50.51 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.928 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.466 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 3.4 ptmt -79.5 -22.19 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -89.56 21.62 3.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.898 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -68.58 145.99 53.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.901 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 26.6 mmm180 63.8 44.43 4.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.872 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.3 mmt -101.86 178.18 4.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.461 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.6 tp -95.19 122.88 38.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.952 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 3.6 ttm -137.53 107.3 6.24 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.891 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.485 ' CD1' ' OD2' ' A' ' 249' ' ' ASP . 7.1 mt 52.51 42.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 68.49 31.41 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 9.9 tpt85 -140.11 146.54 39.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.898 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.461 ' CE1' HD12 ' A' ' 296' ' ' LEU . 31.7 m-85 -97.75 118.14 33.62 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.93 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 253' ' ' PHE . 15.8 m -100.09 143.14 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.149 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.82 100.61 9.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.869 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.75 124.07 44.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.127 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 8.4 m -158.1 147.21 14.69 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.661 0.743 . . . . 0.0 110.883 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.658 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.2 Cg_exo -49.81 137.69 34.58 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.659 2.24 . . . . 0.0 112.391 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -113.11 -176.84 2.99 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.141 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 309' ' ' GLU . 49.0 p -122.94 125.14 44.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.106 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 308' ' ' THR . 41.5 tt0 -36.65 -44.13 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.5 mmt85 -50.56 -49.24 56.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.868 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 9.1 mm100 -63.29 -40.11 96.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.924 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.547 ' HE1' HG23 ' A' ' 319' ' ' ILE . 14.3 t-105 -61.32 -48.99 78.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.946 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.427 HG22 HG12 ' A' ' 319' ' ' ILE . 88.9 t -66.03 -45.87 89.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.125 179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -58.75 -47.04 86.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.064 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.966 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.09 -40.26 58.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.127 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 126.47 47.81 0.2 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.521 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -79.42 -177.57 50.26 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.493 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -119.78 44.01 2.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 110.824 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.547 HG23 ' HE1' ' A' ' 312' ' ' TRP . 2.6 pp -88.83 165.28 2.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.161 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 19.7 m -163.93 148.98 10.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.108 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 4.3 m -95.93 42.59 1.09 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -121.9 90.02 0.44 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.447 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -77.14 150.02 28.95 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.646 2.23 . . . . 0.0 112.315 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 1.7 t -141.27 159.48 42.14 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 -179.799 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.363 0 N-CA-C 112.476 -0.25 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 97.1 p -88.64 166.05 14.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.864 0.364 . . . . 0.0 110.847 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.3 m -134.81 154.11 51.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -128.75 114.82 1.86 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.553 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 2.2 m -171.71 107.68 0.24 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.837 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 68.3 m -155.25 167.18 31.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.848 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.78 -83.96 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.521 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.46 ' HE3' ' N ' ' A' ' 225' ' ' LYS . 0.2 OUTLIER -55.15 162.42 2.05 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.567 0.699 . . . . 0.0 110.937 179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.31 140.21 21.76 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.712 2.275 . . . . 0.0 112.35 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.68 158.72 55.93 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.616 0.722 . . . . 0.0 110.897 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -44.66 129.59 9.22 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.716 2.278 . . . . 0.0 112.352 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.424 ' O ' ' HD3' ' A' ' 231' ' ' PRO . 82.9 mt -76.11 126.25 36.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.118 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 -100.54 102.54 19.31 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.625 0.726 . . . . 0.0 110.859 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.496 ' HA ' HD12 ' A' ' 234' ' ' LEU . 70.9 Cg_exo -41.89 -58.82 1.04 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.656 2.238 . . . . 0.0 112.4 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.566 ' OD1' HG22 ' A' ' 308' ' ' THR . 1.4 t70 -44.45 -36.44 2.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.912 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -65.76 -39.75 91.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.861 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.496 HD12 ' HA ' ' A' ' 231' ' ' PRO . 12.3 mt -64.43 -25.14 67.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.96 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.464 ' O ' ' N ' ' A' ' 307' ' ' ALA . 60.5 m-85 -99.62 109.58 22.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 5.1 m -129.67 147.76 33.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.185 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.642 ' HA ' HD23 ' A' ' 277' ' ' LEU . 8.7 p -102.74 157.92 16.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.407 HG12 ' SD ' ' A' ' 241' ' ' MET . 19.1 t -135.35 124.39 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.15 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -130.12 121.95 27.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.845 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 131.02 39.71 0.25 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.503 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.407 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.2 mpp? -112.17 135.99 21.34 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.568 0.699 . . . . 0.0 110.865 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.54 173.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.678 2.252 . . . . 0.0 112.322 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 27.1 m-85 -77.48 -34.19 54.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.893 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 47.5 m -78.66 -22.2 47.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.446 ' O ' ' CG ' ' A' ' 272' ' ' ASN . . . -39.67 120.0 1.04 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 2.7 ptt? -118.14 166.52 12.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -39.62 -51.69 2.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.871 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -52.3 -52.8 50.95 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.942 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -48.56 -44.61 36.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.849 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.6 t -49.83 -60.25 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.116 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.5 OUTLIER -39.62 -52.86 2.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.832 -179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.4 t0 -34.89 -40.65 0.12 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 302' ' ' VAL . 10.7 t80 -69.74 -67.76 0.46 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.866 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.496 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 29.4 m-85 -91.61 39.39 1.0 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.877 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t-80 -79.75 -35.16 39.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.828 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.71 23.23 5.86 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.479 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 31.4 mt -136.43 175.47 9.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.85 0.357 . . . . 0.0 110.873 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 59.4 mtt180 -81.59 104.3 11.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.824 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 99.2 t -95.01 130.45 43.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.121 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.22 -49.1 3.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.865 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -148.84 154.5 39.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.112 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.15 115.48 12.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.108 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.421 ' HE2' ' C ' ' A' ' 315' ' ' ALA . 83.5 t60 -110.39 137.82 47.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.821 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.26 154.64 38.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.911 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.719 HD21 ' HB1' ' A' ' 315' ' ' ALA . 12.3 mt -118.8 138.24 52.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.911 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.59 154.86 22.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.956 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.502 ' O ' ' CG ' ' A' ' 268' ' ' HIS . 9.9 t70 -86.16 57.0 4.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.903 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.502 ' CG ' ' O ' ' A' ' 267' ' ' ASP . 41.0 p-80 46.3 30.35 1.0 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 4.1 m -132.71 -31.75 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.118 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 100.34 33.08 5.27 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.497 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 36.7 mtp85 -138.29 144.15 40.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.888 0.375 . . . . 0.0 110.87 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.446 ' CG ' ' O ' ' A' ' 245' ' ' ALA . 15.0 m120 -63.36 115.81 4.94 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.945 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -100.65 -52.34 3.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.857 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 145.61 57.97 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.447 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -168.31 115.05 0.68 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.861 0.362 . . . . 0.0 110.878 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.18 177.1 33.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.482 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.642 HD23 ' HA ' ' A' ' 237' ' ' SER . 62.3 mt -126.39 146.79 49.92 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 0.0 110.884 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 21.6 t -126.13 144.55 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -126.19 135.82 52.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.944 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.439 ' O ' HD22 ' A' ' 234' ' ' LEU . 2.3 m-85 -125.5 144.97 50.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.888 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 14.5 mt -52.51 -63.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.956 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 24.5 m -100.35 157.38 33.91 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.707 0.765 . . . . 0.0 110.83 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -78.92 -20.49 10.23 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.69 2.26 . . . . 0.0 112.384 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -66.78 -29.13 69.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.931 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -74.7 -49.06 22.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.861 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.5 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.2 t -64.97 -44.24 90.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.141 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.5 ' N ' ' CG2' ' A' ' 286' ' ' THR . 81.2 t80 -35.32 -35.51 0.05 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.427 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.7 mm-40 -70.32 -49.12 52.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.912 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.26 -25.62 3.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.145 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 80.1 mt -74.08 -54.81 7.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.951 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.418 ' NZ ' ' HB3' ' A' ' 291' ' ' LYS . 0.0 OUTLIER -61.39 -20.19 62.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.931 179.808 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.5 ' O ' ' CG ' ' A' ' 295' ' ' MET . 36.5 mtt-85 -82.36 -16.14 50.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 13.4 p-10 -42.5 151.8 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 65.46 35.14 7.52 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.5 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.2 mmt -102.48 -175.81 2.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.901 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -97.39 147.03 24.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.916 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . 0.449 ' CE ' ' HB2' ' A' ' 253' ' ' PHE . 2.6 ttt -161.24 107.49 1.4 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.884 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 298' ' ' ILE . 13.8 mt 53.95 45.01 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.147 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 65.57 26.55 11.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.877 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? -139.22 152.39 47.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.914 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -97.14 124.14 41.1 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.936 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.523 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.4 m -99.86 145.59 10.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.152 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -116.73 101.7 8.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.879 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 44.8 t -97.48 131.06 45.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.141 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 81.7 p -156.72 152.15 21.99 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.692 0.758 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -52.02 158.61 4.72 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.707 2.271 . . . . 0.0 112.345 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.464 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.13 165.59 25.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.085 179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.566 HG22 ' OD1' ' A' ' 232' ' ' ASP . 21.7 p -118.96 152.14 36.89 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.134 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.443 ' O ' HG23 ' A' ' 313' ' ' VAL . 29.0 tt0 -41.84 -48.24 4.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 7.1 ttm180 -50.24 -45.08 53.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.847 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -63.12 -49.48 74.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.931 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.46 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 66.2 t-105 -58.2 -50.74 72.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 309' ' ' GLU . 92.3 t -53.78 -58.42 3.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.117 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -56.82 -36.77 70.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.126 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.719 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -58.65 -40.91 84.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.127 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 136.48 36.47 0.19 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.485 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -76.62 177.5 51.44 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.458 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -128.16 83.47 2.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.773 0.321 . . . . 0.0 110.87 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 28.9 pt -152.86 152.18 10.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.118 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 47.0 p -74.7 116.82 15.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.144 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 32.9 p -85.89 -61.8 1.67 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.845 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 100.42 90.69 2.07 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.477 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -77.14 -174.35 2.16 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.697 2.264 . . . . 0.0 112.353 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 22.4 t -147.59 155.08 41.46 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.868 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.87 -179.834 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.246 0 N-CA-C 112.464 -0.254 . . . . 0.0 112.464 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 29.3 t -161.55 166.17 27.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.866 -179.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 4.2 m -165.76 166.03 18.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.856 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 128.46 173.25 13.39 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.465 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 41.4 t -127.4 147.96 50.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.867 0.365 . . . . 0.0 110.911 -179.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 50.9 m -94.61 159.05 15.26 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.876 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -167.15 48.82 0.25 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.452 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.457 ' CD ' ' HD2' ' A' ' 226' ' ' PRO . 0.1 OUTLIER -130.0 137.68 31.42 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.656 0.741 . . . . 0.0 110.854 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . 0.457 ' HD2' ' CD ' ' A' ' 225' ' ' LYS . 62.3 Cg_endo -77.08 107.17 2.38 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.706 2.27 . . . . 0.0 112.327 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.45 154.55 66.06 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.603 0.716 . . . . 0.0 110.926 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 229' ' ' ILE . 61.0 Cg_endo -75.28 156.88 41.82 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.705 2.27 . . . . 0.0 112.346 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.401 ' C ' ' O ' ' A' ' 228' ' ' PRO . 67.6 mt -37.22 134.99 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -84.66 112.95 46.26 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.595 0.712 . . . . 0.0 110.86 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.45 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.3 Cg_exo -45.53 -49.71 10.22 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.638 2.225 . . . . 0.0 112.397 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.45 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.0 OUTLIER -34.14 -52.77 0.47 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 -48.12 -56.06 8.76 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.886 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 12.7 mt -58.25 -30.05 66.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.914 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.527 ' CZ ' ' HD3' ' A' ' 279' ' ' LYS . 22.9 m-85 -100.0 98.39 9.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.876 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.409 HG22 ' HE1' ' A' ' 280' ' ' PHE . 14.7 m -117.4 141.57 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.09 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.603 ' HA ' HD23 ' A' ' 277' ' ' LEU . 95.7 p -97.62 149.04 22.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.842 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.667 HG12 ' SD ' ' A' ' 241' ' ' MET . 46.5 t -127.26 117.46 47.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.166 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -122.35 119.25 30.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.818 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 133.68 34.25 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.486 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.667 ' SD ' HG12 ' A' ' 238' ' ' VAL . 3.7 mpp? -105.14 139.74 20.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.571 0.7 . . . . 0.0 110.907 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.93 174.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.677 2.251 . . . . 0.0 112.33 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -80.07 -28.55 39.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 92.1 p -86.54 -20.38 28.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.842 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -39.72 132.09 1.72 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.442 ' O ' ' C ' ' A' ' 247' ' ' GLU . 9.8 ptt? -131.44 160.68 34.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.877 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.478 ' HA ' HD11 ' A' ' 264' ' ' LEU . 0.8 OUTLIER -35.1 -41.18 0.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.28 -65.25 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.876 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -37.91 -49.73 1.25 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.86 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 98.2 t -42.34 -56.28 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.495 ' O ' ' N ' ' A' ' 255' ' ' HIS . 14.8 mtp85 -40.32 -53.48 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 251' ' ' ARG . 20.5 t70 -36.73 -39.21 0.2 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.878 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 292' ' ' ARG . 19.7 t80 -73.83 -58.3 3.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.86 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.58 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 35.6 m-85 -100.08 42.23 1.12 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.886 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.495 ' N ' ' O ' ' A' ' 251' ' ' ARG . 3.7 t60 -79.9 -44.6 20.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.885 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -81.78 32.9 2.63 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.52 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 63.0 mt -140.08 174.43 10.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.423 ' HB2' ' CG ' ' A' ' 285' ' ' ASP . 56.8 mtt180 -80.44 95.46 6.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.849 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 54.1 t -90.2 135.48 26.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.129 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.427 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 0.0 OUTLIER -114.41 -44.58 3.09 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -158.77 164.86 35.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.092 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 87.0 t -145.13 129.57 12.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.124 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.465 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 20.8 t60 -120.41 138.15 53.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.853 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.478 HD11 ' HA ' ' A' ' 247' ' ' GLU . 74.4 mt -128.01 157.72 39.86 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.949 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.53 HD21 ' HB1' ' A' ' 315' ' ' ALA . 16.4 mt -122.6 166.45 14.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.935 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.445 ' HD2' ' N ' ' A' ' 266' ' ' LYS . 0.0 OUTLIER -134.61 176.4 8.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.835 179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -80.45 179.82 7.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.863 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.427 ' CD2' HG13 ' A' ' 269' ' ' VAL . 9.3 p-80 -47.29 -42.76 21.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.852 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.432 HG23 ' N ' ' A' ' 270' ' ' GLY . 28.1 m -77.62 -42.37 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.126 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.432 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 131.11 38.49 0.28 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.495 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 52.6 mtt-85 -115.13 123.5 49.11 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.866 0.365 . . . . 0.0 110.835 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -51.02 112.83 0.78 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.858 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.524 ' H ' ' ND2' ' A' ' 273' ' ' ASN . 0.6 OUTLIER -91.48 -57.27 2.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.895 179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 158.43 46.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.501 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.432 ' ND2' ' OD1' ' A' ' 273' ' ' ASN . 1.8 p30 -145.02 120.04 10.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.807 0.337 . . . . 0.0 110.94 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -156.16 157.77 28.11 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.471 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.603 HD23 ' HA ' ' A' ' 237' ' ' SER . 54.1 mt -110.68 155.51 22.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.952 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.412 ' CG1' ' CZ ' ' A' ' 280' ' ' PHE . 55.4 t -132.17 137.89 53.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.148 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.527 ' HD3' ' CZ ' ' A' ' 235' ' ' TYR . 16.0 tptm -115.61 149.48 38.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.901 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.449 ' N ' ' HG3' ' A' ' 279' ' ' LYS . 38.9 m-85 -136.89 152.82 50.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.01 -67.6 0.44 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.87 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 7.7 m -97.18 158.4 33.33 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.658 0.742 . . . . 0.0 110.861 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.9 -47.09 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.635 2.223 . . . . 0.0 112.369 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -48.51 -24.33 1.26 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . 0.423 ' CG ' ' HB2' ' A' ' 258' ' ' ARG . 8.1 m-20 -76.43 -57.12 4.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.885 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.467 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.0 OUTLIER -56.34 -41.3 75.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.142 -179.893 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.467 ' N ' ' CG2' ' A' ' 286' ' ' THR . 9.5 t80 -36.54 -34.46 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 286' ' ' THR . 57.8 mm-40 -73.47 -47.97 37.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.879 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.58 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -50.95 -39.08 54.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.123 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.621 HD22 ' HD3' ' A' ' 306' ' ' PRO . 36.5 mt -56.97 -45.55 82.8 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -67.32 -40.22 85.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.932 179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.477 ' O ' ' CG ' ' A' ' 295' ' ' MET . 47.1 mtp85 -51.62 -26.01 8.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.889 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.483 ' ND2' ' HG2' ' A' ' 294' ' ' ARG . 5.5 t30 -36.73 151.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.91 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.483 ' HG2' ' ND2' ' A' ' 293' ' ' ASN . 21.4 mmm180 63.91 42.52 5.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . 0.477 ' CG ' ' O ' ' A' ' 292' ' ' ARG . 1.6 mmm -106.13 169.77 8.3 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.9 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.597 HD12 ' CE1' ' A' ' 301' ' ' TYR . 1.6 tp -100.03 120.85 40.47 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.956 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 29.3 ttp -147.75 106.2 3.78 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 298' ' ' ILE . 22.9 mt 68.09 50.12 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.113 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.489 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 8.8 pt20 48.7 30.23 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.932 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 20.3 tpp180 -139.48 138.58 36.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.878 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.597 ' CE1' HD12 ' A' ' 296' ' ' LEU . 37.0 m-85 -89.21 126.75 35.62 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 11.8 m -100.56 149.85 5.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.189 179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 10.3 tt0 -122.53 99.86 6.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.882 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.8 t -96.62 133.79 36.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.149 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 11.3 m -160.42 151.4 15.7 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.676 0.75 . . . . 0.0 110.887 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.621 ' HD3' HD22 ' A' ' 290' ' ' LEU . 77.4 Cg_exo -50.55 152.83 8.49 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.343 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.13 178.0 7.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.125 179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 44.9 p -122.33 153.72 38.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.625 ' O ' HG23 ' A' ' 313' ' ' VAL . 0.6 OUTLIER -52.41 -35.99 53.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.854 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 1.3 tmt_? -54.76 -48.8 72.17 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.841 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 37.7 mt-30 -63.47 -49.12 74.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.886 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.465 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 66.0 t-105 -55.36 -48.94 73.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.894 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 309' ' ' GLU . 74.4 t -60.44 -62.56 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.16 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.13 -42.96 20.26 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.082 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -55.46 -41.99 73.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.149 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.24 42.06 0.34 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.532 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -67.83 -177.76 12.1 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.501 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.492 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 39.6 t60 -124.96 84.39 2.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.775 0.321 . . . . 0.0 110.858 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 17.2 pt -123.72 166.45 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.162 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -155.98 169.86 23.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.145 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 1.2 t -110.68 95.24 5.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 166.43 166.35 25.33 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.439 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.83 116.94 4.35 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.636 2.224 . . . . 0.0 112.309 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 15.9 m -94.68 -59.94 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.826 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 45.7 p . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.848 -179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 57.5 p -128.72 -43.59 1.38 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.904 0.383 . . . . 0.0 110.891 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 33.0 p -130.51 83.27 2.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.871 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -114.77 -142.15 7.78 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.489 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 67.7 p -174.87 130.49 0.32 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.855 0.36 . . . . 0.0 110.846 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 78.9 p -111.34 141.41 44.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.854 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.98 -163.67 19.96 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 47.4 mmtt -105.93 156.62 36.36 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.539 0.685 . . . . 0.0 110.905 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -44.78 99.87 0.03 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.627 2.218 . . . . 0.0 112.338 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 8.9 mt -119.66 157.59 51.66 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.634 0.731 . . . . 0.0 110.863 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -76.12 155.32 37.83 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.659 2.239 . . . . 0.0 112.356 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.6 mm -48.97 125.93 3.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.099 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.425 ' CG ' ' OD1' ' A' ' 232' ' ' ASP . 42.0 t-20 -89.77 111.36 45.74 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.621 0.724 . . . . 0.0 110.865 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.421 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.4 Cg_exo -44.37 -39.86 12.71 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.688 2.258 . . . . 0.0 112.321 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.425 ' OD1' ' CG ' ' A' ' 230' ' ' ASN . 1.2 p-10 -35.81 -39.77 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.88 -63.04 1.25 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.87 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 29.8 mt -47.87 -30.45 4.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.924 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 279' ' ' LYS . 77.7 m-85 -100.4 99.26 9.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 6.4 m -111.9 174.93 2.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.123 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.712 ' OG ' ' HB2' ' A' ' 307' ' ' ALA . 1.1 m -131.82 145.09 51.37 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.551 ' O ' ' HE3' ' A' ' 241' ' ' MET . 5.7 t -122.72 122.12 65.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.132 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -127.54 125.16 39.85 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.828 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 115.53 46.03 0.59 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.506 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.551 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.8 mpp? -112.38 140.91 24.25 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.578 0.704 . . . . 0.0 110.893 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -47.04 161.68 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.688 2.259 . . . . 0.0 112.285 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 272' ' ' ASN . 69.8 t80 -62.13 -37.54 85.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.863 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 53.5 p -79.46 -20.32 47.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.842 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.459 ' O ' ' ND2' ' A' ' 272' ' ' ASN . . . -38.82 114.17 0.36 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.114 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.407 ' O ' ' C ' ' A' ' 247' ' ' GLU . 1.7 ptt? -128.66 171.75 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.887 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 246' ' ' MET . 7.6 mt-10 -37.01 -38.41 0.19 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.895 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -64.69 -55.4 20.3 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.856 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -45.68 -43.45 12.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.846 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.846 HG21 HG11 ' A' ' 262' ' ' VAL . 83.8 t -49.8 -53.45 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.068 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 255' ' ' HIS . 66.6 mtt180 -41.84 -60.1 1.48 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -40.96 -34.75 0.44 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.825 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.504 ' CZ ' HG21 ' A' ' 302' ' ' VAL . 9.1 t80 -75.45 -59.07 2.91 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.41 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 44.4 m-85 -100.31 43.42 1.06 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.858 -179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 6.1 t60 -79.26 107.07 11.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.842 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.91 -23.51 3.53 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.488 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 12.4 mt -100.49 152.25 20.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.76 0.314 . . . . 0.0 110.956 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.562 ' HD2' HD12 ' A' ' 281' ' ' LEU . 4.2 mmt180 -57.7 122.12 12.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.4 t -100.33 128.63 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.404 ' CG ' ' HD2' ' A' ' 279' ' ' LYS . 0.0 OUTLIER -102.34 -42.98 5.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.837 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -174.72 144.37 0.82 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.086 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . 0.846 HG11 HG21 ' A' ' 250' ' ' VAL . 73.0 t -127.31 112.34 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.496 ' O ' HD23 ' A' ' 264' ' ' LEU . 83.3 t60 -101.5 139.32 37.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.8 179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 263' ' ' HIS . 28.8 mt -138.71 106.85 5.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.907 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 26.3 mt -54.18 154.51 4.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.928 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -121.36 165.89 14.87 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.914 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.403 ' OD1' ' O ' ' A' ' 271' ' ' ARG . 1.0 OUTLIER -66.16 -175.48 0.33 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.911 179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.564 ' CD2' HG13 ' A' ' 269' ' ' VAL . 25.9 p-80 -61.32 -32.17 72.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.839 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.564 HG13 ' CD2' ' A' ' 268' ' ' HIS . 34.7 m -87.41 -44.36 16.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.119 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.5 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 139.49 41.65 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.489 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.459 ' HG2' ' CG2' ' A' ' 269' ' ' VAL . 5.1 ptt85 -128.82 125.3 37.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.341 . . . . 0.0 110.909 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.574 ' O ' ' CE1' ' A' ' 243' ' ' PHE . 21.4 t-20 -38.21 143.33 0.13 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.89 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -118.69 -45.88 2.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.915 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.32 35.68 0.12 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.475 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -152.2 121.51 6.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.889 0.376 . . . . 0.0 110.845 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.45 ' H ' ' HE3' ' A' ' 241' ' ' MET . . . -157.7 -171.32 23.53 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.476 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 13.8 mt -130.1 173.91 10.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.7 t -153.11 136.6 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.112 179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 235' ' ' TYR . 2.8 tmtt? -121.24 146.49 46.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.91 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.525 ' CD1' ' OG1' ' A' ' 286' ' ' THR . 10.9 m-85 -128.11 135.6 50.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.867 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.562 HD12 ' HD2' ' A' ' 258' ' ' ARG . 16.2 mt -50.74 -58.89 4.81 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.902 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.7 m -99.76 153.46 37.76 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.706 0.765 . . . . 0.0 110.873 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.55 -45.58 0.15 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.698 2.265 . . . . 0.0 112.383 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -44.84 -29.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -77.7 -50.81 11.67 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.901 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.525 ' OG1' ' CD1' ' A' ' 280' ' ' PHE . 22.3 m -51.22 -45.33 61.9 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.139 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . . . . . . . . . 10.7 t80 -37.8 -47.94 1.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.865 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -57.6 -44.47 85.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.93 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 286' ' ' THR . . . -57.49 -47.43 81.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.11 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.508 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -60.06 -23.31 63.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.873 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -87.81 -15.74 36.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.872 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 39.0 mtp85 -93.18 17.34 11.19 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.857 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.53 170.75 7.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 40.8 mmm-85 38.89 48.27 1.35 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.859 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 19.5 mtt -109.12 174.73 5.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.512 HD12 ' CE1' ' A' ' 301' ' ' TYR . 3.0 tp -97.57 124.22 41.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . 0.434 ' SD ' HG11 ' A' ' 302' ' ' VAL . 3.7 ttm -136.57 111.34 8.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.881 179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.665 HG22 ' O ' ' A' ' 298' ' ' ILE . 52.0 mt 48.97 43.58 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.179 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 65.2 mt-30 68.06 28.98 6.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 -139.82 139.44 36.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.834 -179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.512 ' CE1' HD12 ' A' ' 296' ' ' LEU . 25.6 m-85 -86.94 119.01 26.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.906 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.504 HG21 ' CZ ' ' A' ' 253' ' ' PHE . 11.7 m -100.51 135.18 37.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.163 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -105.56 113.64 27.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.869 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 22.1 t -105.46 114.69 45.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.133 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 84.1 p -149.1 146.34 21.17 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.699 0.761 . . . . 0.0 110.831 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.508 ' HD3' HD22 ' A' ' 290' ' ' LEU . 75.2 Cg_exo -48.65 161.74 0.44 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.674 2.25 . . . . 0.0 112.372 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.712 ' HB2' ' OG ' ' A' ' 237' ' ' SER . . . -137.74 179.98 6.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 74.3 p -124.39 145.24 49.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.138 -179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -39.11 -44.58 1.18 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.905 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.61 -53.77 50.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.898 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -54.67 -48.39 72.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 71.9 t-105 -55.74 -52.14 64.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.911 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 98.6 t -61.19 -57.86 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.098 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.96 -52.82 18.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.114 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . . . . . . . . . . . -50.35 -40.43 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.118 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 122.08 42.4 0.44 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.476 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -83.95 154.94 31.14 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.529 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -104.95 121.63 44.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.727 0.298 . . . . 0.0 110.869 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 2.6 pt -127.75 133.93 66.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.103 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 27.9 m -165.16 128.51 2.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.17 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 75.7 m -143.46 176.28 9.3 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 133.91 -152.03 20.4 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.5 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.29 -11.64 17.45 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.694 2.262 . . . . 0.0 112.384 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 14.4 m -84.75 167.62 15.94 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.861 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 9.7 t . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.86 -179.805 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 5.9 t -125.43 171.21 10.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.863 0.363 . . . . 0.0 110.873 -179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 70.2 m -123.95 -58.36 1.57 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.818 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 95.17 109.93 2.36 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.476 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.406 ' O ' ' C ' ' A' ' 223' ' ' SER . 89.2 p -171.54 169.99 5.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.909 0.385 . . . . 0.0 110.87 -179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.406 ' C ' ' O ' ' A' ' 222' ' ' SER . 37.7 t -38.16 147.42 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.858 -179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 162.65 159.46 10.38 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.488 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 23.7 mmtp -69.6 160.28 80.25 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.597 0.713 . . . . 0.0 110.891 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.96 87.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.688 2.258 . . . . 0.0 112.33 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 10.5 mt -88.37 157.35 50.37 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.649 0.738 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -44.62 137.77 8.38 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.631 2.22 . . . . 0.0 112.409 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 87.5 mt -38.64 150.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -96.88 109.13 47.34 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.608 0.718 . . . . 0.0 110.895 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 73.3 Cg_exo -47.85 -48.97 14.66 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.707 2.272 . . . . 0.0 112.32 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 64.2 m-20 -37.46 -44.71 0.66 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.804 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.87 -63.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.859 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 17.9 mt -45.09 -31.26 1.31 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.934 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.588 ' O ' ' HB3' ' A' ' 307' ' ' ALA . 78.1 m-85 -99.88 98.88 9.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.983 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.1 m -114.01 146.26 18.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -104.94 151.22 24.16 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.853 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.478 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.7 t -129.48 116.15 37.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.146 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 54.9 m-70 -119.07 124.99 48.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.864 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 121.68 51.7 0.24 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.475 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.478 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.4 mpp? -119.73 139.66 28.36 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.537 0.684 . . . . 0.0 110.902 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.36 144.2 10.11 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.647 2.232 . . . . 0.0 112.408 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -52.57 -32.37 40.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.884 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 245' ' ' ALA . 85.7 p -79.96 -24.11 41.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.847 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 244' ' ' SER . . . -35.26 139.16 0.11 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.126 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 7.3 ptp -139.42 171.01 14.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.855 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -43.06 -41.04 3.37 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.905 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 25.6 t30 -60.53 -59.42 5.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.874 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -44.05 -49.79 8.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.899 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 95.3 t -50.5 -55.88 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.107 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' A' ' 252' ' ' ASP . 27.3 mtp85 -41.84 -55.54 3.02 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.811 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 9.0 t0 -37.38 -38.6 0.24 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.83 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.485 ' CD1' ' CE1' ' A' ' 254' ' ' PHE . 9.1 t80 -67.59 -64.48 0.85 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.892 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.676 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 26.4 m-85 -100.06 47.36 0.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.861 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . . . . . . . . . 6.3 p-80 -85.47 -37.69 19.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.856 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.38 30.37 3.07 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.505 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 68.0 mt -139.18 179.85 6.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.818 0.342 . . . . 0.0 110.903 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 36.5 mtt85 -81.0 96.02 6.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.94 130.72 37.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.132 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -109.88 -46.21 3.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.865 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -161.12 164.51 30.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.042 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 90.5 t -138.99 140.9 37.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.094 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -130.39 136.78 49.42 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 36.9 mt -134.02 132.09 39.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.983 HD21 ' HB1' ' A' ' 315' ' ' ALA . 19.2 mt -93.08 143.96 25.73 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.921 179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -123.94 150.54 44.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.87 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.503 ' OD2' HG13 ' A' ' 269' ' ' VAL . 8.1 t70 -66.16 168.48 8.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.854 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.468 ' N ' ' CG ' ' A' ' 267' ' ' ASP . 3.7 p80 -51.44 -21.55 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 270' ' ' GLY . 32.7 m -78.68 -45.75 25.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.163 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.51 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 125.06 30.01 0.97 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 53.3 mtt180 -128.73 165.07 21.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.359 . . . . 0.0 110.895 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.16 128.2 35.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.914 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 267' ' ' ASP . 0.4 OUTLIER -100.06 -48.1 4.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 142.83 47.09 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.481 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -162.18 124.64 2.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 110.855 -179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -145.28 175.3 24.93 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.494 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.433 ' HB3' ' CE3' ' A' ' 312' ' ' TRP . 20.1 mt -138.6 130.51 28.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.828 0.347 . . . . 0.0 110.949 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 88.9 t -113.87 141.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.135 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.464 ' HG3' ' CE2' ' A' ' 235' ' ' TYR . 0.0 OUTLIER -126.93 140.38 52.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.907 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 280' ' ' PHE . 1.1 m-85 -125.48 176.43 6.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 13.0 mt -84.1 -62.55 1.54 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 68.6 m -99.56 152.77 37.92 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.638 0.732 . . . . 0.0 110.884 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.8 -27.53 12.36 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.684 2.256 . . . . 0.0 112.351 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -57.36 -53.07 62.27 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.89 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -65.05 -34.42 78.38 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.877 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 287' ' ' PHE . 81.9 m -63.41 -55.43 24.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.444 ' C ' ' O ' ' A' ' 286' ' ' THR . 2.8 t80 -34.36 -53.66 0.51 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.859 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -41.39 -53.66 3.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.676 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -47.31 -42.09 20.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.123 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.404 HD22 ' HD3' ' A' ' 306' ' ' PRO . 39.4 mt -61.79 -42.43 98.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.04 -14.62 55.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.946 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 20.9 mtp85 -96.93 14.66 24.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.85 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -65.0 152.35 43.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 57.56 37.55 27.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.901 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 3.1 mtt -100.27 178.39 4.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.893 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 12.8 mt -99.14 155.95 17.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.937 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.9 ttm -169.0 105.12 0.4 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.859 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 298' ' ' ILE . 24.2 mt 61.0 40.79 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 68.31 27.35 6.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -139.94 139.08 36.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.841 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -85.53 127.56 34.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.429 HG21 ' CE2' ' A' ' 253' ' ' PHE . 5.5 m -104.29 146.96 11.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -112.95 97.53 6.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 16.3 t -94.84 122.44 46.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.12 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 49.9 m -158.29 158.27 29.64 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.662 0.744 . . . . 0.0 110.868 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.404 ' HD3' HD22 ' A' ' 290' ' ' LEU . 60.3 Cg_exo -53.13 161.91 3.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.682 2.254 . . . . 0.0 112.338 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 235' ' ' TYR . . . -137.61 -175.17 3.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.095 179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 309' ' ' GLU . 31.3 p -131.96 132.3 43.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.174 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.407 ' C ' ' O ' ' A' ' 308' ' ' THR . 13.1 tt0 -37.47 -46.23 0.79 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.882 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -48.21 -46.45 35.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.85 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -65.94 -39.35 90.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.95 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.433 ' CE3' ' HB3' ' A' ' 277' ' ' LEU . 42.8 t-105 -64.33 -41.36 96.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.872 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.5 t -70.32 -51.72 35.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.134 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -57.0 -45.29 83.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.079 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.983 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -52.21 -37.01 53.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.063 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 125.7 30.83 0.86 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.464 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -62.44 126.04 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.492 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -46.12 -37.21 6.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 110.865 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.849 HD13 ' N ' ' A' ' 320' ' ' THR . 0.0 OUTLIER -42.14 121.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.164 179.936 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.849 ' N ' HD13 ' A' ' 319' ' ' ILE . 14.2 t -152.2 151.91 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.183 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 41.6 m -61.49 110.44 1.46 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.877 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 171.45 88.61 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.481 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.85 121.32 5.82 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.687 2.258 . . . . 0.0 112.309 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 82.9 p -120.3 148.57 43.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.821 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 8.5 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.855 -179.798 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 N-CA-C 112.457 -0.257 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 7.6 t -113.2 88.29 2.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.883 0.373 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 27.8 m -143.43 170.73 15.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.903 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -166.41 -126.66 0.84 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.47 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 92.2 p -161.99 151.17 15.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.862 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 25.8 p -163.55 164.35 24.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.818 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -165.39 60.83 0.24 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.492 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . 0.534 ' O ' HD12 ' A' ' 227' ' ' LEU . 42.3 mttt -127.08 144.23 49.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.597 0.713 . . . . 0.0 110.908 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -76.98 90.51 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.67 2.246 . . . . 0.0 112.325 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.534 HD12 ' O ' ' A' ' 225' ' ' LYS . 5.9 mp -110.1 154.2 42.87 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.606 0.717 . . . . 0.0 110.892 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.19 158.15 33.65 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.549 HG21 ' HG3' ' A' ' 283' ' ' PRO . 25.0 mt -75.04 134.18 29.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.101 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -86.73 112.46 47.09 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.617 0.723 . . . . 0.0 110.892 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.409 ' O ' ' C ' ' A' ' 232' ' ' ASP . 72.5 Cg_exo -45.31 -30.27 5.26 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.677 2.252 . . . . 0.0 112.34 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 231' ' ' PRO . 0.5 OUTLIER -36.34 -39.86 0.21 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.921 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -71.91 -59.1 2.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.843 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 231' ' ' PRO . 14.4 mt -47.91 -29.38 3.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.895 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.568 ' CE2' ' HD3' ' A' ' 279' ' ' LYS . 87.5 m-85 -99.68 100.05 10.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 16.3 m -116.0 166.54 9.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.584 ' HA ' HD23 ' A' ' 277' ' ' LEU . 43.8 p -121.6 145.12 48.31 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.504 ' O ' ' CE ' ' A' ' 241' ' ' MET . 17.1 t -127.63 114.72 37.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.124 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 18.1 m-70 -117.71 121.41 40.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.851 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 130.31 40.21 0.26 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.488 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.535 ' HE1' ' N ' ' A' ' 276' ' ' GLY . 2.9 mpp? -114.77 134.09 22.48 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.56 0.695 . . . . 0.0 110.872 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -46.84 173.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.675 2.25 . . . . 0.0 112.314 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 54.2 m-85 -69.16 -39.81 78.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.896 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 75.6 m -72.87 -24.73 60.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.877 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -37.0 122.5 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.054 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.44 ' O ' ' C ' ' A' ' 247' ' ' GLU . 15.4 ptp -138.32 173.61 11.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 246' ' ' MET . 18.5 tt0 -35.18 -49.53 0.49 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.872 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -53.74 -52.35 60.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -47.18 -57.25 5.35 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.871 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 97.5 t -41.95 -54.86 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.583 HH12 HG11 ' A' ' 259' ' ' VAL . 1.6 mpt_? -47.26 -44.5 22.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.907 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . . . . . . . . . 15.2 t0 -51.93 -32.69 34.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.882 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.463 ' HB2' ' CE ' ' A' ' 297' ' ' MET . 27.3 t80 -84.02 -46.56 11.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.884 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.534 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 48.0 m-85 -100.25 36.23 1.91 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.427 ' N ' ' O ' ' A' ' 251' ' ' ARG . 2.1 t-160 -75.6 106.17 7.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.845 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 134.26 -17.07 4.33 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.417 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -105.79 147.44 28.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.849 0.357 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.517 ' HB3' HD12 ' A' ' 281' ' ' LEU . 9.7 mmp_? -55.82 122.91 12.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.875 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.583 HG11 HH12 ' A' ' 251' ' ' ARG . 45.5 t -100.53 124.55 54.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.072 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . 0.432 ' OD1' ' C ' ' A' ' 260' ' ' ASP . 2.6 t0 -101.16 -44.4 5.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.862 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 279' ' ' LYS . . . -163.67 157.7 19.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.7 t -137.57 138.6 44.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.122 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.402 ' O ' HD23 ' A' ' 264' ' ' LEU . 79.8 t60 -134.78 150.0 50.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 263' ' ' HIS . 9.7 mt -148.16 125.86 11.84 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.922 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 1.07 HD21 ' HB1' ' A' ' 315' ' ' ALA . 58.2 mt -73.91 139.85 45.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.916 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.446 ' HB3' ' N ' ' A' ' 271' ' ' ARG . 32.9 mttp -120.51 167.16 12.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.662 ' OD2' HG22 ' A' ' 269' ' ' VAL . 16.8 t0 -65.86 166.35 11.35 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.862 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . 0.582 ' CE1' HG13 ' A' ' 269' ' ' VAL . 13.3 p-80 -48.52 -29.34 4.08 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.662 HG22 ' OD2' ' A' ' 267' ' ' ASP . 8.6 m -86.13 -28.15 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.132 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 118.13 41.47 0.64 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.467 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.649 ' HG2' HG23 ' A' ' 269' ' ' VAL . 20.4 mmt180 -122.75 114.19 20.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.798 0.333 . . . . 0.0 110.906 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 271' ' ' ARG . 23.8 t-20 -35.32 108.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.56 HD22 ' ND2' ' A' ' 275' ' ' ASN . 0.6 OUTLIER -76.71 -41.01 46.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.899 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.409 ' O ' ' CE ' ' A' ' 241' ' ' MET . . . 154.21 -48.06 0.52 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.508 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.56 ' ND2' HD22 ' A' ' 273' ' ' ASN . 0.3 OUTLIER -71.33 155.51 40.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.851 0.357 . . . . 0.0 110.867 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.535 ' N ' ' HE1' ' A' ' 241' ' ' MET . . . -168.18 -174.77 37.3 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.476 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.584 HD23 ' HA ' ' A' ' 237' ' ' SER . 25.4 mt -141.39 156.03 45.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.795 0.331 . . . . 0.0 110.958 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 95.4 t -136.82 149.76 26.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 235' ' ' TYR . 19.8 tptm -134.98 136.41 42.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.928 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -119.63 168.89 10.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.881 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 258' ' ' ARG . 27.3 mt -72.04 -63.62 1.1 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.895 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 31.7 m -100.09 154.64 37.12 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.893 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.549 ' HG3' HG21 ' A' ' 229' ' ' ILE . 61.5 Cg_endo -76.34 -17.21 16.88 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.707 2.271 . . . . 0.0 112.331 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -67.73 -50.45 57.29 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.916 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -63.98 -42.03 97.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.443 ' O ' ' C ' ' A' ' 287' ' ' PHE . 90.0 m -54.01 -55.77 24.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.111 -179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.443 ' C ' ' O ' ' A' ' 286' ' ' THR . 4.5 t80 -34.57 -50.12 0.43 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.836 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -45.04 -49.68 11.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.534 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -51.74 -50.73 60.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.452 HD22 ' HD3' ' A' ' 306' ' ' PRO . 46.9 mt -51.36 -35.01 36.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.937 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . . . . . . . . . 31.4 mttp -67.75 -26.98 66.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.879 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 253' ' ' PHE . 23.5 mtp85 -84.08 16.67 2.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -67.96 150.01 49.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.875 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 9.6 mmm180 61.6 34.48 17.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.894 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 4.9 mmt -102.64 175.78 5.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.923 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.9 mt -93.52 157.02 16.41 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.867 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . 0.503 ' SD ' HG11 ' A' ' 302' ' ' VAL . 8.2 ttm -169.65 105.27 0.35 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.855 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.611 HG22 ' O ' ' A' ' 298' ' ' ILE . 26.5 mt 61.19 39.59 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.178 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 7.9 mm-40 70.49 26.09 4.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.95 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -139.87 150.64 44.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.856 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -92.12 123.55 35.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.973 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.503 HG11 ' SD ' ' A' ' 297' ' ' MET . 11.8 m -100.08 141.42 17.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.127 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -111.54 108.29 17.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.906 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.4 HG12 HD23 ' A' ' 290' ' ' LEU . 42.6 t -102.18 120.38 51.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 6.4 m -155.74 150.51 20.47 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.63 0.728 . . . . 0.0 110.878 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.452 ' HD3' HD22 ' A' ' 290' ' ' LEU . 78.4 Cg_exo -50.56 155.34 5.35 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.711 2.274 . . . . 0.0 112.374 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -136.54 165.14 26.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.071 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.416 ' O ' ' C ' ' A' ' 309' ' ' GLU . 20.3 p -110.09 130.33 55.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.111 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 308' ' ' THR . 32.1 tt0 -35.64 -45.28 0.36 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 13.6 ttp-105 -49.14 -49.83 40.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -62.94 -46.03 89.68 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.875 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.549 ' CD1' ' HA3' ' A' ' 317' ' ' GLY . 11.6 t-105 -56.44 -48.06 77.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 95.8 t -61.23 -58.69 6.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -49.17 -51.56 31.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.123 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 1.07 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -49.07 -42.96 40.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.09 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 141.61 39.06 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.492 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . 0.549 ' HA3' ' CD1' ' A' ' 312' ' ' TRP . . . -69.32 136.68 28.53 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.515 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.421 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 28.9 t60 -95.89 89.6 5.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.744 0.307 . . . . 0.0 110.856 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 23.5 pt -125.58 147.02 30.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.1 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 81.2 p -90.33 171.87 9.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.13 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 36.7 t -102.63 -58.11 1.93 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.86 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -171.59 162.63 35.14 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -45.5 119.93 2.96 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.696 2.264 . . . . 0.0 112.377 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 2.2 m -125.7 103.11 7.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.8 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 26.5 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.862 -179.865 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.374 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 19.3 m -88.49 134.58 33.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.883 0.373 . . . . 0.0 110.85 -179.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 96.6 p -85.72 -25.06 26.68 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.831 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 120.94 148.59 8.01 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.512 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 84.2 p -154.88 150.47 27.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 0.0 110.875 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 28.6 m -136.76 153.34 50.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.827 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 123.26 -73.89 0.39 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.456 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.73 153.44 49.19 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.588 0.709 . . . . 0.0 110.903 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.84 146.58 26.45 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.7 2.267 . . . . 0.0 112.376 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.1 pp -78.42 153.33 79.01 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.62 0.724 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.0 143.24 28.81 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 122.65 2.233 . . . . 0.0 112.338 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 66.9 mt -51.68 130.71 12.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.132 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -93.49 110.92 49.9 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.622 0.725 . . . . 0.0 110.878 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 233' ' ' ASP . 73.4 Cg_exo -48.09 -47.05 20.45 Favored 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.712 2.275 . . . . 0.0 112.3 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 231' ' ' PRO . 100.0 m-20 -35.85 -34.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.866 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 231' ' ' PRO . 9.2 t0 -76.33 -65.2 0.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 283' ' ' PRO . 27.2 mt -46.04 -25.75 0.62 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.932 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.539 ' CE2' ' HD2' ' A' ' 279' ' ' LYS . 2.1 m-85 -100.14 105.87 17.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.44 HG22 ' HE1' ' A' ' 280' ' ' PHE . 4.0 m -125.95 154.35 34.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.072 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.474 ' HG ' ' CE1' ' A' ' 239' ' ' HIS . 29.6 t -113.6 153.64 28.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.499 ' O ' ' CE ' ' A' ' 241' ' ' MET . 22.6 t -129.57 115.01 32.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . 0.474 ' CE1' ' HG ' ' A' ' 237' ' ' SER . 38.8 m-70 -119.17 124.41 46.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.823 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 126.69 40.89 0.33 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.486 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.499 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -115.33 134.76 22.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.604 0.716 . . . . 0.0 110.88 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -47.24 155.86 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.672 2.248 . . . . 0.0 112.334 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -66.69 -8.98 31.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 68.3 p -102.0 -13.63 17.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -51.41 120.83 5.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.104 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.424 ' O ' ' C ' ' A' ' 247' ' ' GLU . 2.2 ptt? -117.21 163.57 16.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 246' ' ' MET . 10.6 tt0 -36.31 -37.97 0.14 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -63.82 -53.0 57.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.886 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -50.59 -51.89 44.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . 0.472 HG21 HD21 ' A' ' 264' ' ' LEU . 87.3 t -49.46 -55.71 4.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.137 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.0 mtt-85 -40.79 -56.51 2.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.849 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 251' ' ' ARG . 18.3 t0 -35.78 -39.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.851 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.476 ' CE2' HG21 ' A' ' 302' ' ' VAL . 12.1 t80 -69.75 -63.53 1.06 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.879 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.436 ' CE1' ' CD1' ' A' ' 253' ' ' PHE . 21.9 m-85 -97.9 44.12 1.05 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.849 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.401 ' N ' ' O ' ' A' ' 251' ' ' ARG . 15.1 t-80 -83.8 -37.12 22.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.839 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . -82.69 26.38 4.17 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.527 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.572 HD21 ' CD ' ' A' ' 288' ' ' GLU . 56.9 mt -135.89 -178.6 5.21 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.844 0.355 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 82.2 mtt180 -87.21 106.45 17.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.876 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 92.7 t -94.71 134.85 30.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.144 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -116.35 -45.34 2.83 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.885 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -162.61 137.67 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.089 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.48 137.96 51.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.117 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -124.3 135.79 53.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.874 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . 0.472 HD21 HG21 ' A' ' 250' ' ' VAL . 85.4 mt -133.42 131.11 39.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.93 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.565 HD21 ' HB1' ' A' ' 315' ' ' ALA . 25.5 mt -86.27 166.6 15.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.907 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 13.7 mmtp -125.08 170.37 11.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.946 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -78.01 174.87 10.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.873 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -45.29 -37.9 5.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.835 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 270' ' ' GLY . 35.3 m -81.97 -45.66 19.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.107 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.506 ' N ' HG23 ' A' ' 269' ' ' VAL . . . 137.91 32.49 0.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.501 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . 0.5 ' HD2' HG21 ' A' ' 269' ' ' VAL . 21.3 mtt-85 -119.96 130.67 54.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.815 0.34 . . . . 0.0 110.849 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 19.4 m120 -41.55 136.41 1.84 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.911 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.3 -47.75 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.878 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 143.83 40.79 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.497 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -151.6 118.02 5.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.914 0.388 . . . . 0.0 110.868 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.11 -176.86 27.79 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.46 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 312' ' ' TRP . 18.0 mt -125.75 169.27 12.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 62.7 t -152.26 141.98 15.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.099 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . 0.539 ' HD2' ' CE2' ' A' ' 235' ' ' TYR . 1.6 mtpm? -115.38 166.97 11.28 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.917 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.443 ' O ' HD22 ' A' ' 234' ' ' LEU . 12.7 m-85 -152.45 139.21 18.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 16.4 mt -53.31 -63.73 1.05 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.938 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -99.57 144.37 28.18 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.639 0.733 . . . . 0.0 110.893 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.5 ' HA ' HD23 ' A' ' 234' ' ' LEU . 59.0 Cg_endo -72.22 -21.7 23.16 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.382 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 32.5 tp60 -63.12 -40.02 96.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -71.95 -38.96 69.71 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.839 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.403 ' O ' ' C ' ' A' ' 287' ' ' PHE . 33.8 m -55.87 -48.98 74.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.153 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.467 ' CD1' ' HE2' ' A' ' 291' ' ' LYS . 2.7 t80 -37.36 -50.92 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.853 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.572 ' CD ' HD21 ' A' ' 257' ' ' LEU . 14.0 mt-10 -43.87 -50.78 7.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.912 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.404 ' C ' HG11 ' A' ' 304' ' ' VAL . . . -49.36 -50.13 41.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.088 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 31.7 mt -54.07 -44.93 71.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.912 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.467 ' HE2' ' CD1' ' A' ' 287' ' ' PHE . 50.0 mttt -60.84 -25.03 66.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.898 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 26.1 mtt-85 -89.24 14.42 11.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.868 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.467 ' ND2' ' HD3' ' A' ' 294' ' ' ARG . 38.8 t30 -65.62 146.36 54.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.857 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.467 ' HD3' ' ND2' ' A' ' 293' ' ' ASN . 0.4 OUTLIER 63.52 35.56 11.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.906 -179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 2.9 mmt -100.51 171.1 7.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.892 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . . . . . . . . . 11.1 mt -92.05 156.71 17.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.889 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 6.8 ttm -169.54 104.97 0.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.893 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.534 HG22 ' O ' ' A' ' 298' ' ' ILE . 17.7 mt 61.94 41.46 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.143 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 69.06 25.84 5.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.9 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -140.13 146.43 38.84 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -91.39 126.73 36.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.909 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.476 HG21 ' CE2' ' A' ' 253' ' ' PHE . 3.0 m -101.69 144.04 13.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.151 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -112.18 113.63 25.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.871 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.404 HG11 ' C ' ' A' ' 289' ' ' ALA . 39.9 t -103.36 119.89 52.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.103 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . 0.419 ' HA ' ' HD3' ' A' ' 306' ' ' PRO . 81.1 p -151.94 145.34 17.58 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.674 0.749 . . . . 0.0 110.843 -179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 305' ' ' SER . 67.9 Cg_exo -51.88 164.94 0.91 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.678 2.252 . . . . 0.0 112.348 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.412 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -139.08 178.19 7.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.057 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 309' ' ' GLU . 16.7 p -131.27 138.33 49.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.127 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.45 ' C ' ' O ' ' A' ' 308' ' ' THR . 40.7 tt0 -34.6 -46.24 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 17.7 mtp180 -50.24 -50.92 48.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.888 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . 0.406 ' N ' ' O ' ' A' ' 308' ' ' THR . 70.0 mt-30 -59.86 -52.57 64.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.935 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.464 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 45.5 t-105 -52.16 -51.09 60.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.947 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 86.2 t -62.33 -59.31 4.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.36 -51.21 20.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.098 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.565 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -51.82 -40.98 61.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.102 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 129.25 49.74 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.471 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . -69.62 120.37 9.95 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.498 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.44 ' O ' ' C ' ' A' ' 319' ' ' ILE . 7.7 m170 -38.7 -45.99 1.18 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.776 0.322 . . . . 0.0 110.848 -179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.44 ' C ' ' O ' ' A' ' 318' ' ' HIS . 41.1 pt -34.11 149.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.109 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 25.7 m -160.62 124.32 3.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 9.6 t -67.74 145.8 54.38 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.885 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 144.3 102.62 0.39 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.469 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.6 106.94 2.35 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.359 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 5.0 t -89.63 111.34 22.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.876 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.874 -179.827 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.466 -0.254 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 15.2 t -140.95 124.55 16.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.869 0.366 . . . . 0.0 110.876 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 47.6 t -100.13 131.46 46.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.852 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 116.39 148.58 9.07 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.518 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 3.0 m -117.96 127.31 53.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.848 0.356 . . . . 0.0 110.842 -179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 56.9 m -64.36 167.54 6.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.85 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -140.07 -124.35 2.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.517 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.41 143.05 81.18 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.573 0.702 . . . . 0.0 110.868 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.45 141.61 10.41 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.645 2.23 . . . . 0.0 112.322 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 37.5 mt -135.25 157.2 77.23 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.591 0.71 . . . . 0.0 110.933 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -44.16 154.05 0.29 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.736 2.291 . . . . 0.0 112.345 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.73 HG23 ' HG3' ' A' ' 283' ' ' PRO . 85.3 mt -37.55 127.67 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.108 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -71.22 136.68 84.32 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.644 0.735 . . . . 0.0 110.87 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.65 -50.23 0.11 Allowed 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.71 2.273 . . . . 0.0 112.313 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -43.46 -44.05 5.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.89 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -51.79 -51.2 58.13 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.875 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 9.7 mt -64.55 -27.18 68.78 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.857 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . 0.45 ' O ' ' N ' ' A' ' 307' ' ' ALA . 96.4 m-85 -101.6 99.09 9.34 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.906 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 10.5 m -113.23 157.59 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.155 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.785 ' HA ' HD23 ' A' ' 277' ' ' LEU . 67.4 p -114.12 142.88 45.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.424 ' O ' ' CE ' ' A' ' 241' ' ' MET . 23.9 t -126.13 116.09 44.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.169 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 99.9 m-70 -122.17 126.42 48.26 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 125.69 40.73 0.37 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.424 ' CE ' ' O ' ' A' ' 238' ' ' VAL . 3.1 mpp? -110.25 137.71 20.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.858 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.84 -179.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.622 2.214 . . . . 0.0 112.362 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -81.55 -35.75 29.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 46.4 p -78.79 -21.39 47.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.863 -179.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . . . . . . . . . . . -41.1 123.6 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.127 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . 0.457 ' O ' ' C ' ' A' ' 247' ' ' GLU . 5.1 ptp -127.45 163.8 23.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . 0.457 ' C ' ' O ' ' A' ' 246' ' ' MET . 26.1 tt0 -34.2 -37.79 0.06 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.874 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . 0.416 ' N ' ' O ' ' A' ' 246' ' ' MET . 15.3 t-20 -64.73 -64.65 0.82 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.892 -179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -40.13 -38.64 0.78 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.878 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 72.4 t -52.68 -55.45 11.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.415 ' O ' ' N ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -43.9 -51.89 7.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.862 -179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 251' ' ' ARG . 5.5 t70 -36.89 -39.61 0.23 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.862 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.431 ' CD2' ' CE1' ' A' ' 254' ' ' PHE . 20.9 t80 -69.86 -65.8 0.67 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.885 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.819 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 37.9 m-85 -92.36 40.15 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.919 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.415 ' N ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t60 -82.86 104.75 13.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.829 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.29 3.55 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.507 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . . . . . . . . . 14.4 mt -103.48 167.59 9.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.804 0.335 . . . . 0.0 110.948 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 40.1 mtm180 -67.73 100.54 0.93 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.854 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 97.5 t -93.19 127.98 44.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.1 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -100.15 -46.17 5.4 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.876 179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -168.48 159.19 10.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.106 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 86.6 t -135.45 118.22 22.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.141 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . 0.4 ' HB2' ' CH2' ' A' ' 312' ' ' TRP . 64.1 t60 -101.77 140.06 36.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.819 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 67.9 mt -133.16 141.34 48.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.922 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.695 HD21 ' HB1' ' A' ' 315' ' ' ALA . 18.6 mt -101.13 174.92 5.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.423 ' HB3' ' C ' ' A' ' 270' ' ' GLY . 15.5 mmtp -136.5 168.87 18.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.863 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -71.12 -176.53 1.44 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -36.6 67.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.811 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 16.6 m -89.71 -18.01 7.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.124 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . 0.423 ' C ' ' HB3' ' A' ' 266' ' ' LYS . . . 109.9 43.01 1.15 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.484 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 56.6 mtp180 -121.56 133.91 55.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.845 0.355 . . . . 0.0 110.901 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -51.89 124.72 13.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.874 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -112.18 -44.65 3.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.882 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 140.36 40.68 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . 0.41 ' HB2' HD12 ' A' ' 265' ' ' LEU . 5.2 p30 -138.42 112.01 8.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 0.0 110.874 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -147.12 166.26 28.5 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.519 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.785 HD23 ' HA ' ' A' ' 237' ' ' SER . 76.1 mt -121.81 146.95 46.57 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.84 0.353 . . . . 0.0 110.914 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . . . . . . . . . 64.4 t -118.4 140.15 43.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.15 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.03 124.68 44.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.948 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -109.84 162.63 14.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.901 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 65.7 mt -77.57 -65.24 0.99 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.911 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 49.9 m -99.98 154.25 37.34 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.633 0.73 . . . . 0.0 110.86 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.73 ' HG3' HG23 ' A' ' 229' ' ' ILE . 60.6 Cg_endo -74.93 -0.93 10.53 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.689 2.259 . . . . 0.0 112.308 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -86.17 -41.03 15.03 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.893 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.52 -50.9 67.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.902 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.52 ' CG2' ' N ' ' A' ' 287' ' ' PHE . 1.6 t -45.63 -46.18 14.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.52 ' N ' ' CG2' ' A' ' 286' ' ' THR . 65.3 t80 -42.58 -31.97 0.51 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.872 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.483 ' HA ' ' CD ' ' A' ' 291' ' ' LYS . 13.6 mm-40 -74.23 -35.84 63.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.897 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.819 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -73.57 -42.62 61.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.431 HD22 ' HD3' ' A' ' 306' ' ' PRO . 58.0 mt -58.97 -45.27 90.96 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.483 ' CD ' ' HA ' ' A' ' 288' ' ' GLU . 5.5 ptmt -62.8 -20.22 64.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 28.9 mtp85 -89.28 13.63 12.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . 0.469 ' ND2' ' HE ' ' A' ' 294' ' ' ARG . 0.6 OUTLIER -59.77 141.83 54.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.469 ' HE ' ' ND2' ' A' ' 293' ' ' ASN . 0.6 OUTLIER 62.26 53.3 2.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 8.3 mmt -103.99 169.34 8.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.539 HD12 ' CE1' ' A' ' 301' ' ' TYR . 2.0 tp -100.1 118.46 36.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.867 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 15.5 ttp -146.2 107.32 4.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.543 HG22 ' O ' ' A' ' 298' ' ' ILE . 33.6 mt 68.63 53.23 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.065 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . 0.461 ' CG ' ' O ' ' A' ' 298' ' ' ILE . 5.7 pt20 48.25 25.04 0.77 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.923 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -140.18 132.84 28.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.872 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . 0.539 ' CE1' HD12 ' A' ' 296' ' ' LEU . 10.1 m-85 -80.82 149.02 29.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.952 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 4.7 m -123.8 138.19 54.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.108 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -105.95 107.46 18.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.25 119.19 50.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.098 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 85.4 p -153.1 147.96 19.56 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.646 0.736 . . . . 0.0 110.842 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.431 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.0 Cg_exo -49.51 154.43 4.32 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.68 2.253 . . . . 0.0 112.387 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . 0.45 ' N ' ' O ' ' A' ' 235' ' ' TYR . . . -137.18 169.5 17.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.114 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 309' ' ' GLU . 26.4 p -106.51 129.03 54.54 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.14 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 308' ' ' THR . 9.8 tm-20 -36.72 -43.92 0.45 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -48.77 -49.5 38.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.929 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -59.97 -41.06 91.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.4 ' CH2' ' HB2' ' A' ' 263' ' ' HIS . 39.8 t-105 -56.64 -47.25 80.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.919 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 87.3 t -67.21 -59.3 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.122 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -47.44 -51.4 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.089 179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.695 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.1 -42.88 30.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . -179.86 -41.75 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.508 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 76.34 78.57 0.69 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.476 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . 0.474 ' O ' ' CD2' ' A' ' 318' ' ' HIS . 22.6 t60 -103.03 41.06 1.29 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.779 0.323 . . . . 0.0 110.873 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . . . . . . . . . 10.8 tt -89.05 139.28 17.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.097 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 23.3 m -110.02 -54.06 2.61 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.153 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 6.0 t -62.67 103.08 0.39 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.89 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . -132.96 61.86 0.65 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.464 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -77.44 143.47 21.91 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.666 2.244 . . . . 0.0 112.31 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 83.5 p -112.23 -11.77 13.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.869 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 60.7 p . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.848 -179.802 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.3 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' SER . . . . . . . . . . . . . 2.1 t -119.91 86.04 2.49 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.869 0.366 . . . . 0.0 110.794 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' SER . . . . . . . . . . . . . 9.4 t 56.59 42.87 26.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.866 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -167.93 92.67 0.1 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . . . . . . . . . 58.4 m -147.2 168.64 21.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.91 0.386 . . . . 0.0 110.872 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 69.7 m -125.57 167.47 15.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.854 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -169.05 134.61 3.27 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.531 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.56 122.69 0.37 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.604 0.716 . . . . 0.0 110.907 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -77.05 92.79 1.1 Allowed 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.7 2.266 . . . . 0.0 112.365 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 71.0 mt -124.61 155.78 68.9 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 110.931 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -75.29 135.36 18.45 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.659 2.239 . . . . 0.0 112.303 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 42.8 mt -63.37 135.63 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.152 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ASN . . . . . 0.451 ' ND2' ' OD1' ' A' ' 232' ' ' ASP . 28.9 t30 -100.11 106.46 41.77 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.668 0.747 . . . . 0.0 110.883 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.401 ' O ' ' C ' ' A' ' 232' ' ' ASP . 71.6 Cg_exo -46.1 -63.02 0.36 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.685 2.257 . . . . 0.0 112.347 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ASP . . . . . 0.451 ' OD1' ' ND2' ' A' ' 230' ' ' ASN . 8.0 p-10 -36.72 -47.08 0.64 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -55.04 -60.65 3.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.857 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LEU . . . . . . . . . . . . . 19.1 mt -48.75 -28.72 3.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -99.78 98.63 9.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.94 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.408 ' CG2' ' HB ' ' A' ' 278' ' ' VAL . 16.6 m -109.8 170.75 3.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.083 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' SER . . . . . 0.562 ' HA ' HD23 ' A' ' 277' ' ' LEU . 63.8 p -131.58 146.01 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' VAL . . . . . 0.55 ' O ' ' HE3' ' A' ' 241' ' ' MET . 38.8 t -129.4 115.99 37.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.14 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' HIS . . . . . . . . . . . . . 8.2 m-70 -118.1 130.42 56.12 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.863 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' GLY . . . . . . . . . . . . . . . 116.65 51.98 0.37 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.498 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' MET . . . . . 0.55 ' HE3' ' O ' ' A' ' 238' ' ' VAL . 2.7 mpp? -120.23 143.1 34.96 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.625 0.726 . . . . 0.0 110.823 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 245' ' ' ALA . 58.0 Cg_endo -71.29 156.95 58.14 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.655 2.236 . . . . 0.0 112.337 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -52.82 -33.61 49.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' SER . . . . . . . . . . . . . 29.8 t -71.53 -29.09 64.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . . . -45.53 112.79 0.5 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.088 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' MET . . . . . . . . . . . . . 19.8 ptp -126.23 173.32 9.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -37.61 -56.9 1.0 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.86 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -49.56 -58.32 5.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.857 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ASP . . . . . 0.533 ' OD1' HD11 ' A' ' 298' ' ' ILE . 30.6 m-20 -41.65 -48.0 4.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.876 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' VAL . . . . . . . . . . . . . 61.7 t -46.53 -57.48 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.104 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ARG . . . . . 0.406 ' O ' ' C ' ' A' ' 252' ' ' ASP . 31.4 mtp180 -40.74 -61.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ASP . . . . . 0.406 ' C ' ' O ' ' A' ' 251' ' ' ARG . 21.6 t70 -36.93 -36.72 0.12 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.875 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' PHE . . . . . 0.44 ' CD2' ' CZ ' ' A' ' 254' ' ' PHE . 12.5 t80 -71.42 -63.54 1.1 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.868 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PHE . . . . . 0.891 ' CE1' ' HB1' ' A' ' 289' ' ' ALA . 45.5 m-85 -95.12 41.98 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.851 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' HIS . . . . . 0.54 ' CG ' ' O ' ' A' ' 255' ' ' HIS . 0.3 OUTLIER -84.93 100.62 11.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.816 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' GLY . . . . . . . . . . . . . . . 140.87 -14.25 2.87 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.485 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' LEU . . . . . 0.459 HD21 ' OE1' ' A' ' 288' ' ' GLU . 21.4 mt -102.49 172.59 6.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.81 0.338 . . . . 0.0 110.942 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 48.7 mtt180 -76.33 86.16 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.92 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -77.52 138.99 19.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.127 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -115.16 -48.39 2.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' ALA . . . . . . . . . . . . . . . -160.56 162.82 33.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.065 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' VAL . . . . . . . . . . . . . 70.6 t -135.36 128.31 48.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.136 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' HIS . . . . . . . . . . . . . 50.7 t60 -112.42 140.18 47.37 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.866 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' LEU . . . . . . . . . . . . . 65.0 mt -142.22 138.18 31.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.697 HD21 ' HB1' ' A' ' 315' ' ' ALA . 29.4 mt -87.49 168.85 12.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -129.68 -175.83 3.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.886 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.435 ' CG ' ' HB3' ' A' ' 273' ' ' ASN . 4.8 m-20 -116.31 -60.32 1.87 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -131.77 -75.14 0.51 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.891 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . . . . . . . . . 27.4 m -103.84 43.82 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' GLY . . . . . . . . . . . . . . . 81.32 37.85 16.66 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.504 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -98.47 122.1 41.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.836 0.35 . . . . 0.0 110.882 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -49.46 116.7 1.84 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.89 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ASN . . . . . 0.435 ' HB3' ' CG ' ' A' ' 267' ' ' ASP . 9.8 p-10 -88.99 -43.64 10.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.922 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 131.5 40.9 0.22 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.443 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -163.83 131.6 3.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.905 0.383 . . . . 0.0 110.878 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -158.98 174.54 35.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.498 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 237' ' ' SER . 18.9 mt -128.29 169.03 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.849 0.357 . . . . 0.0 110.898 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' VAL . . . . . 0.408 ' HB ' ' CG2' ' A' ' 236' ' ' VAL . 62.1 t -138.4 142.34 35.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' LYS . . . . . . . . . . . . . 41.1 tptt -119.09 145.69 45.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.878 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' PHE . . . . . 0.408 ' CZ ' HG11 ' A' ' 278' ' ' VAL . 93.2 m-85 -134.9 161.85 34.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.868 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.83 -60.96 2.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.872 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 12.3 m -100.07 152.66 37.89 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.663 0.744 . . . . 0.0 110.843 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' PRO . . . . . 0.438 ' HA ' HG22 ' A' ' 286' ' ' THR . 61.5 Cg_endo -76.7 -2.07 12.25 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.689 2.259 . . . . 0.0 112.349 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -86.09 -47.65 9.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.912 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.45 -37.37 86.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.907 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.642 HG23 ' N ' ' A' ' 287' ' ' PHE . 15.3 t -67.65 -52.33 39.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.142 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' PHE . . . . . 0.642 ' N ' HG23 ' A' ' 286' ' ' THR . 0.1 OUTLIER -41.53 -32.45 0.35 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 -179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.459 ' OE1' HD21 ' A' ' 257' ' ' LEU . 46.3 mt-10 -63.77 -68.02 0.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.896 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.891 ' HB1' ' CE1' ' A' ' 254' ' ' PHE . . . -33.3 -45.91 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.072 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.679 ' HA ' HG12 ' A' ' 304' ' ' VAL . 60.9 mt -49.95 -51.21 43.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.943 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 288' ' ' GLU . 5.1 pttt -57.86 -16.66 12.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.951 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ARG . . . . . . . . . . . . . 23.1 mtp180 -92.5 25.77 2.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -74.12 155.65 38.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.86 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 12.4 mmm180 63.09 36.11 12.47 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.87 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' MET . . . . . . . . . . . . . 9.6 mmm -100.43 177.84 4.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.912 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 296' ' ' LEU . 12.2 mt -96.95 151.27 19.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.901 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' MET . . . . . . . . . . . . . 8.0 ttm -164.92 106.71 0.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.876 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 298' ' ' ILE . 57.3 mt 56.7 45.9 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.11 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 65.23 25.9 12.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.925 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -140.01 146.81 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.861 -179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -90.84 130.77 36.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . . . . . . . . . 7.0 m -106.96 143.51 17.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -110.78 97.26 6.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.679 HG12 ' HA ' ' A' ' 290' ' ' LEU . 80.8 t -89.77 114.18 27.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.137 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' SER . . . . . . . . . . . . . 70.4 m -150.38 144.63 17.63 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.647 0.737 . . . . 0.0 110.879 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . 0.607 ' HD3' HD22 ' A' ' 290' ' ' LEU . 76.1 Cg_exo -49.52 155.95 3.19 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.688 2.259 . . . . 0.0 112.319 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' ALA . . . . . . . . . . . . . . . -137.53 -175.29 4.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.145 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' THR . . . . . . . . . . . . . 36.9 p -124.81 152.78 43.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.147 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -50.79 -46.28 59.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.863 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.0 mtm180 -48.43 -53.09 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLN . . . . . . . . . . . . . 73.7 mt-30 -59.12 -43.7 91.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' TRP . . . . . 0.477 ' HA ' ' CD1' ' A' ' 277' ' ' LEU . 33.8 t-105 -59.29 -45.68 90.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.927 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' VAL . . . . . . . . . . . . . 85.8 t -68.22 -53.61 27.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.118 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -50.54 -51.71 45.29 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.07 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ALA . . . . . 0.697 ' HB1' HD21 ' A' ' 265' ' ' LEU . . . -48.21 -43.22 31.83 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.105 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' GLY . . . . . . . . . . . . . . . 173.92 -40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.463 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' GLY . . . . . . . . . . . . . . . 78.77 109.54 0.21 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.545 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -109.13 -45.85 3.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.828 0.347 . . . . 0.0 110.896 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ILE . . . . . 0.474 HG13 ' N ' ' A' ' 320' ' ' THR . 20.5 pt -39.9 -34.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.139 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.474 ' N ' HG13 ' A' ' 319' ' ' ILE . 69.4 p 33.97 41.97 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.097 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' SER . . . . . . . . . . . . . 82.7 p -63.76 153.41 36.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLY . . . . . . . . . . . . . . . 134.08 161.97 9.8 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.473 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.69 168.92 22.76 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.7 2.267 . . . . 0.0 112.314 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 80.1 p -128.1 -36.14 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 32.4 m . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.853 -179.827 . . . . . . . . 0 0 . 1 stop_ save_